gene_symbol,polymorphism_id,position,significance,p_value,reference,sex_of_organism,longevity_effect,ethnicity,data_type,age_related_change_type,polymorphism_type,nucleotide_change,amino_acid_change,polymorphism_other,allele_variant,non_associated_allele,frequency_controls,frequency_experiment,n_of_controls,n_of_experiment,mean_age_of_controls,min_age_of_controls,max_age_of_controls,mean_age_of_experiment,min_age_of_experiment,max_age_of_experiment,study_type ,pmid,comment_ru,comment_en
ABCC4,rs4148544,intron,Significant,0.00977,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,24.6,29.7,,1173,,60,75,,85,105,GWAS,,,
ABO,rs514659,,Non-significant,0.147,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
ABO,rs2519093,,Non-significant,0.062,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,C,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
ABO,rs514659,,Non-significant,0.302,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
ABO,rs2519093,,Non-significant,0.784,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,C,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
ABO,rs2519093,,Significant,0.000000019,10.7554/eLife.39856.001,both,increased parental lifespan,European,genomic,,SNP,,,,C,,,,,1012240,,,,71.63,40,117,iGWAS,,,
ABO ,rs514659,intron,Significant,0.000000251,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/C,,,A,C,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
ABO ,rs545971,intron,Significant,0.000000256,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,C/T,,,C,T,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
ABO ,rs612169,intron,Significant,0.000000259,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,A,G,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
ABO ,rs687289,intron,Significant,0.000000226,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,G,G,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
ABO ,rs687621,intron,Significant,0.000000239,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,A,G,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
ABO ,rs674302,intron,Significant,0.000000285,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/T,,,T,A,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
ABO ,rs529565,intron,Significant,0.000000308,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,C/T,,,T,C,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
ABO ,rs505922,intron,Significant,0.000000379,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,C/T,,,T,C,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
ABO ,rs643434,intron,Significant,0.00000122,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,G,A,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
ABO ,rs644234,intron,Significant,0.00000135,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,G/T,,,T,G,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
ABO ,rs657152,intron,Significant,0.000000583,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/C,,,C,A,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
ACE,rs1799752,,Significant,0.045,10.1177/0003319712475075,both,longevity,Greek,genomic,,In/Del,,,,In,Del,41,62,105,12,,18,80,,99,,candidate genes study,,,
ADCY1,multiple,,Significant,0.0424,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,,,,,,,,,500,450,73.14,43,93,98.21,95,110,gene-based association approach,,,SKAT analysis
ADIPOQ,rs1063539,,Non-significant,0.2,10.1073/pnas.0801030105,male,longevity,Japanese,genomic,,SNP,,,,major,,26.3,29.7,402,213,,,81,,95,,candidate genes study,,,
ADIPOQ,rs182052,,Non-significant,0.22,10.1073/pnas.0801030105,male,longevity,Japanese,genomic,,SNP,,,,major,,50.7,54.5,402,213,,,81,,95,,candidate genes study,,,
ADIPOQ,rs266729,,Non-significant,0.08,10.1073/pnas.0801030105,male,longevity,Japanese,genomic,,SNP,,,,major,,76.1,80.5,402,213,,,81,,95,,candidate genes study,,,
ADIPOQ,,,Significant,0.026,,both,longevity,Polish,genomic,decreased gene expression,SNP,-11391G > A,,,A,G,,,414,148,,,,,,,candidate genes study,23339001,,
ADRA1A,,3'UTR,Significant,0.0145,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,T,C,99.1,99.9,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
ADRB2,rs1042718,,Significant,,10.1111/acel.12011,both,longevity,Chinese,genomic,,SNP,C/A,,,A,C,29.7,34.7,1028,963,46.2,,,101.5,,,candidate genes study,,,
ADRB2,rs1042719,,Significant,,10.1111/acel.12011,both,longevity,Chinese,genomic,,SNP,G/C,,,C,G,39.9,46,1028,963,46.2,,,101.5,,,candidate genes study,,,
AFX,rs12116012,,Non-significant,"0,41",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AFX,rs5981072,,Non-significant,"0,74",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AFX,rs5980742,,Non-significant,"0,66",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AFX,rs1130009,,Non-significant,"0,98",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AFX,rs12857595,,Non-significant,"0,92",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AFX,rs11574625,,Non-significant,"0,89",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AFX,rs12840573,,Non-significant,"0,64",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AGER,,,Non-significant,,10.3390/ijms141123203,both,longevity,Caucasian,genomic,,SNP,-374T/A,,,A,T,46,47,135,119,62,,79,93,90,,candidate genes study,,,
AGER,,,Significant,0.028,10.3390/ijms141123203,male,longevity,Caucasian,genomic,,SNP,-374T/A,,,AA,"TT, AT",18,43,56,28,,,79,,90,,candidate genes study,,,
AGTR1,rs2272656,,Non-significant,,10.1007/s11357-012-9408-8,both,longevity,Italian,genomic,,SNP,A>G,,,,,,,376,173,65.9,49,78,100.9,99,106,candidate genes study,,,
AGTR1,rs5182,,Non-significant,0.818,10.1007/s11357-012-9408-8,both,longevity,Italian,genomic,,SNP,C>T,,,C,,"0,58,8",59.6,376,173,65.9,49,78,100.9,99,106,candidate genes study,,,
AGTR1,rs12721225,,Non-significant,0.332,10.1007/s11357-012-9408-8,both,longevity,Italian,genomic,,SNP,G>T,,,G,,99.2,99.7,376,173,65.9,49,78,100.9,99,106,candidate genes study,,,
AGTR1,rs5183,,Non-significant,0.716,10.1007/s11357-012-9408-8,both,longevity,Italian,genomic,,SNP,A>G,,,A,,94.4,95,376,173,65.9,49,78,100.9,99,106,candidate genes study,,,
AGTR1,rs5186,,Non-significant,0.302,10.1007/s11357-012-9408-8,both,longevity,Italian,genomic,,SNP,A>C,,,C,,2.8,3.1,376,173,65.9,49,78,100.9,99,106,candidate genes study,,,
AGTR1,rs5189,,Non-significant,0.379,10.1007/s11357-012-9408-8,both,longevity,Italian,genomic,,SNP,G>T,,,G,,94.6,95.9,376,173,65.9,49,78,100.9,99,106,candidate genes study,,,
AGTR1,rs380400,,Non-significant,,10.1007/s11357-012-9408-8,both,longevity,Italian,genomic,,SNP,G>A,,,,,,,376,173,65.9,49,78,100.9,99,106,candidate genes study,,,
AGTR1,rs275653,,Non-significant,0.555,10.1007/s11357-012-9408-8,both,longevity,Japanese,genomic,decreased gene expression,SNP,A>G,,,G,,8.4,9.2,442,598,70.1,69,72,104.5,99,115,candidate genes study,,,
AGTR1,rs422858,,Significant,0.007,10.1007/s11357-012-9408-8,both,longevity,Italian,genomic,,SNP,A>C,,,C,,15.8,22.5,376,173,65.9,49,78,100.9,99,106,candidate genes study,,Исследование проведено на итальянских долгожителях (173 итальянских долгожителей и 376 молодых людей из контрольной группы).,
AGTR1,rs275653,,Significant,0.007,10.1007/s11357-012-9408-8,both,longevity,Italian,genomic,decreased gene expression,SNP,A>G,,,G,,15.8,22.5,376,173,65.9,49,78,100.9,99,106,candidate genes study,,"Исследование проводилось на итальянской (173 итальянских долгожителей и 376 молодых людей из контрольной группы) и японской (598 долгожителей, 422 молодых человека из контрольной группы). В комбинированном анализе rs275653 был связан с крайней продолжительностью жизни либо на рецессивной модели (P = 0,007, отношение шансов (OR) 3,57), либо на уровне генотипа (P = 0,015). Анализ сортировки активируемых флуоресценцией клеток показал, что субъекты, гомозиготные по минорному аллелю rs275653, имели меньше AT1R-положительных полиморфно-ядерных клеток периферической крови. Кроме того, rs275653 был связан с понижением артериального давления у долгожителей.",
AGTR1,rs2307085,,Significant,0.023,10.1007/s11357-012-9408-8,both,longevity,Italian,genomic,,SNP,C>A,,,A,,0.4,1.7,376,173,65.9,49,78,100.9,99,106,candidate genes study,,,
AGTR1,rs275653,,Significant,0.046,10.1007/s11357-012-9408-8,both,longevity,Japanese,genomic,decreased gene expression,SNP,A>G,,,GG,,,1.2,442,598,70.1,69,72,104.5,99,115,candidate genes study,,,
AIF1 ,rs2269475,intron,Significant,0.000000753,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/G,,,A,G,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
AKR1C2,rs61856137,"upstream, –27000",Significant,0.00000016,10.1038/srep21243,both,longevity,Chinese,genomic,,SNP,T>G,,,T,G,94.4,97.1,2178,2299,48.4,,,102.7,,,GWAS,,,
AKT1,rs2498804,,Non-significant,"0,23",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT1,rs2494732,,Non-significant,"0,95",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT1,rs12881616,,Non-significant,"0,53",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT1,rs1130233,,Non-significant,"0,4",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT1,rs2494738,,Non-significant,"0,52",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT1,rs2494743,,Non-significant,"0,86",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT1,rs1130214,,Non-significant,"0,69",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT1,rs3803304,,Significant,0.041,10.1111/j.1474-9726.2009.00493.x,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,,363,383,79.5,43,94,97.7,95,108,candidate genes study,,,
AKT1,rs3803304,,Significant,0.049,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT1,rs3803304,,Significant,0.033,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
AKT1,rs3803304,,Significant,0.0004,10.1111/j.1474-9726.2009.00493.x,both,longevity,"Caucasian, Ashkenazi Jewish",genomic,,SNP,,,,,,,,1673,955,79.1,43,94,96.5,92,108,meta-analysis of candidate gene studies,,,
AKT2,rs874269,,Non-significant,"0,9",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT2,rs2304188,,Non-significant,"0,72",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT2,rs11670860,,Non-significant,"0,94",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT2,rs3730051,,Non-significant,"0,17",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT2,rs8100018,,Non-significant,"0,25",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT3,rs2994329,,Non-significant,"0,8",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT3,rs884328,,Non-significant,"0,89",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT3,rs3006927,,Non-significant,"0,67",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT3,rs9428576,,Non-significant,"0,44",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT3,rs1058304,,Non-significant,"0,8",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT3,rs4515770,,Non-significant,"0,54",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT3,rs7523742,,Non-significant,"0,87",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT3,rs1121276,,Non-significant,"0,73",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT3,rs3753549,,Non-significant,"0,67",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT3,rs320320,,Non-significant,0.067,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT3,rs10157763,,Non-significant,"0,29",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT3,rs12753750,,Non-significant,"0,27",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
AKT3,rs11590190,,Non-significant,"0,3",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
ANKRD20A9P,rs2440012,nc_exon,Significant,0.0000000373,10.1038/srep21243,both,longevity,Chinese,genomic,,SNP,G>C,,,G,A,91.6,94.6,2178,2299,48.4,,,102.7,,,GWAS,,,
AOX1,AOX1[rs2465661]+RAD23B[rs11573709,,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
AOX1,AOX1[rs2256977]+KL[rs2283368],,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
APOB,rs12713450,"exon, missense",Significant,,10.1111/acel.12261,both,longevity,,genomic,,SNP,,T/M,,A,G,0.62,28.57142857,,7,,,,,94,104,family study,,,
APOB,rs1801703,"exon, missense",Significant,,10.1111/acel.12261,both,longevity,,genomic,,SNP,,V/M,,T,C,1.23,21.42857143,,7,,,,,94,104,family study,,,
APOB,rs12720854,"exon, missense",Significant,,10.1111/acel.12261,both,longevity,,genomic,,SNP,,S/G,,C,T,0.62,28.57142857,,7,,,,,94,104,family study,,,
APOC1,rs4420638,,Significant,"3,55 × 10−13",10.1093/gerona/glab023,both,longevity,German,genomic,,SNP,,,,,G,,,6941,1248,,,59,99,94,110,single-variant association approach,,,
APOC1,"rs439401, rs445925, rs4420638",,Significant,"2,59 × 10−11",10.1093/gerona/glab023,both,longevity,German,genomic,,,,,,,,,,6941,1248,,,59,99,94,110,gene-based association approach,,,SKAT-CommonRare function method
APOC1,rs4420638,"downstream, 500",Significant,"2,13 × 10^−5",10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,3757,6036,,55,80,,90,,"meta-analysis of GWAS, replication of previous findings",,,
APOC1,rs10414043,"upstream, 2000",Significant,"9,12 × 10−23",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,G,A,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
APOC1 ,rs4420638,,Significant,"3,40 × 10−36",10.1093/hmg/ddu139,both,longevity,European,genomic,,SNP,,,,A,G,,,72228,10266,,,,,90,,"GWAS, discovery + replication",,,
APOC1 ,rs4420638,,Significant,"4,09 × 10−21",10.1093/hmg/ddu139,both,longevity,European,genomic,,SNP,,,,A,G,85.5,80.5,15102,5405,,,,,90,,GWAS,,,
APOC1 ,rs4420638,,Significant,"2,95 × 10−18",10.1093/hmg/ddu139,both,longevity,European,genomic,,SNP,,,,A,G,83.5,79.8,57126,4861,,,,,90,,"GWAS, replication",,,
APOC1 ,rs4420638,,Significant,"9,6 × 10−8",10.1111/acel.12039,both,longevity,Caucasian,genomic,,SNP,,,,,,,,1907,1228,,,,,90,,GWAS,,,"Families participating in the GEHA study have at least two siblings meeting four inclusion criteria: (i) participants are at least 90 years old, (ii) participants have at least one living brother or sister who fulfils the first criterion and is willing to participate, (iii) the nonagenarian sibship has an identical mother and father, and (iv) the parents of the nonagenarian sibship are European and Caucasian. In total 2,249 sibships have been recruited."
APOC1 ,rs4420638,"downstream, 500",Significant,0,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,A,G,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
APOC3,rs2542052,promoter,Significant,0.0001,10.1371/journal.pbio.0040113,both,longevity,Ashkenazi Jewish,genomic,decreased gene expression,SNP,-641A>C,,,CC,"AA, AC",10,25,258,213,70.75,,,98.2,95,107,candidate genes study,,"Гомозиготный генотип по аллелю 641C был более распространен среди долгожителей и их потомков. Этот генотип был связан со значительно более низкими уровнями APOC3 в сыворотке и благоприятным паттерном уровней и размеров липопротеинов. Исследование проводилось на ашкеназских еврейских долгожителях (n долгожителей = 213, n потомков = 216, n контрольной группы = 258). ",
APOE,,,Non-significant,0.065,10.1016/j.mad.2004.08.025,female,longevity,Ashkenazi Jewish,genomic,,VNTR,,,"E2, E3, E4",E2,E4,,,320,74,21.89,13,33,,75,,candidate genes study,,,
APOE,rs769449,,Significant,0.0002,10.1007/s11357-011-9373-7,both,longevity,Danish,genomic,,SNP,,,,,,,,736,1089,50.6,46,55,93.2,92.2,93.8,candidate genes study,,,Single-SNP-based test
APOE,rs769449,intron,Significant,0.018,10.1007/s11357-011-9373-7,both,longevity,Danish,genomic,,SNP,A/G,,,A,G,83.4,87.7,736,1089,50.6,46,55,93.2,92.2,93.8,candidate genes study,,,
APOE,rs405509+rs440446+rs769449,,Significant,"9,68 × 10−5",10.1007/s11357-011-9373-7,both,longevity,Danish,genomic,,haplotype,A+G+A,,,,,,,736,1089,50.6,46,55,93.2,92.2,93.8,candidate genes study,,,
APOE,rs769449,intron,Significant,"5,20 × 10−17",10.1007/s11357-011-9373-7,both,longevity,German,genomic,,SNP,,,,A,G,88.1,94.5,1104,1613,67.2,,,98.4,,,candidate genes study,,,
APOE,,,Significant,0.025,10.1016/j.mad.2004.08.025,male,longevity,Ashkenazi Jewish,genomic,,VNTR,,,"E2, E3, E4",E2,E4,,,121,150,21.89,13,33,,75,,candidate genes study,,,
APOE,rs429358,,Significant,"1,3 × 10^−56",10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,E4,T,C,,,25483,11262,,,75,,89,,meta-analysis of GWAS,,,
APOE,rs7412,,Significant,"2,4 × 10^−11",10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,E2,T,C,,,25483,11262,,,75,,89,,meta-analysis of GWAS,,,
APOE,rs429358,,Significant,"3,9 × 10^−34",10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,E4,T,C,,,25483,3484,,,75,,98,,meta-analysis of GWAS,,,
APOE,rs7412,,Significant,"3,2 × 10^−12",10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,E2,T,C,,,25483,3484,,,75,,98,,meta-analysis of GWAS,,,
APOE,rs429358,,Significant,"5,2 × 10^−36",10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,E4,T,C,,,4987,2557,,,75,,89,,"meta-analysis of GWAS, replication",,,
APOE,rs7412,,Significant,"2,4 × 10^−6",10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,E2,T,C,,,4987,2557,,,75,,89,,"meta-analysis of GWAS, replication",,,
APOE,rs429358,,Significant,"4,0 × 10^−32",10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,E4,T,C,,,4987,1911,,,75,,98,,"meta-analysis of GWAS, replication",,,
APOE,rs7412,,Significant,"2,0 × 10^−6",10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,E2,T,C,,,4987,1911,,,75,,98,,"meta-analysis of GWAS, replication",,,
APOE,rs429358,,Significant,"1,0 × 10^−61",10.1038/s41467-019-11558-2,both,longevity,"European, East Asian, African American",genomic,,SNP,,,E4,T,C,,,27993,13617,,,75,,89,,meta-analysis of GWAS,,,
APOE,rs7412,,Significant,"1,7 × 10^−12",10.1038/s41467-019-11558-2,both,longevity,"European, East Asian, African American",genomic,,SNP,,,E2,T,C,,,27993,13617,,,75,,89,,meta-analysis of GWAS,,,
APOE,rs429358,,Significant,"1,3 × 10^−36",10.1038/s41467-019-11558-2,both,longevity,"European, East Asian, African American",genomic,,SNP,,,E4,T,C,,,27993,5662,,,75,,98,,meta-analysis of GWAS,,,
APOE,rs7412,,Significant,"1,7 × 10^−12",10.1038/s41467-019-11558-2,both,longevity,"European, East Asian, African American",genomic,,SNP,,,E2,T,C,,,27993,5662,,,75,,98,,meta-analysis of GWAS,,,
APOE,rs405509,"upstream, –200 ",Significant,0.0000792,10.1038/srep21243,both,longevity,Chinese,genomic,,SNP,G>T,,,T,G,31.6,37.4,2178,2299,48.4,,,102.7,,,GWAS,,"Ассоциация была значимой в двух выборках: из южного региона Китая (n долгожителей = 1063, n контрольной группы = 887) и из северного региона Китая (n долгожителей = 1115, n контрольной группы = 1412).",
APOE,rs769449,,Significant,"7,77 × 10−15",10.1093/gerona/glab023,both,longevity,German,genomic,,SNP,,,,,A,,,6941,1248,,,59,99,94,110,single-variant association approach,,,
APOE,"rs769449, rs769452",,Significant,"3,25 × 10−15",10.1093/gerona/glab023,both,longevity,German,genomic,,,,,,,,,,6941,1248,,,59,99,94,110,gene-based association approach,,,SKAT-CommonRare function method
APOE,rs769449,intron,Significant,"1,08 × 10−23",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,G,A,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
APOE,rs405509,,Significant,"1,04 × 10−07",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,G,T,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,suggestive significant
APOE,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,APOE[promoter+promoter+promoter+exon4+exon4]+HRAS[promoter+promoter+promoter+promoter+promoter+promoter+exon1]+LASS1[exon1+exon1],Significant,0.0000288,10.1111/j.1474-9726.2010.00600.x,both,longevity,Caucasian,genomic,,haplotype,,,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,HRAS-CGCGCGT+ApoE-ATTTC+LASS1-CCT,,1,7.3,188,147,40.62,20,59,100.57,98,,candidate genes study,,ε3-содержащий гаполотип ApoE (ATTTC) в комбинации с гаплотипом HRAS (CGCGCGT) и гаплотипами LASS1 (CCT) или (CGT) ассоциирован с высокой продолжительностью жизни. Генетический анализ был проведен на популяциях их Джорджии (N=650) и (N=869) Луизианы.,
APOE,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,APOE[promoter+promoter+promoter+exon4+exon4]+HRAS[promoter+promoter+promoter+promoter+promoter+promoter+exon1]+LASS1[exon1+exon1],Significant,0.0000466,10.1111/j.1474-9726.2010.00600.x,both,longevity,Caucasian,genomic,,haplotype,,,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,HRAS-CGCGCGT+ApoE-ATTTC+LASS1-CGT,,8.4,19.1,188,147,40.62,20,59,100.57,98,,candidate genes study,,,
APOE,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,APOE[promoter+promoter+promoter+exon4+exon4]+HRAS[promoter+promoter+promoter+promoter+promoter+promoter+exon1]+LASS1[exon1+exon1],Significant,0.0000568,10.1111/j.1474-9726.2010.00600.x,both,longevity,Caucasian,genomic,,haplotype,,,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,HRAS-CGCGCGT+ApoE-ATTTC+LASS1-CCT,,3.9,10.5,251,204,43.87,20,59,92.8,90,,candidate genes study,,,
APOE,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,APOE[promoter+promoter+promoter+exon4+exon4]+HRAS[promoter+promoter+promoter+promoter+promoter+promoter+exon1]+LASS1[exon1+exon1],Significant,0.0000005,10.1111/j.1474-9726.2010.00600.x,both,longevity,Caucasian,genomic,,haplotype,,,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,HRAS-CGCGCGT+ApoE-ATTTC+LASS1-CGT,,6.7,17.5,251,204,43.87,20,59,92.8,90,,candidate genes study,,,
APOE ,rs405509,"upstream, 2000",Significant,0.000000559,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/C,,,C,A,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
APOE ,rs405509,"upstream, 2000",Significant,0.00000000479,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,G/T,,,G,G,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
ASB17,"rs149522654, rs11161887, rs3795251",,Significant,"4,42 × 10−05",10.1093/gerona/glab023,both,longevity,German,genomic,,,,,,,,,,6941,1248,,,59,99,94,110,gene-based association approach,,,SKAT-CommonRare function method
ASIC2,rs7213812,intron,Significant,0.00000633,10.1038/srep21243,both,longevity,Chinese,genomic,,SNP,C>A,,,A,C,15.5,19.6,2178,2299,48.4,,,102.7,,,GWAS,,,
ATM,rs189037,,Significant,0.037,10.1007/s10072-012-1188-5,both,longevity,Italian,genomic,,SNP,,,,CT,,,,150,128,67.2,,,98.7,,,candidate genes study,,"Изученная группа состояла из 278 итальянцев: 128 долгожителей (78,1% женщин, средний возраст на момент обследования 98,7 ± 5,1 года; 52,3% в возрасте 100 лет) и 150 не состоящих в родстве здоровых субъектов в качестве контрольной группы (56,7% женщин, средний возраст на момент обследования 67,2 ± 9,1 года). Не было существенных различий в распределении генотипов C/T в группе долгожителей по сравнению с контрольной (p = 0,12). Группа долгожителей была разделена на две подгруппы (<100 лет и ≥100 лет, последние были названы столетними), и была обнаружена статистически значимая разница по частоте генотипа C/T у столетних по сравнению с контрольной группой (p = 0,037). Распределение генотипа и аллеля rs189037 находилось в равновесии Харди – Вайнберга в контрольной группе (p = 0,59), но не в группе долгожителей (p = 0,03). Это верно и для подгруппы столетних (р = 0,028).",
ATM,rs189037,,Significant,0.004,10.1016/j.mad.2010.08.009,both,longevity,"Chinese, Han",genomic,,SNP,,,,CT,"CC, TT",45.9,53,886,875,49.06,18,85,94.6,90,108,candidate genes study,,"1761 образец крови был взят у 875 долгожителей и 886 не связанных родством участников. Все участники были китайцами народности хань из одного региона. Среди долгожителей были 280 мужчин и 595 женщин в возрасте от 90 до 108 лет, средний возраст 94,6 года, без серьезных заболеваний; в контрольную группу вошли 395 женщин и 491 мужчина в возрасте от 18 до 85 лет, средний возраст 49,06 года. В семьях участников из контрольной группы не было родственников старше 90 лет. Была обнаружена значимая связь между генотипами и продолжительностью жизни (P = 0,01). У долгожителей наблюдалась более высокая частота генотипа CT, чем у контрольной группы (53,0% против 45,9%, P = 0,004). Доля генотипа CT увеличивается с возрастом как в группе долгоживущих людей, так и в контрольной группе, наблюдалась более высокая частота генотипа CT у долгоживущих людей. Исследование 42 здоровых пожилых людей показало, что при генотипе TT наблюдается самый высокий уровень экспрессии мРНК ATM, не было обнаружено значительных различий между генотипами CC и CT (CC против TT, P = 0,001; CT против TT, P = 0,006; CC против CT, P = 0,818), но наблюдалась явная тенденция к увеличению экспрессии АТМ от генотипа СС к генотипу ТТ. rs189037 SNP образует сайт связывания активирующего белка 2a (AP-2a). AP-2a прочно связывается с олигонуклеотидом, содержащим аллель C, и слабо - с олигонуклеотидным зондом с аллелем T.",
ATM,ATM[rs170548]+LONP1[rs2436514],,Significant,0.002,10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,ATM[A]+LONP1[AG],,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
ATXN2,rs7137828,,Non-significant,0.019,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
ATXN2,rs7137828,,Non-significant,0.018,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
ATXN2,rs7137828,,Significant,0,10.18632/aging.101334,both,increased parental lifespan,European,genomic,,,,,,,,,,,389166,,,,56.66,40,73,GWAS,,,
ATXN2 ,rs653178,intron,Significant,0.000000964,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/G,,,A,G,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
B3GALTL,,,Significant,0.000000047,10.18632/aging.101334,female,increased mothers' lifespan,European,genomic,,,,,,T,,,,,212672,,,,54.65,,,GWAS,,,
BACE2,rs28656880,upstream,Significant,0.0432,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,C,T,4.8,7,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
BCL3,rs4803750,intron,Significant,0.00000224,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/G,,,G,A,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
BCL3,rs4803750,intron,Significant,0.00000023,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,G,A,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
BCL3,rs1531517,intron,Significant,0.000000819,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,A,G,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
BEND3,rs1627804,,Non-significant,0.486,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,C,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
BEND3,rs1627804,,Non-significant,0.288,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,C,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
BEND3,rs1627804,,Significant,0.00000004,10.18632/aging.101334,both,increased parents' age at death,European,genomic,,,,,,C,,,,,208118,,,,75.41,51,105,GWAS,,,
BEND4,rs1487614,"upstream, –114000",Significant,0.000000287,10.1038/srep21243,both,longevity,Chinese,genomic,,SNP,T>C,,,T,C,85.7,98.9,2178,2299,48.4,,,102.7,,,GWAS,,,
BFSP1,"rs145703098, rs140116733, rs6080719, rs147718368, rs143865632, rs142092768",,Significant,"1,25 × 10−03",10.1093/gerona/glab023,both,longevity,German,genomic,,,,,,,,,,6941,1248,,,59,99,94,110,gene-based association approach,,,SKAT-CommonRare function method
BPIFB4,rs2070325,"exon, missense",Significant,0.0000598,10.1161/CIRCRESAHA.117.305875,both,longevity,"Italian, Southern",genomic,,SNP,G>A,Ile229Val,,GG,,6,14,553,410,33,18,48,96.6,90,109,GWAS,,"Итальянская выборка: 410 долгожителя (возрастной диапазон 90–109 лет; средний возраст 96,6 года, соотношение мужчин и женщин 1,47) и 553 человека в контрольной группе (возрастной диапазон 18–48 лет; средний возраст 33,0 года, соотношение мужчин и женщин 1.56). OR = 2,42 (1,56–3,77), p = 5,98E-05",
BPIFB4,rs2070325,"exon, missense",Significant,0.0036,10.1161/CIRCRESAHA.117.305875,both,longevity,German,genomic,,SNP,G>A,Ile229Val,,GG,,10,14,1104,1628,,60,75,98.8,95,110,"GWAS, replication",,"Немецкая выборка: 1628 долгожителей (возрастной диапазон 95–110 лет; средний возраст 98,8 лет) и 1104 человека в контрольной группе (возрастной диапазон 60-75 лет; средний возраст 66,8 года). Когорта США: 1461 долгожитель с возрастным диапазоном 91–119 лет (средний возраст 100,8 года) и 526 человека в контрольной группе с возрастным диапазоном 0–35 лет (средний возраст 28,2 года). Для немецкой когорты: OR = 1,43; 95% ДИ = 1,12–1,80; P = 0,0036 Для когорты США: OR = 1,60; 95% ДИ = 1,14–2,24; P = 0,0063 Мета-анализ двух популяций подтвердил этот вывод (3060 долгожителей и 1609 контролей: OR = 1,49; 95% CI = 1,22–1,81; P = 7,59 × 10-5; мощность> 0,90)",
BPIFB4,rs2070325,"exon, missense",Significant,0.0063,10.1161/CIRCRESAHA.117.305875,both,longevity,"Caucasian, American",genomic,,SNP,G>A,Ile229Val,,GG,,9,13,526,1461,28.2,0,35,100.8,91,119,"GWAS, replication",,,
BPIFB4,rs2070325,"exon, missense",Significant,"7,59 × 10–5",10.1161/CIRCRESAHA.117.305875,both,longevity,"German, American",genomic,,SNP,G>A,Ile229Val,,GG,,,,1609,3060,,0,75,,91,119,meta-analysis of GWAS,,,
BRD1,rs138863,,Non-significant,0.17,10.1001/jamanetworkopen.2018.1670,female,longevity,"Chinese, Han",genomic,,SNP,,,,major,,98,97,1526,1614,48.2,40,64,103.1,100,,GWAS,,,
BRD1,rs138863,,Significant,"9,5 × 10-6",10.1001/jamanetworkopen.2018.1670,male,longevity,"Chinese, Han",genomic,,SNP,,,,major,,96,99,773,564,48.7,40,64,101.5,100,,GWAS,,,
BSND,rs12117661,,Non-significant,0.000000547,10.1038/ncomms15842,both,increased parents' age at death,European,genomic,,,,,,,,,,,276796,,,,,40,,iGWAS,,,
BSND,rs12117661,,Non-significant,0.262,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
BSND,rs12117661,,Non-significant,0.445,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
BTBD9,rs3800358,3'UTR,Significant,0.00541,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,25.9,31.6,,1173,,60,75,,85,105,GWAS,,,
BTNL2 ,rs3763305,intron,Significant,0.0000000978,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/G,,,A,G,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
C2 ,rs1042663,"exon, synonymous",Significant,0.000000883,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/G,,,A,G,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
C2 ,rs550605,intron,Significant,0.0000018,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/G,,,G,A,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
C20orf187,rs6108784,,Non-significant,0.812,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
C20orf187,rs6108784,,Non-significant,0.429,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
C20orf187,rs6108784,,Significant,0.00000000012,10.18632/aging.101334,male,increased fathers' lifespan,European,genomic,,,,,,,,,,,176494,,,,45.35,,,GWAS,,,
C3,rs10411506,intron,Significant,0.0161,10.1016/j.exger.2009.02.004,both,longevity,"Caucasian, African-American",genomic,,SNP,,,,,,,,900,479,,,79,,92,,candidate genes study,,"Когорта CHS: 5888 взрослых мужчин и женщин 65 лет и старше из США. 4925 человек или 95% определили свою этническую принадлежность как белые. В группу долгожителей относили людей, доживших как минимум до 92 лет (n = 479; 61% женщин), а в контрольную группу - людей, умерших в возрасте до 79 лет (n = 900; 46% женщин). ).",
C5orf67,rs3936510,,Non-significant,0.00000519,10.1038/ncomms15842,both,increased parents' age at death,European,genomic,,,,,,A,,,,,276796,,,,,40,,iGWAS,,,
C5orf67,rs3936510,,Non-significant,0.383,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
C5orf67,rs3936510,,Non-significant,0.542,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
C7orf50,rs10256972,intron,Significant,0.00224,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,36.5,43.6,,1173,,60,75,,85,105,GWAS,,,
CACNA1C,rs2370413,intron,Significant,0.0011,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,35.2,42.6,,1173,,60,75,,85,105,GWAS,,,
CADM2,rs9822731,,Non-significant,0.053,10.1093/gerona/glu166,both,increased lifespan,Caucasian,genomic,,SNP,,,,,,,,,4567,,,,,25,110,"meta-analysis of GWAS, replication",,,
CADM2,rs9822731,,Non-significant,0.726,10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,914,801,73,54,90,104,95,119,"meta-analysis of GWAS, replication",,,
CADM2,rs9841144,−236,Non-significant,0.825,10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,16121,5409,,,65,,90,,"meta-analysis of GWAS, replication",,,
CADM2,rs9841144,−236,Significant,"9,66 × 10^−7",10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,3757,6036,,55,80,,90,,meta-analysis of GWAS,,,suggestive significant
CAMK2B,rs148569268,downstream,Significant,0.0147,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,G,A,2.6,4.7,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
CAMK2B,,3'UTR,Significant,0.0433,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,T,C,99.3,99.9,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
CAPN9,rs4477283,,Non-significant,0.397,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
CAPN9,rs4477283,,Non-significant,0.554,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
CARS,rs739401,intron,Significant,0.00154,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,32.4,39.5,,1173,,60,75,,85,105,GWAS,,,
CCL5,,,Significant,0.014,10.1016/j.cyto.2011.12.021,male,longevity,Spanish,genomic,,SNP,-403G/A,,,A,G,7,17,35,32,29,17,40,89.4,85,97,candidate genes study,,,
CCL5,,intron,Significant,0.008,10.1016/j.cyto.2011.12.021,both,longevity,Spanish,genomic,,SNP,Int1.1T/C,,,CC,,0,6.2,110,104,,17,40,,85,100,candidate genes study,,,
CCL5,,intron,Significant,0.02,10.1016/j.cyto.2011.12.021,female,longevity,Spanish,genomic,,SNP,Int1.1T/C,,,CC,,0,7.2,75,72,28,17,39,89.4,85,100,candidate genes study,,,
CCND1,rs7177,,Non-significant,0.1102,10.1093/gerona/glv058,both,longevity,"Italian, Calabrian",genomic,,SNP,,,,C,,42.91,48.26,302,320,75.1,,,96,90,,candidate genes study,,,
CDH4,rs2024714,intron,Significant,0.00743,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,26.8,35.3,,1173,,60,75,,85,105,GWAS,,,
CDKN1A,rs3176344,,Non-significant,0.08,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,G,A,95.7,98.2,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs3176349,,Non-significant,0.148,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,G,T,94.7,97.2,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs3176343,,Non-significant,0.107,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,G,A,92.5,95.6,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs876581,,Non-significant,0.103,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,G,A,90.8,94.4,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs2145047,,Non-significant,0.31,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,A,G,94.5,96.3,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs1321312,,Non-significant,0.181,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,C,G,80.2,84.5,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs4135234,,Non-significant,0.344,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,G,A,82,84.9,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs762623,,Non-significant,0.401,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,G,A,81.2,83.9,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs4713999,,Non-significant,0.295,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,G,A,54.1,58.7,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs3829966,,Non-significant,0.444,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,C,T,83.1,85.4,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs6457940,,Non-significant,0.487,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,C,A,68.9,71.6,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs2395655,,Non-significant,0.563,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,A,G,49.6,52.1,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs4135237,,Non-significant,0.689,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,G,T,82.9,84.2,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs4714003,,Non-significant,0.789,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,C,T,90.8,91.4,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs730506,,Non-significant,0.852,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,G,C,74.8,75.5,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs733590,,Non-significant,0.875,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,T,C,54.2,54.8,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs3829963,,Non-significant,0.969,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,C,A,86.4,86.5,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs9462209,,Non-significant,0.228,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,G,T,41.1,46.6,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs3829967,,Non-significant,0.16,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,C,T,21.2,26.1,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs12192827,,Non-significant,0.242,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,T,C,12.2,15.6,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs10947623,,Non-significant,0.199,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,A,G,12.6,16.5,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs2894409,,Non-significant,0.036,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,T,C,8.8,14.6,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs9470367,,Non-significant,0.949,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,C,G,32.1,32.3,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs6457931,,Non-significant,0.936,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,G,T,44.7,45,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs4151702,,Non-significant,0.93,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,C,G,25.4,25.7,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs4331968,,Non-significant,0.655,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,T,A,28.2,29.9,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs6457938,,Non-significant,0.614,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,A,G,29,30.9,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs4711459,,Non-significant,0.655,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,C,T,13.9,15.3,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs6920453,,Non-significant,0.537,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,T,C,20.7,22.8,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs3829965,,Non-significant,0.539,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,G,A,14.2,16.1,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs1321309,,Non-significant,0.326,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,T,C,40,44,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs12192877,,Non-significant,0.41,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,A,C,13.4,15.8,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs4711461,,Non-significant,0.364,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,,,,T,C,13.6,16.3,184,184,,,,,90,,candidate genes study,,,
CDKN1A,rs1801270,"exon, missense",Significant,0.02,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,C>A,Ser31Arg,,C,,90.7,95.7,184,184,,,,,90,,candidate genes study,,"SNP rs1801270 (С>A) вызывает замену Ser на Arg в аминокислоте 31. rs1801270 встречался значительно реже среди долгожителей Италии, чем в среднем по популяции (n долгожителей = 184, n контрольной группы = 184).",
CDKN1A,rs1059234,3'UTR,Significant,0.026,10.18632/aging.100041,both,longevity,Italian,genomic,,SNP,C>T,,,С,,90.2,95.1,184,184,,,,,90,,candidate genes study,,"SNP rs1059234 (C>T) приводит к замене нуклеотида в 3'-нетранслируемой области. rs1059234 встречался значительно реже среди долгожителей Италии, чем в среднем по популяции (n долгожителей = 184, n контрольной группы = 184).",
CDKN2B ,rs1063192,3'UTR,Significant,0.0000000259,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/G,,,G,A,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
CDKN2B ,rs3217992,3'UTR,Significant,0.00000606,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/G,,,G,A,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
CDKN2B-AS1,rs1333045,,Non-significant,0.003,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
CDKN2B-AS1,rs1333045,,Non-significant,0.005,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
CDKN2B-AS1,rs1063192,,Non-significant,"5,62 × 10−02",10.1093/gerona/glab023,both,longevity,French,genomic,,SNP,,,,G,,,,1824,1270,,,61,102.4,91,115,"single-variant association approach, replication",,,
CDKN2B-AS1,rs1063192,,Non-significant,1,10.1093/gerona/glab023,both,longevity,Danish,genomic,,SNP,,,,G,,,,1002,738,66.3,,,97.4,90,102.5,"single-variant association approach, replication",,,
CDKN2B-AS1,rs1556516,,Significant,0,10.18632/aging.101334,both,increased parental lifespan,European,genomic,,,,,,,G,,,,389166,,,,56.66,40,73,GWAS,,,
CDKN2B-AS1,rs1556516,,Significant,0,10.7554/eLife.39856.001,both,increased parental lifespan,European,genomic,,SNP,,,,,G,,,,1012240,,,,71.63,40,117,GWAS,,,
CDKN2B-AS1,rs4977756,,Significant,0.00001389,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
CDKN2B-AS1,rs1556516,,Significant,0.0003994,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
CDKN2B-AS1,rs4977756,,Significant,0.0000003502,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
CDKN2B-AS1,rs1556516,,Significant,0.00007082,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
CDKN2B-AS1,rs7039467,,Significant,"1,1 × 10^−7",10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,G,,,25483,3484,,,75,,98,,meta-analysis of GWAS,,,suggestive significant
CDKN2B-AS1,rs7039467,,Significant,"2,1 × 10^−7",10.1038/s41467-019-11558-2,both,longevity,"European, East Asian, African American",genomic,,SNP,,,,A,G,,,27993,5662,,,75,,98,,meta-analysis of GWAS,,,suggestive significant
CDKN2B-AS1,rs1063192,,Significant,"2,99 × 10−05",10.1093/gerona/glab023,both,longevity,German,genomic,,SNP,,,,G,,,,6941,1248,,,59,99,94,110,single-variant association approach,,,
CDKN2B-AS1,rs4977756,intron,Significant,0.0000000246,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/G,,,G,A,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
CDKN2B-AS1,rs2157719,intron,Significant,0.0000000991,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/G,,,G,A,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
CDKN2B-AS1,rs10120688,intron,Significant,0.00000029,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/G,,,G,A,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
CDKN2B-AS1,rs2151280,intron,Significant,0.00000157,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/G,,,G,A,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
CDKN2B-AS1,rs2383207,intron,Significant,0.00000169,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/G,,,A,G,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
CDKN2B-AS1,rs1412832,intron,Significant,0.00000309,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/G,,,G,A,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
CDKN2B-AS1,rs10116277,intron,Significant,0.00000519,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/C,,,C,A,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
CDKN2BAS,rs1333045,,Significant,0.0000000177,10.1038/ncomms15842,both,increased parents' age at death,European,genomic,,,,,,A,,,,,276796,,,,,40,,iGWAS,,,
CELSR2,rs646776,,Non-significant,0.158,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
CELSR2,rs646776,,Non-significant,0.303,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
CELSR2,rs646776,,Significant,0.0000000697,10.1038/ncomms15842,both,increased parents' age at death,European,genomic,,,,,,G,,,,,276796,,,,,40,,iGWAS,,,
CEP89,rs62127362,,Significant,"4,3 × 10^−7",10.1038/s41467-019-11558-2,both,longevity,"European, East Asian, African American",genomic,,SNP,,,,G,C,,,27993,13617,,,75,,89,,meta-analysis of GWAS,,,suggestive significant
CETP,rs9923854,intron,Non-significant,0.133,10.1007/s11357-011-9373-7,both,longevity,German,genomic,,SNP,,,,A,C,10.6,11.9,1104,1613,67.2,,,98.4,,,candidate genes study,,,
CETP,rs5882,"exon, missense",Significant,"<0,001",10.1001/jama.290.15.2030,both,longevity,Ashkenazi Jewish,genomic,,SNP,,I405V,,GG (VV),,,,847,213,69.8,,,98.2,95,107,candidate genes study,,"В схеме случай-контроль 213 пробандов-евреев-ашкенази с исключительной продолжительностью жизни (средний [SD] возраст, 98,2 [5,3] года) и их потомство (n = 216; средний [SD] возраст, 68,3 [6,7] лет) были отобраны из 1998–2002 гг., В то время как контрольная группа евреев-ашкенази (n = 258) и участники Фрамингемского исследования потомства (n = 589) были приняты в качестве контрольных групп. У пробандов и потомков частота гомозиготности по аллелю валина 405 CETP (генотип VV) соответственно увеличивалась в 2,9 и 3,6 раза (у мужчин) и в 2,7 и 1,5 раза (у женщин) по сравнению с контрольной группой. (P <0,001 для обоих).",
CETP,rs289714,,Significant,0.019,10.1007/s11357-011-9373-7,both,longevity,Danish,genomic,,SNP,,,,,,,,736,1089,50.6,46,55,93.2,92.2,93.8,candidate genes study,,,Single-SNP-based test
CETP,rs4784744,,Significant,0.027,10.1007/s11357-011-9373-7,both,longevity,Danish,genomic,,SNP,,,,,,,,736,1089,50.6,46,55,93.2,92.2,93.8,candidate genes study,,,Single-SNP-based test
CETP,rs5883,,Significant,0.022,10.1007/s11357-011-9373-7,both,longevity,Danish,genomic,,SNP,,,,,,,,736,1089,50.6,46,55,93.2,92.2,93.8,candidate genes study,,,Single-SNP-based test
CETP,rs9923854,,Significant,"4,42 × 10−10",10.1007/s11357-011-9373-7,both,longevity,Danish,genomic,,SNP,,,,,,,,736,1089,50.6,46,55,93.2,92.2,93.8,candidate genes study,,,Single-SNP-based test
CETP,rs9930761,,Significant,0.004,10.1007/s11357-011-9373-7,both,longevity,Danish,genomic,,SNP,,,,,,,,736,1089,50.6,46,55,93.2,92.2,93.8,candidate genes study,,,Single-SNP-based test
CETP,rs9923854,intron,Significant,"1,0 × 10−4",10.1007/s11357-011-9373-7,both,longevity,Danish,genomic,,SNP,C/A,,,A,C,9.1,16.4,736,1089,50.6,46,55,93.2,92.2,93.8,candidate genes study,,,
CETP,rs5882+rs9923854+rs1800777,,Significant,"2,35 × 10−5",10.1007/s11357-011-9373-7,both,longevity,Danish,genomic,,haplotype,G+C+G,,,,,,,736,1089,50.6,46,55,93.2,92.2,93.8,candidate genes study,,,
CETP,rs1800774+rs5882+rs9923854,,Significant,"2,11 × 10−5",10.1007/s11357-011-9373-7,both,longevity,Danish,genomic,,haplotype,G+G+C,,,,,,,736,1089,50.6,46,55,93.2,92.2,93.8,candidate genes study,,,
CETP,rs5882,,Significant,0.008,10.1371/journal.pone.0072537,both,longevity,Chinese,genomic,,SNP,,,,G,,,,515,506,41.4,20,69,92.45,80,109,candidate genes study,,"Исследование случай-контроль в Китае (n = 1021) показало, что CETP 405V является аллелем, ассоциированным с долголетием, долголетия во всех генетических моделях (P аддитивный = 0,008; P доминантный = 0,008, OR (доминантный) = 0,673; P рецессивный = 0,017, OR (рецессивный). ) = 0,654) после корректировки на аллель аполипопротеина E (APOE) ε4, индекс массы тела и холестерин липопротеинов высокой плотности.",
CETP,rs5882,,Significant,"<0,001",10.1371/journal.pone.0072537,both,longevity,"East Asian, Europeans, Caucasian American",genomic,,SNP,,,,,,,,2080,2321,,27.4,71.3,,89,101.7,meta-analysis of candidate gene studies,,,
CETP,rs708272,,Significant,0.03,10.2174/1874192401004010014,both,longevity,Greek,genomic,,SNP,,,TaqIB,A,,47,60,67,69,,,,,90,,candidate genes study,,"Частота аллеля B2 полиморфизма TaqIB была выше при синдроме долголетия (LS) по сравнению с группой без LS (p = 0,03), тогда как частота аллеля B1 была выше в группе без LS (p = 0,03).",
CFB ,rs541862,intron,Significant,0.00000611,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/G,,,G,A,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
CHRNA3,rs1317286,,Non-significant,0.678,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
CHRNA3,rs1317286,,Non-significant,0.931,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
CHRNA3,rs1317286,,Significant,0,10.18632/aging.101334,both,increased parental lifespan,European,genomic,,,,,,,A,,,,389166,,,,56.66,40,73,GWAS,,,
CHRNA4,rs2273500,,Non-significant,0.652,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
CHRNA4,rs2273500,,Non-significant,0.381,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
CHRNA4,rs2273500,,Significant,0.000000015,10.18632/aging.101334,male,increased fathers' lifespan,European,genomic,,,,,,,,,,,176494,,,,45.35,,,GWAS,,,
CHRNA5,rs951266,,Non-significant,0.508,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
CHRNA5,rs951266,,Non-significant,0.758,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
CHRNA5,rs951266,,Significant,0.000000000433,10.1038/ncomms15842,both,increased parents' age at death,European,genomic,,,,,,,,,,,276796,,,,,40,,iGWAS,,,
CLSTN2,rs1834497,intron,Significant,0.00979,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,44.7,50.4,,1173,,60,75,,85,105,GWAS,,,
CLU,rs9331893,intron,Significant,0.0008,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,increased gene expression,SNP,,,,T,C,0.8,2.8,500,450,73.14,43,93,98.21,95,110,candidate genes study,,,
CLU,rs9331906,intron,Significant,0.0085,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,T,C,0.8,2.3,500,450,73.14,43,93,98.21,95,110,candidate genes study,,,
CLU,multiple,,Significant,0.0059,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,,,,,,,,,500,450,73.14,43,93,98.21,95,110,gene-based association approach,,,SKAT analysis
COQ7,rs8051232,,Non-significant,0.9,10.1073/pnas.0801030105,male,longevity,Japanese,genomic,,SNP,,,,major,,85,85.3,402,213,,,81,,95,,candidate genes study,,,
COQ7,rs11074359,,Non-significant,0.43,10.1073/pnas.0801030105,male,longevity,Japanese,genomic,,SNP,,,,major,,82.9,84.7,402,213,,,81,,95,,candidate genes study,,,
COQ7,rs7192898,,Non-significant,0.73,10.1073/pnas.0801030105,male,longevity,Japanese,genomic,,SNP,,,,major,,83,83.8,402,213,,,81,,95,,candidate genes study,,,
CREB1,multiple,,Significant,0.0097,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,,,,,,,,,500,450,73.14,43,93,98.21,95,110,gene-based association approach,,,SKAT analysis
CSMD1,rs11136774,,Non-significant,0.85,10.1001/jamanetworkopen.2018.1670,female,longevity,"Chinese, Han",genomic,,SNP,,,,major,,75,75,1526,1614,48.2,40,64,103.1,100,,GWAS,,,
CSMD1,rs11136774,,Significant,"2,6 × 10-6",10.1001/jamanetworkopen.2018.1670,male,longevity,"Chinese, Han",genomic,,SNP,,,,minor,,21,30,773,564,48.7,40,64,101.5,100,,GWAS,,,
CTGF,rs6917644,,Non-significant,0.61,10.1093/gerona/glw116,male,longevity,Japanese American,genomic,,SNP,T>C,,,,,,,440,347,78.1,72,81,97,95,107,candidate genes study,,,
CTGF,rs9493150,,Non-significant,0.49,10.1093/gerona/glw116,male,longevity,Japanese American,genomic,,SNP,C>T,,,,,,,440,347,78.1,72,81,97,95,107,candidate genes study,,,
CTGF,rs2151532,,Non-significant,0.96,10.1093/gerona/glw116,male,longevity,Japanese American,genomic,,SNP,A>G,,,,,,,440,347,78.1,72,81,97,95,107,candidate genes study,,,
CTGF,rs928501,,Non-significant,0.54,10.1093/gerona/glw116,male,longevity,Japanese American,genomic,,SNP,G>T,,,,,,,440,347,78.1,72,81,97,95,107,candidate genes study,,,
CTGF,rs11966728,,Non-significant,0.4,10.1093/gerona/glw116,male,longevity,Japanese American,genomic,,SNP,T>C,,,,,,,440,347,78.1,72,81,97,95,107,candidate genes study,,,
CTGF,rs9388949,,Non-significant,0.27,10.1093/gerona/glw116,male,longevity,Japanese American,genomic,,SNP,C>T,,,,,,,440,347,78.1,72,81,97,95,107,candidate genes study,,,
CTGF,rs9399005,,Significant,0.035,10.1093/gerona/glw116,male,longevity,Japanese American,genomic,,SNP,,,,CC,,40.6,48.8,440,347,78.1,72,81,97,95,107,candidate genes study,,Генетическое исследование 440 американских мужчин японского происхождения в возрасте ≥95 лет и 374 мужчин со средней продолжительностью жизни выявило статистически достоверную ассоциацию с долголетием для гетерозигот CTGF rs9399005.,
CTGF,rs7768619,,Significant,0.051,10.1093/gerona/glw116,male,longevity,Japanese American,genomic,,SNP,,,,TC,,41.2,52.5,440,347,78.1,72,81,97,95,107,candidate genes study,,Генетическое исследование 440 американских мужчин японского происхождения в возрасте ≥95 лет и 374 мужчин со средней продолжительностью жизни выявило статистически достоверную ассоциацию с долголетием для гетерозигот CTGF rs7768619.,
CYP19,rs4646,,Significant,0.038,10.1093/gerona/glq160,both,longevity,Italian,genomic,,SNP,G>T,,,"GT,TT",GG,55,69.4,258,108,83.1,,,,90,,candidate genes study,,,
CYP1B1,GSS[rs2236270]+CYP1B1[rs162557]+GLRX[rs3756704],,Significant,0.001,10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,, GSS[AC]/CYP1B1[GG]/GLRX[AG],,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
CYP1B1-AS1,rs13406646,,Non-significant,0.78,10.1001/jamanetworkopen.2018.1670,male,longevity,"Chinese, Han",genomic,,SNP,,,,major,,19,19,773,564,48.7,40,64,101.5,100,,GWAS,,,
CYP1B1-AS1,rs13406646,,Significant,"9,8 × 10-6",10.1001/jamanetworkopen.2018.1670,female,longevity,"Chinese, Han",genomic,,SNP,,,,minor,,16,21,1526,1614,48.2,40,64,103.1,100,,GWAS,,,
DHFRP3,rs12472681,,Non-significant,0.54,10.1001/jamanetworkopen.2018.1670,male,longevity,"Chinese, Han",genomic,,SNP,,,,major,,76,77,773,564,48.7,40,64,101.5,100,,GWAS,,,
DHFRP3,rs12472681,,Significant,"5,5 × 10-6",10.1001/jamanetworkopen.2018.1670,female,longevity,"Chinese, Han",genomic,,SNP,,,,minor,,2,5,1526,1614,48.2,40,64,103.1,100,,GWAS,,,
DPP4,rs2909448,,Non-significant,0.00000463,10.1038/ncomms15842,both,increased parents' age at death,European,genomic,,,,,,,,,,,276796,,,,,40,,iGWAS,,,
DPP4,rs2909448,,Non-significant,0.425,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
DPP4,rs2909448,,Non-significant,0.435,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
DRD2,rs6276,,Significant,"1,964 × 10-4",10.1093/gerona/glv058,both,longevity,"Italian, Calabrian",genomic,,SNP,,,,major,,51.76,60.94,302,320,75.1,,,96,90,,candidate genes study,,,
DRD2,rs6278,,Significant,"5,267 × 10-3",10.1093/gerona/glv058,both,longevity,"Italian, Calabrian",genomic,,SNP,,,,major,,82.97,88.87,302,320,75.1,,,96,90,,candidate genes study,,,
DRD4,,3'UTR,Significant,"6,15 × 10−10",10.1523/JNEUROSCI.3515-12.2013,both,longevity,European,genomic,,VNTR,,,3'UTR VNTR,7R,,11.9,20.5,2902,310,,7,45,,90,109,candidate genes study,,,
DRD4,,3'UTR,Significant,"1,7 × 10−9",10.1523/JNEUROSCI.3515-12.2013,female,longevity,European,genomic,,VNTR,,,3'UTR VNTR,7R,,21.9,39.3,,219,,,,,90,,candidate genes study,,,
DRD4,,3'UTR,Significant,0.034,10.1523/JNEUROSCI.3515-12.2013,male,longevity,European,genomic,,VNTR,,,3'UTR VNTR,7R,,21.9,29.7,,91,,,,,90,,candidate genes study,,,
DSC2,rs1790706,,Significant,"9,59 × 10−05",10.1093/gerona/glab023,both,longevity,German,genomic,,SNP,,,,,A,,,6941,1248,,,59,99,94,110,single-variant association approach,,,
EBF1,rs2149954,,Non-significant,0.072,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,T,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
EBF1,rs2149954,,Non-significant,0.012,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,T,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
EBF1,rs2149954,,Non-significant,"1,85 × 10−6",10.1093/hmg/ddu139,both,longevity,European,genomic,,SNP,,,,T,,36,39.6,15112,5406,,,,,90,,GWAS,,,
EBF1,rs2149954,,Non-significant,"5,98 × 10−4",10.1093/hmg/ddu139,both,longevity,European,genomic,,SNP,,,,T,,35.2,37.4,60262,7298,,,,,90,,"GWAS, replication",,,
EBF1,rs2149954,,Significant,"1,74 × 10−8",10.1093/hmg/ddu139,both,longevity,European,genomic,,SNP,,,,T,,,,75374,12704,,,,,90,,"GWAS, discovery + replication",,,
ECE1,rs12143832,,Significant,"2,0 × 10^−7",10.1038/s41467-019-11558-2,both,longevity,"European, East Asian, African American",genomic,,SNP,,,,T,C,,,27993,13617,,,75,,89,,meta-analysis of GWAS,,,suggestive significant
EGFR,rs2241055,,Non-significant,0.2,10.1093/gerona/glw116,male,longevity,Japanese American,genomic,,SNP,C>G,,,,,,,440,347,78.1,72,81,97,95,107,candidate genes study,,,
EGFR,rs2075102,,Non-significant,0.23,10.1093/gerona/glw116,male,longevity,Japanese American,genomic,,SNP,C>A,,,,,,,440,347,78.1,72,81,97,95,107,candidate genes study,,,
EGFR,rs845562,,Non-significant,0.54,10.1093/gerona/glw116,male,longevity,Japanese American,genomic,,SNP,G>A,,,,,,,440,347,78.1,72,81,97,95,107,candidate genes study,,,
EGFR,rs2740763,,Non-significant,0.14,10.1093/gerona/glw116,male,longevity,Japanese American,genomic,,SNP,T>A,,,,,,,440,347,78.1,72,81,97,95,107,candidate genes study,,,
EGFR,rs2075101,,Significant,0.00049,10.1093/gerona/glw116,male,longevity,Japanese American,genomic,,SNP,A>G,,,AG,,31.4,19.5,440,347,78.1,72,81,97,95,107,candidate genes study,27365368,"Сравнение частот аллелей и генотипов 41 SNP EGFR между 440 американскими мужчинами японского происхождения в возрасте ≥95 лет и 374 мужчинами средней продолжительности жизни выявило связь с долголетием на уровне p <0,05 для 7 SNP в EGFR. rs2075101 остался значимым после применения поправки на множественное сравнение Бонферрони. ",
EGFR,rs1050171,,Significant,0.00088,10.1093/gerona/glw116,male,longevity,Japanese American,genomic,,SNP,G>A,,,GA,,36,19.4,440,347,78.1,72,81,97,95,107,candidate genes study,27365368,"Сравнение частот аллелей и генотипов 41 SNP EGFR между 440 американскими мужчинами японского происхождения в возрасте ≥95 лет и 374 мужчинами средней продолжительности жизни выявило связь с долголетием на уровне p <0,05 для 7 SNP в EGFR. rs1050171 остался значимым после применения поправки на множественное сравнение Бонферрони. ",
EGFR,rs7795728,,Significant,0.087,10.1093/gerona/glw116,male,longevity,Japanese American,genomic,,SNP,G>C,,,GA,,29.7,19.7,440,347,78.1,72,81,97,95,107,candidate genes study,,,
EGFR,rs7795743,,Significant,0.0049,10.1093/gerona/glw116,male,longevity,Japanese American,genomic,,SNP,G>A,,,GA,,29.7,19.7,440,347,78.1,72,81,97,95,107,candidate genes study,,,
EGFR,rs13222385,,Significant,0.018,10.1093/gerona/glw116,male,longevity,Japanese American,genomic,,SNP,A>G,,,AG,,16.8,24.8,440,347,78.1,72,81,97,95,107,candidate genes study,,,
EGFR,rs845561,,Significant,0.027,10.1093/gerona/glw116,male,longevity,Japanese American,genomic,,SNP,C>T,,,CT,,29.7,38.6,440,347,78.1,72,81,97,95,107,candidate genes study,,,
EGFR,rs1554718,,Significant,0.013,10.1093/gerona/glw116,male,longevity,Japanese American,genomic,,SNP,T>C,,,TC,,21.4,30.5,440,347,78.1,72,81,97,95,107,candidate genes study,,,
EGFR,rs17336995,3'UTR,Significant,0.0262,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,A,G,0.1,0.8,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
EGFR,multiple,,Significant,0.0216,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,,,,,,,,,500,450,73.14,43,93,98.21,95,110,gene-based association approach,,,SKAT analysis
EGFR,rs2072454+rs2293347+rs3807362+rs884225,,Significant,0.003,10.3858/emm.2009.41.11.083,female,longevity,Korean,genomic,,haplotype,,,,C+G+C+A,C+A+C+A,,,84,32,12.44,12,13,102.16,100,107,candidate genes study,19641380,"Ген EGFR показал генетическую ассоциацию с долголетием в любой возрастной группе женщин (то есть женщин в возрасте старше 90 лет и столетних женщин). Рецептор эпидермального фактора роста (EGFR, P = 0,003) неизменно давал статистические доказательства его связи с долголетием.",
EGFR,rs2293347,,Significant,0.007,10.3858/emm.2009.41.11.083,female,longevity,Korean,genomic,,SNP,,,,G,,,,84,81,12.44,12,13,98.33,90,107,candidate genes study,19641380,"Ген EGFR показал генетическую ассоциацию с долголетием в любой возрастной группе женщин (то есть женщин в возрасте старше 90 лет и столетних женщин). Рецептор эпидермального фактора роста (EGFR, P = 0,003) неизменно давал статистические доказательства его связи с долголетием.",
ELOVL6,rs28391193,,Non-significant,0.948,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
ELOVL6,rs28391193,,Non-significant,0.712,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
EPHA6,rs10934524,"upstream, –383000",Significant,0.000000533,10.1038/srep21243,both,longevity,Chinese,genomic,,SNP,T>C,,,C,T,41.3,46.2,2178,2299,48.4,,,102.7,,,GWAS,,,
EPHX2,rs7844965,,Non-significant,0.831,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
EPHX2,rs7844965,,Non-significant,0.792,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
EPHX2,rs7844965,,Significant,0.0000000077,10.18632/aging.101334,both,increased parental lifespan,European,genomic,,,,,,,,,,,389166,,,,56.66,40,73,GWAS,,,
ERCC1,rs3212961+rs762562,,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
ERCC1,rs3212961+rs3212964,,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
ERCC1,WRN[rs11574218]+ERCC1[rs3212961],,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
ERCC2,rs1052559,"exon, missense",Significant,0.017,10.1007/s10522-009-9246-y,both,longevity,Polish,genomic,decreased gene expression,SNP,,Lys751Gln,,AC,"AA, CC",44,57,413,149,27.1,,,101.1,,,candidate genes study,,"Анализ был проведен у 149 долгожителей (средний возраст 101,1 года) и у 413 молодых людей (средний возраст 27,1 года). Распределение генотипов Lys751Gln достоверно различалось между этими группами (P = 0,017). У долгожителей гомозиготные генотипы AA и CC встречались реже, чем у молодых контролей (29% против 36%, OR = 0,71 и 14% против 20%, OR = 0,652, соответственно). Анализ уровня мРНК XPD в мононуклеарных клетках крови людей, разделенных на три возрастные группы (средний возраст 28,7, 65,8 и 92,7 года), показал, что крайнее долголетие связано со снижением среднего уровня специфической мРНК; различия между группами молодых или людей среднего возраста и очень пожилыми были значительными (P <0,0001, P <0,0001, соответственно). Кроме того, образец метилирования промотора XPD был проанализирован у 30 человек, разделенных на три возрастные группы (29,5, 65,9 и 101,4 года). Общее метилирование промотора XPD — редкое событие; однако старение связано с увеличением уровня метилирования перед сайтом начала транскрипции.",
ERCC2,TP53[rs2078486]+ERCC2[rs50871],,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
ERCC2,ERCC2[rs50871]+TP53[rs2078486],,Significant,0.001,10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,ERCC2[C]+TP53[G],,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
ERCC2,rs1799793,,Significant,0.012,10.2174/1874609810666170707101548,,longevity,Belarusian,genomic,,SNP,,,,CC,,,,,354,,,,,80,,candidate genes study,,"Зависимое от возраста увеличение частоты гомозиготных носителей аллелей XPD 312Asp и XPD 751Lys дикого типа наблюдалось среди контрольной группы, особенно среди субъектов старше 80 лет (r = 0,67, p = 0,012). Статистически значимая корреляция была также обнаружена между частотой гомозиготных аллелей дикого типа во всех тестируемых локусах и возрастом в здоровом населении старше 60 лет (r = 0,35, p = 0,046), предполагая связь между продолжительностью жизни и долголетием, с одной стороны, и нормальным функционированием этих генов и их продуктов, с другой стороны. Гомозиготные носители аллелей дикого типа были менее восприимчивы к раку мочевого пузыря, опухолевой инвазии, повышению степени злокачественности и рецидивам, но их эффекты были специфичными в отношении клинико-патологических характеристик и особенностей образа жизни. Аллельные варианты были идентифицированы у 354 клинически здоровых людей (беларусов) из контрольной группы и 418 пациентов с раком мочевого пузыря.",
ERCC2,rs13181,,Significant,0.012,10.2174/1874609810666170707101548,,longevity,Belarusian,genomic,,SNP,,,,TT,,,,,354,,,,,80,,candidate genes study,,"Зависимое от возраста увеличение частоты гомозиготных носителей аллелей XPD 312Asp и XPD 751Lys дикого типа наблюдалось среди контрольной группы, особенно среди субъектов старше 80 лет (r = 0,67, p = 0,012). Статистически значимая корреляция была также обнаружена между частотой гомозиготных аллелей дикого типа во всех тестируемых локусах и возрастом в здоровом населении старше 60 лет (r = 0,35, p = 0,046), предполагая связь между продолжительностью жизни и долголетием, с одной стороны, и нормальным с другой стороны, функционирование этих генов и их продуктов. Гомозиготные носители аллелей дикого типа были менее восприимчивы к раку мочевого пузыря, опухолевой инвазии, повышению степени злокачественности и рецидивам, но их эффекты были специфичными в отношении клинико-патологических характеристик и особенностей образа жизни. Аллельные варианты были идентифицированы у 354 клинически здоровых людей (беларусов) из контрольной группы и 418 пациентов с раком мочевого пузыря.",
ESR1,rs2234693,,Significant,0.035,10.1093/gerona/glq160,both,longevity,Italian,genomic,,SNP,–401T>C,,PvuII,CC,,18.8,29.6,258,108,83.1,,,,90,,candidate genes study,20819792,"Носительство полиморфизма ESR1 PvuII (–401 T/C) с генотипом PP (отсутствие сайта рестрикции для полиморфизма ESR1 PvuII –401 T/C) было достоверно ассоциировано с продолжительностью жизни более 90 лет (OR = 2,20, p = 0,035). Этническая принадлежность: итальянцы. Размер выборки: 258 человек (43,3% мужчин), родившихся между 1900 и 1930 годами (средний возраст: 83,1 ± 5,7 года). В течение 9-летнего периода наблюдения уровень смертности составил 63,7% (51,9% мужчин): 58,2% участников (n = 85) умерли, не дожив до 90 лет. Выборка долгожителей (n = 108) включала участников в возрасте 90 лет и старше в 2000 г. (независимо от того, были ли участники еще живы или умерли) и в возрасте 90 лет и старше в 2009 г. Контрольная выборка была составлена из лиц, умерших в период с 2000 по 2009 год.",
EXO1,EXO1[rs1635518]+KL[rs9527026],,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
EXOC3L2,rs74444983,,Non-significant,0.374,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
EXOC3L2,rs74444983,,Non-significant,0.142,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,T,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
EXOC3L2,rs74444983,,Significant,0.0000000091,10.18632/aging.101334,male,increased fathers' lifespan,European,genomic,,,,,,,,,,,176494,,,,45.35,,,GWAS,,,
FADS1 ,rs174555,intron,Significant,0.00000156,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,C/T,,,C,T,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
FADS1 ,rs174548,intron,Significant,0.0000017,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,C/G,,,G,C,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
FADS1 ,rs174549,intron,Significant,0.00000171,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,A,G,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
FADS1 ,rs174556,intron,Significant,0.00000213,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,C/T,,,T,C,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
FADS1 ,rs174541,near-gene-3,Significant,0.00000298,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,C/T,,,C,T,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
FAM13A,rs2704588,intron,Significant,0.000000238,10.1038/srep21243,both,longevity,Chinese,genomic,,SNP,C>T,,,C,T,98.2,99.6,2178,2299,48.4,,,102.7,,,GWAS,,,
FAM19A1,rs1027238,,Non-significant,0.37,10.1001/jamanetworkopen.2018.1670,male,longevity,"Chinese, Han",genomic,,SNP,,,,minor,,9,8,773,564,48.7,40,64,101.5,100,,GWAS,,,
FAM19A1,rs1027238,,Significant,"2,8 × 10-6",10.1001/jamanetworkopen.2018.1670,female,longevity,"Chinese, Han",genomic,,SNP,,,,major,,89,93,1526,1614,48.2,40,64,103.1,100,,GWAS,,,
FAM19A5,rs5771675,intron,Significant,0.00985,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,30.9,36.5,,1173,,60,75,,85,105,GWAS,,,
FEN1 ,rs4246215,3'UTR,Significant,0.00000296,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,G/T,,,T,G,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
FN3KRP,rs1046896,,Non-significant,"7,38 × 10−01",10.1093/gerona/glab023,both,longevity,French,genomic,,SNP,,,,,T,,,1824,1270,,,61,102.4,91,115,"single-variant association approach, replication",,,
FN3KRP,rs1046896,,Non-significant,1,10.1093/gerona/glab023,both,longevity,Danish,genomic,,SNP,,,,,T,,,1002,738,66.3,,,97.4,90,102.5,"single-variant association approach, replication",,,
FN3KRP,rs1046896,,Significant,"7,40 × 10−07",10.1093/gerona/glab023,both,longevity,German,genomic,,SNP,,,,,T,,,6941,1248,,,59,99,94,110,single-variant association approach,,,
FN3KRP,"rs138953335, rs61743692, rs144986629, rs142718764, rs1046896",,Significant,"9,19 × 10−06",10.1093/gerona/glab023,both,longevity,German,genomic,,,,,,,,,,6941,1248,,,59,99,94,110,gene-based association approach,,,SKAT-CommonRare function method
FOXO1A,rs2297626,intron,Non-significant,0.512,10.1016/j.exger.2004.05.007,both,longevity,Japanese,genomic,,SNP,,,,,,,,122,122,33.3,19,63,106.8,105,,candidate genes study,,,Более 80% выборки женского пола.
FOXO1A,rs2297627,intron,Non-significant,0.495,10.1016/j.exger.2004.05.007,both,longevity,Japanese,genomic,,SNP,,,,,,,,122,122,33.3,19,63,106.8,105,,candidate genes study,,,Более 80% выборки женского пола.
FOXO1A,rs2755209,,Non-significant,0.48,10.1073/pnas.0801030105,male,longevity,Japanese,genomic,,SNP,,,,major,,70.9,72.8,402,213,,,81,,95,,candidate genes study,,,
FOXO1A,rs2721069,,Non-significant,0.62,10.1073/pnas.0801030105,male,longevity,Japanese,genomic,,SNP,,,,major,,69.3,70.7,402,213,,,81,,95,,candidate genes study,,,
FOXO1A,rs2755213,,Non-significant,0.77,10.1073/pnas.0801030105,male,longevity,Japanese,genomic,,SNP,,,,major,,64.2,65,402,213,,,81,,95,,candidate genes study,,,
FOXO1A,rs1334241,,Non-significant,0.48,10.1111/j.1474-9726.2009.00493.x,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,,363,383,79.5,43,94,97.7,95,108,candidate genes study,,,
FOXO1A,rs3751437,,Non-significant,"0,64",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO1A,rs4325426,,Non-significant,"0,28",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO1A,rs2297627,,Non-significant,"0,27",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO1A,rs2297626,,Non-significant,0.079,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO1A,rs9532580,,Non-significant,"0,1",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO1A,rs7337995,,Non-significant,"0,48",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO1A,rs1334241,,Non-significant,0.17,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
FOXO1A,rs1334241,,Non-significant,0.87,10.1111/j.1474-9726.2009.00493.x,both,longevity,"Caucasian, Ashkenazi Jewish",genomic,,SNP,,,,,,,,1673,955,79.1,43,94,96.5,92,108,meta-analysis of candidate gene studies,,,
FOXO1A,rs1334241,,Significant,0.032,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO3,rs10457180,intron,Non-significant,"8,56 × 10^−5",10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,3757,6036,,55,80,,90,,meta-analysis of GWAS,,,suggestive significant
FOXO3,rs2153960,,Non-significant,0.822,10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,914,801,73,54,90,104,95,119,"meta-analysis of GWAS, replication",,,
FOXO3,rs1935949,,Non-significant,,10.4103/1008-682X.123673,both,longevity,mixed,genomic,,SNP,,,,C,,,,2098,1435,,,89,,90,,meta-analysis of candidate gene studies,,"Мета-анализ ассоциации полиморфизма FOXO3A rs1935949 с продолжительностью жизни был проведен в пяти независимых исследованиях, включая 1435 случаев и 2098 контролей. Была обнаружена достоверная ассоциация между полиморфизмом rs1935949 и продолжительностью жизни в отношении аллеля C по сравнению с аллелем T (OR = 1,14, 95% CI = 1,01–1,27).",
FOXO3,rs2802292,,Non-significant,0.34,10.4103/1008-682X.123673,female,longevity,mixed,genomic,,SNP,,,,G,,,,739,1354,,,81,,90,,meta-analysis of candidate gene studies,,,
FOXO3,rs2764264,,Non-significant,0.5,10.4103/1008-682X.123673,female,longevity,mixed,genomic,,SNP,,,,C,,,,505,975,,,89,,90,,meta-analysis of candidate gene studies,,,
FOXO3,rs2153960,,Significant,0.021,10.1093/gerona/glu166,both,increased lifespan,Caucasian,genomic,,SNP,,,,,,,,,4567,,,,,25,110,"meta-analysis of GWAS, replication",,,
FOXO3,rs2802292,,Significant,0.00006814,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
FOXO3,rs10457180,,Significant,0.000009498,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
FOXO3,rs2802292,,Significant,0.00008341,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
FOXO3,rs10457180,,Significant,0.0000648,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
FOXO3,rs2764264,,Significant,0.0002,10.1073/pnas.0801030105,male,longevity,Japanese,genomic,,SNP,,,,minor,,24.8,34.7,402,213,,,81,,95,,candidate genes study,,"Участники, дожившие до 95 лет и старше, были классифицированы как пациенты с «долгожительством» (n = 213). Участники, умершие в возрасте до 81 года, были контрольной группой «средней продолжительности жизни» (n = 402) (население Гавайев и Гонолулу).",
FOXO3,rs13217795,,Significant,0.0006,10.1073/pnas.0801030105,male,longevity,Japanese,genomic,,SNP,,,,minor,,24.8,34,402,213,,,81,,95,,candidate genes study,,"Участники, дожившие до 95 лет и старше, были классифицированы как пациенты с «долгожительством» (n = 213). Участники, умершие в возрасте до 81 года, были контрольной группой «средней продолжительности жизни» (n = 402) (население Гавайев и Гонолулу).",
FOXO3,rs2802292,,Significant,"<0,0001",10.1073/pnas.0801030105,male,longevity,Japanese,genomic,,SNP,,,,G,,25.5,37.1,402,213,,,81,,95,,candidate genes study,,"Участники, дожившие до 95 лет и старше, были классифицированы как пациенты с «долгожительством» (n = 213). Участники, умершие в возрасте до 81 года, были контрольной группой «средней продолжительности жизни» (n = 402) (население Гавайев и Гонолулу). Генотипы GG и TG чаще встречались у долгожителей. Те долгожители, которые обладали одним или несколькими аллелями G, имели больше шансов быть здоровыми на исходном уровне, чем те, кто был гомозиготным по распространенному аллелю (TT).",
FOXO3,rs2802292,,Significant,0.000000000185,10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,G,,,,9664,10574,,55,80,,90,,"meta-analysis of GWAS, replication of previous findings",,,
FOXO3,rs10457180,intron,Significant,0.023,10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,16121,5409,,,65,,90,,"meta-analysis of GWAS, replication",,,
FOXO3,rs4946936,,Significant,0.01058,10.1093/gerona/glv058,both,longevity,"Italian, Calabrian",genomic,,SNP,,,,T,,37.65,44.44,302,320,75.1,,,96,90,,candidate genes study,,,
FOXO3,rs2802292,,Significant,"<0,001",10.4103/1008-682X.123673,male,longevity,mixed,genomic,,SNP,,,,G,,,,1650,990,,,81,,90,,meta-analysis of candidate gene studies,,"Анализ четырех исследований (990 случаев и 1650 контролей) с использованием модели случайных эффектов для изучения роли полиморфизма rs2802292, в частности, в долголетии мужчин. Полиморфизм rs2802292 показал достоверную ассоциацию с продолжительностью жизни у мужчин (OR = 1,54, 95% ДИ = 1,33–1,79, P <0,001). Не было выявлено значимой связи полиморфизма rs2802292 с продолжительностью жизни женщин.",
FOXO3,rs2764264,,Significant,0.01,10.4103/1008-682X.123673,male,longevity,mixed,genomic,,SNP,,,,C,,,,968,807,,,89,,90,,meta-analysis of candidate gene studies,,"В подгрупповой анализ rs2764264 у мужчин были включены два исследования, включающих 807 случаев и 968 контролей. Наблюдалась достоверная ассоциация между rs2764264 и мужской продолжительностью жизни (OR = 1,38, 95% CI = 1,15–1,66, P = 0,001). Результат показал отсутствие связи полиморфизма rs2764264 с продолжительностью жизни женщин. Достоверная ассоциация rs2764264 с продолжительностью жизни для аллеля C по сравнению с T (OR = 1,20, 95% CI = 1,04–1,37, P = 0,01) была обнаружена в общей популяции.",
FOXO3,rs13217795,,Significant,0.001,10.4103/1008-682X.123673,both,longevity,mixed,genomic,,SNP,,,,C,,,,1481,1706,,,89,,90,,meta-analysis of candidate gene studies,,"Специфический для мужчин метаанализ был проведен в трех исследованиях. Полиморфизм rs13217795 показал значительную связь с мужской продолжительностью жизни (OR = 1,39, 95% CI = 1,15–1,67, P = 0,001). Обнаружена достоверная ассоциация между полиморфизмом FOXO3A rs13217795 и продолжительностью жизни в отношении аллеля C по сравнению с T (OR = 1,27, 95% CI = 1,10–1,46, P = 0,001) в общей популяции.",
FOXO3,rs2802288,,Significant,0.003,10.4103/1008-682X.123673,both,longevity,mixed,genomic,,SNP,,,,A,,,,1688,1214,,,89,,90,,meta-analysis of candidate gene studies,,"В метаанализ полиморфизма FOXO3A rs2802288 были включены четыре независимых исследования, включающих 1688 случаев и 1214 контролей. Достоверная ассоциация полиморфизма rs2802288 с увеличенной продолжительностью жизни была обнаружена для аллеля A по сравнению с аллелем G (OR = 1,24, 95% CI = 1,07–1,43, P = 0,003).",
FOXO3A,rs2153960,,Non-significant,0.81,10.1111/j.1474-9726.2009.00493.x,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,,363,383,79.5,43,94,97.7,95,108,candidate genes study,,,
FOXO3A,rs3778588,,Non-significant,0.19,10.1111/j.1474-9726.2009.00493.x,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,,363,383,79.5,43,94,97.7,95,108,candidate genes study,,,
FOXO3A,rs9486902,,Non-significant,0.99,10.1111/j.1474-9726.2009.00493.x,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,,363,383,79.5,43,94,97.7,95,108,candidate genes study,,,
FOXO3A,rs9486913,,Non-significant,0.32,10.1111/j.1474-9726.2009.00493.x,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,,363,383,79.5,43,94,97.7,95,108,candidate genes study,,,
FOXO3A,rs9384679,,Non-significant,"0,35",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO3A,rs6927268,,Non-significant,"0,15",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO3A,rs17069632,,Non-significant,"0,88",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO3A,rs6930527,,Non-significant,"0,99",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO3A,rs12198276,,Non-significant,"0,3",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO3A,rs1536057,,Non-significant,"0,49",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO3A,rs12202049,,Non-significant,"0,57",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO3A,rs3778586,,Non-significant,"0,89",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO3A,rs3800230,,Non-significant,"0,37",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO3A,rs1044891,,Non-significant,0.53,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
FOXO3A,rs1935949,,Non-significant,0.23,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
FOXO3A,rs2153960,,Non-significant,0.19,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
FOXO3A,rs3778588,,Non-significant,0.84,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
FOXO3A,rs4946935,,Non-significant,0.11,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
FOXO3A,rs9486902,,Non-significant,0.93,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
FOXO3A,rs9486913,,Non-significant,0.6,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
FOXO3A,rs1044891,,Non-significant,0.14,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,1400,572,75.9,79,,95,92,,meta-analysis of candidate gene studies,,,
FOXO3A,rs2153960,,Non-significant,0.019,10.1111/j.1474-9726.2009.00493.x,both,longevity,"Caucasian, Ashkenazi Jewish",genomic,,SNP,,,,,,,,1673,955,79.1,43,94,96.5,92,108,meta-analysis of candidate gene studies,,,
FOXO3A,rs3778588,,Non-significant,0.023,10.1111/j.1474-9726.2009.00493.x,both,longevity,"Caucasian, Ashkenazi Jewish",genomic,,SNP,,,,,,,,1673,955,79.1,43,94,96.5,92,108,meta-analysis of candidate gene studies,,,
FOXO3A,rs9486902,,Non-significant,0.073,10.1111/j.1474-9726.2009.00493.x,both,longevity,"Caucasian, Ashkenazi Jewish",genomic,,SNP,,,,,,,,1673,955,79.1,43,94,96.5,92,108,meta-analysis of candidate gene studies,,,
FOXO3A,rs9486913,,Non-significant,0.053,10.1111/j.1474-9726.2009.00493.x,both,longevity,"Caucasian, Ashkenazi Jewish",genomic,,SNP,,,,,,,,1673,955,79.1,43,94,96.5,92,108,meta-analysis of candidate gene studies,,,
FOXO3A,PARP1[rs1136410]+FOXO3A[rs479744],,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
FOXO3A,rs1935949,,Significant,0.016,10.1111/j.1474-9726.2009.00493.x,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,,363,383,79.5,43,94,97.7,95,108,candidate genes study,,,
FOXO3A,rs4946935,,Significant,0.029,10.1111/j.1474-9726.2009.00493.x,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,,363,383,79.5,43,94,97.7,95,108,candidate genes study,,,
FOXO3A,rs9486902,,Significant,0.005,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO3A,rs1044891,,Significant,0.0083,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO3A,rs9486913,,Significant,0.0051,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO3A,rs2153960,,Significant,0.015,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO3A,rs3778588,,Significant,0.0047,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO3A,rs1935949,,Significant,0.042,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO3A,rs4946935,,Significant,0.041,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
FOXO3A,rs1935949,,Significant,0.0014,10.1111/j.1474-9726.2009.00493.x,both,longevity,"Caucasian, Ashkenazi Jewish",genomic,,SNP,,,,,,,,1673,955,79.1,43,94,96.5,92,108,meta-analysis of candidate gene studies,,,
FOXO3A,rs4946935,,Significant,0.00087,10.1111/j.1474-9726.2009.00493.x,both,longevity,"Caucasian, Ashkenazi Jewish",genomic,,SNP,,,,,,,,1673,955,79.1,43,94,96.5,92,108,meta-analysis of candidate gene studies,,,
FOXO3A,rs13217795,,Significant,0.0018,10.18632/aging.100703,both,longevity,Chinese,genomic,,SNP,,,,"TT, TC",CC,93.9,88,508,567,51.7,,,94.1,,,candidate genes study,,,
FPGT-TNNI3K,rs146254978,,Significant,0.000000046,10.18632/aging.101334,both,increased parents' age at death,European,genomic,,,,,,,T,,,,208118,,,,75.41,51,105,GWAS,,,
FRK,rs118113034,,Non-significant,0.9,10.1001/jamanetworkopen.2018.1670,male,longevity,"Chinese, Han",genomic,,SNP,,,,minor,,2,2,773,564,48.7,40,64,101.5,100,,GWAS,,,
FRK,rs118113034,,Significant,"8,5 × 10-6",10.1001/jamanetworkopen.2018.1670,female,longevity,"Chinese, Han",genomic,,SNP,,,,major,,98,99,1526,1614,48.2,40,64,103.1,100,,GWAS,,,
FSHR,,"exon, missense",Significant,0.036,10.1089/rej.2012.1365,female,longevity,"Italian, Southern",genomic,,SNP,,Asn/Ser,680,Ser/Ser,,8,25,36,59,,,,,90,,candidate genes study,,,
FSTL5,rs12711357,,Non-significant,0.75,10.1001/jamanetworkopen.2018.1670,male,longevity,"Chinese, Han",genomic,,SNP,,,,major,,76,77,773,564,48.7,40,64,101.5,100,,GWAS,,,
FSTL5,rs12711357,,Significant,"9,1 × 10-6",10.1001/jamanetworkopen.2018.1670,female,longevity,"Chinese, Han",genomic,,SNP,,,,major,,75,80,1526,1614,48.2,40,64,103.1,100,,GWAS,,,
FTH1P5,rs6904450,,Non-significant,0.319,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
FTH1P5,rs6904450,,Non-significant,0.655,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
FTH1P5,rs6904450,,Significant,0.000000045,10.1038/ncomms15842,both,increased parents' age at death,European,genomic,,,,,,,,,,,276796,,,,,40,,iGWAS,,,
FTL1,rs3794396,,Significant,0.0007,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,,,,,374,440,78.1,72,81,97,95,106,candidate genes study,,,
FTL1,rs7987649,,Significant,0.0189,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,,,,,374,440,78.1,72,81,97,95,106,candidate genes study,,,
FTL1,rs9513099,,Significant,0.025,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,,,,,374,440,78.1,72,81,97,95,106,candidate genes study,,,
FTO,rs9939973,,Non-significant,0.00000122,10.1038/ncomms15842,both,increased parents' age at death,European,genomic,,,,,,,A,,,,276796,,,,,40,,iGWAS,,,
FTO,rs9939973,,Non-significant,0.075,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
FTO,rs9939973,,Non-significant,0.252,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
FURIN,rs17514846,,Non-significant,0.116,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,C,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
FURIN,rs17514846,,Non-significant,0.123,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,C,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
FURIN,rs17514846,,Significant,0.00000000071,10.18632/aging.101334,both,increased parental lifespan,European,genomic,,,,,,,C,,,,389166,,,,56.66,40,73,GWAS,,,
FURIN,rs6224,,Significant,0.00000000013,10.7554/eLife.39856.001,both,increased parental lifespan,European,genomic,,SNP,,,,,G,,,,1012240,,,,71.63,40,117,GWAS,,,
GH1,rs2665802,intron,Significant,0.019,10.1111/j.1474-9728.2005.00148.x,female,longevity,Dutch,genomic,decreased gene expression,SNP,"A>G, A>T",,,T,A,,,,866,,,,,85,,candidate genes study,,"У женщин, являющихся носителями аллеля T, рост был на 2 см ниже (P = 0,007), а смертность в возрасте старше 85 лет - на 20% ниже (P = 0,019) по сравнению с носителями аллеля A. Испытуемые были жителями Лейдена (Нидерланды) в возрасте от 85 лет. ",
GHR,rs12153009,,Non-significant,0.47,10.1111/j.1474-9726.2009.00493.x,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,,363,383,79.5,43,94,97.7,95,108,candidate genes study,,,
GHR,rs3764451,,Non-significant,0.61,10.1111/j.1474-9726.2009.00493.x,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,,363,383,79.5,43,94,97.7,95,108,candidate genes study,,,
GHR,rs6883523,,Non-significant,0.64,10.1111/j.1474-9726.2009.00493.x,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,,363,383,79.5,43,94,97.7,95,108,candidate genes study,,,
GHR,rs906817,,Non-significant,"0,34",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs17574650,,Non-significant,"0,12",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs2972411,,Non-significant,"0,49",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs17575164,,Non-significant,"0,66",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs6451620,,Non-significant,"0,57",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs2940935,,Non-significant,"0,61",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs4130113,,Non-significant,"0,62",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs4129472,,Non-significant,"0,34",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs4410646,,Non-significant,"0,43",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs6898743,,Non-significant,"0,98",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs12233949,,Non-significant,"0,16",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs9292854,,Non-significant,"0,18",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs13182117,,Non-significant,"0,26",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs7727694,,Non-significant,"0,13",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs4413537,,Non-significant,"0,3",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs6179,,Non-significant,"0,91",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs6180,,Non-significant,0.065,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs12518414,,Non-significant,0.086,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs6451625/rs4493680,,Non-significant,"0,55",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs12153009,,Non-significant,0.55,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
GHR,rs2940923,,Non-significant,0.44,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
GHR,rs3764451,,Non-significant,0.86,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
GHR,rs4292454,,Non-significant,0.49,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
GHR,rs4866941,,Non-significant,0.27,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
GHR,rs6883523,,Non-significant,0.48,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
GHR,rs6887528,,Non-significant,0.38,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
GHR,rs4292454,,Non-significant,0.39,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,1400,572,75.9,79,,95,92,,meta-analysis of candidate gene studies,,,
GHR,rs4866941,,Non-significant,0.19,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,1400,572,75.9,79,,95,92,,meta-analysis of candidate gene studies,,,
GHR,rs6887528,,Non-significant,0.25,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,1400,572,75.9,79,,95,92,,meta-analysis of candidate gene studies,,,
GHR,rs3764451,,Non-significant,0.094,10.1111/j.1474-9726.2009.00493.x,both,longevity,"Caucasian, Ashkenazi Jewish",genomic,,SNP,,,,,,,,1673,955,79.1,43,94,96.5,92,108,meta-analysis of candidate gene studies,,,
GHR,rs6883523,,Non-significant,0.52,10.1111/j.1474-9726.2009.00493.x,both,longevity,"Caucasian, Ashkenazi Jewish",genomic,,SNP,,,,,,,,1673,955,79.1,43,94,96.5,92,108,meta-analysis of candidate gene studies,,,
GHR,,,Non-significant,0.14,10.1126/sciadv.1602025,male,longevity,Caucasian,genomic,,In/Del,,,d3-GHR,d3/d3,,8.3,26.5,,61,,75,85,,86,95,candidate genes study,,,
GHR,rs4130113,,Significant,0.015,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,,,,,374,440,78.1,72,81,97,95,106,candidate genes study,,,
GHR,rs4130113,,Significant,0.015,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,AA,"AG,GG",,,374,440,78.1,72,81,97,95,106,candidate genes study,,,
GHR,rs2940923,,Significant,0.023,10.1111/j.1474-9726.2009.00493.x,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,,363,383,79.5,43,94,97.7,95,108,candidate genes study,,,
GHR,rs2940935,,Significant,0.046,10.1111/j.1474-9726.2009.00493.x,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,,363,383,79.5,43,94,97.7,95,108,candidate genes study,,,
GHR,rs3764451,,Significant,0.0093,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs2940923,,Significant,0.0094,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs12153009,,Significant,0.017,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs6883523,,Significant,0.042,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs4866941,,Significant,0.0027,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs4292454,,Significant,0.043,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs6887528,,Significant,0.012,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHR,rs2940935,,Significant,0.011,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
GHR,rs12153009,,Significant,0.033,10.1111/j.1474-9726.2009.00493.x,both,longevity,"Caucasian, Ashkenazi Jewish",genomic,,SNP,,,,,,,,1673,955,79.1,43,94,96.5,92,108,meta-analysis of candidate gene studies,,,
GHR,rs2940923,,Significant,0.0013,10.1111/j.1474-9726.2009.00493.x,both,longevity,"Caucasian, Ashkenazi Jewish",genomic,,SNP,,,,,,,,1673,955,79.1,43,94,96.5,92,108,meta-analysis of candidate gene studies,,,
GHR,rs2940935,,Significant,0.0031,10.1111/j.1474-9726.2009.00493.x,both,longevity,"Caucasian, Ashkenazi Jewish",genomic,,SNP,,,,,,,,1673,955,79.1,43,94,96.5,92,108,meta-analysis of candidate gene studies,,,
GHR,,,Significant,0.02,10.1126/sciadv.1602025,male,longevity,Amish,genomic,,In/Del,,,d3-GHR,d3/d3,,5,21,,152,45,25,,75,,85,candidate genes study,,,
GHR,,,Significant,"<0,05",10.1126/sciadv.1602025,male,longevity,Ashkenazi Jewish,genomic,,In/Del,,,d3-GHR,d3/d3,,4,12,94,102,71,43,92,,95,,candidate genes study,,,
GHR,,,Significant,0.02,10.1126/sciadv.1602025,male,longevity,French,genomic,,In/Del,,,d3-GHR,d3/d3,,6.45,30,,61,,,99,,100,,candidate genes study,,,
GHR,,,Significant,0.02,10.1126/sciadv.1602025,male,longevity,"Ashkenazi Jewish, Amish, Caucasian",genomic,,In/Del,,,d3-GHR,d3/d3,,6.45,30,,470,,,99,,100,,meta-analysis of candidate gene studies,,"Генетический полиморфизм d3-GHR (делеция экзона 3) модулирует чувствительность к GH1 у людей и, как было обнаружено, положительно влияет на продолжительность жизни мужчин. Многомерный регрессионный анализ показывает, что гомозиготность по d3 может увеличить продолжительность жизни мужчин до 10 лет. Гомозиготные люди также показали более низкие уровни IGF1 в сыворотке. Линейное увеличение распространенности гомозиготности d3-GHR с возрастом в четырех независимых когортах долгожителей: 841 участник [567 из Проекта генов долголетия (LGP) (увеличение на 8%; P = 0,01), 152 - из амишей старого порядка (Увеличение на 16%; P = 0,02), 61 из исследования сердечно-сосудистой системы (увеличение на 14,2%; P = 0,14) и 61 из французского исследования долгожителей (увеличение на 23,5%; P = 0,02)]. Кроме того, мега-анализ мужчин во всех когортах показал значительную положительную тенденцию с возрастом (рост на 26%; P = 0,007), предполагая, что половой диморфизм влияет на действие GH в долголетии.",
GHRH,rs4988492,,Non-significant,0.087,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHRHR,rs2267723,intron,Non-significant,0.934,10.1016/j.exger.2012.02.010,both,longevity,German,genomic,,SNP,,,,G,A,,,1140,1613,67.2,,,,95,110,candidate genes study,,,
GHRHR,rs6954044,,Non-significant,"0,56",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHRHR,rs17159769,,Non-significant,"0,7",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHRHR,rs2302019,,Non-significant,"0,71",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHRHR,rs4988494,,Non-significant,"0,12",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHRHR,rs2267721,,Non-significant,"0,17",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHRHR,rs2267723,,Non-significant,"0,4",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHRHR,rs4988496,,Non-significant,"0,4",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHRHR,rs4988498,,Non-significant,"0,21",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHRHR,rs4723038,,Non-significant,"0,38",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHRHR,rs2741,,Non-significant,"0,77",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHRHR,rs4988505,,Non-significant,"0,54",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHRHR,rs11761979,,Non-significant,0.064,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHRHR,rs2228078,,Non-significant,0.96,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
GHRHR,rs2228078,,Non-significant,0.21,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,1400,572,75.9,79,,95,92,,meta-analysis of candidate gene studies,,,
GHRHR,rs2267723,intron,Significant,0.00011,10.1016/j.exger.2012.02.010,both,longevity,Danish,genomic,,SNP,,,,A,G,,,800,1200,50.5,46,55,93.2,92.2,93.8,candidate genes study,,,
GHRHR,rs2267723+rs4988505,,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
GHRHR,rs2228078,,Significant,0.048,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
GHRL,rs696217,exon,Significant,0.0472,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,G,T,12,15,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
GHSR,rs572169,"exon, synonymous",Non-significant,0.097,10.1016/j.exger.2012.02.010,both,longevity,German,genomic,,SNP,,,,A,G,,,1140,1613,67.2,,,,95,110,candidate genes study,,,
GHSR,rs572169,"exon, synonymous",Significant,0.0045,10.1016/j.exger.2012.02.010,both,longevity,Danish,genomic,,SNP,,,,G,A,,,800,1200,50.5,46,55,93.2,92.2,93.8,candidate genes study,,,
GHSR,rs572169+rs512692,,Significant,0.001,10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,GG+T,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
GHSR,GHSR[rs572169]/PTPN1[rs6067484],,Significant,0.001,10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,GHSR[GG]+PTPN1[AG],,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
GHSR,GHSR/[rs572169]+GHSR[rs512692]+/PAPPA[rs4837525],,Significant,0.001,10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,GHSR[GG]+GHSR[TT]+PAPPA[AG],,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
GHSR,GHSR[rs572169]+MRE11A[rs533984],,Significant,0.001,10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,GHSR[GG]+MRE11A[G],,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
GHSR,GHSR[rs572169]+MRE11A[rs533984]+PARK7[rs225119],,Significant,0.001,10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,GHSR[GG]+MRE11A[G]+PARK7[G],,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
GLRX,GSS[rs2236270]+CYP1B1[rs162557]+GLRX[rs3756704],,Significant,0.001,10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,, GSS[AC]/CYP1B1[GG]/GLRX[AG],,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
GPR78,rs7676745,intergenic,Significant,"4,3 × 10^−8",10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,A,,,25483,11262,,,75,,89,,meta-analysis of GWAS,,,
GPR78,rs7676745,,Significant,"1,7 × 10^−7",10.1038/s41467-019-11558-2,both,longevity,"European, East Asian, African American",genomic,,SNP,,,,G,A,,,27993,13617,,,75,,89,,meta-analysis of GWAS,,,suggestive significant
GPX1,rs1050450,,Significant,0.008,10.1016/j.mad.2009.01.005,both,longevity,Danish,genomic,,SNP,,,,"TT, TC",,,,,1650,,,,,92,93,candidate genes study,,"Были изучены 1650 человек из датской когорты 1905 года (время наблюдения: 1998-2008 годы, возраст на момент поступления: 92-93 года, количество смертей: 1589 (96,3%)). Была исследована связь со старением и долголетие. Было обнаружено снижение смертности лиц, имеющих аллели GPX1 rs1050450 T HR (GPX1 (TT/TC)) = 0,93, p = 0,008). Наблюдались умеренные положительные ассоциации с хорошей самооценкой здоровья, снижением инвалидности и повышением когнитивных способностей.",
GRHL1,rs2008465,,Non-significant,0.114,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
GRHL1,rs2008465,,Non-significant,0.035,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
GRIK2,rs9377361,,Non-significant,0.981,10.1093/gerona/glu166,both,increased lifespan,Caucasian,genomic,,SNP,,,,,,,,,4567,,,,,25,110,"meta-analysis of GWAS, replication",,,
GRIK2,rs1416280,,Non-significant,0.16,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,C,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
GRIK2,rs1416280,,Non-significant,0.862,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,C,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
GRIK2,rs9377361,,Non-significant,0.833,10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,914,801,73,54,90,104,95,119,"meta-analysis of GWAS, replication",,,
GRIK2,rs1416280,369,Non-significant,0.276,10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,16121,5409,,,65,,90,,"meta-analysis of GWAS, replication",,,
GRIK2,rs1416280,369,Significant,"5,09 × 10^−8",10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,3757,6036,,55,80,,90,,meta-analysis of GWAS,,,suggestive significant
GRN,rs63750412,,Significant,"5,18 × 10−05",10.1093/gerona/glab023,both,longevity,German,genomic,,SNP,,,,T,,,,6941,1248,,,59,99,94,110,single-variant association approach,,,
GRN,"rs63750723, rs63750043, rs63750541, rs63750412",,Significant,"1,59 × 10−05",10.1093/gerona/glab023,both,longevity,German,genomic,,,,,,,,,,6941,1248,,,59,99,94,110,gene-based association approach,,,SKAT-CommonRare function method
GSR,rs1002149,5',Non-significant,0.47,10.1016/j.exger.2012.02.010,both,longevity,German,genomic,,SNP,,,,A,C,,,1140,1613,67.2,,,,95,110,candidate genes study,,,
GSR,rs1002149,5',Significant,0.0335,10.1016/j.exger.2012.02.010,both,longevity,Danish,genomic,,SNP,,,,C,A,,,800,1200,50.5,46,55,93.2,92.2,93.8,candidate genes study,,,
GSS,GSS[rs2236270]+CYP1B1[rs162557]+GLRX[rs3756704],,Significant,0.001,10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,, GSS[AC]/CYP1B1[GG]/GLRX[AG],,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,"Была обнаружена трехуровневая комбинация SNP, достоверно связанная с продолжительностью жизни rs2236270 (ген GSS)‐ rs162557 (ген CYP1B1)‐rs3756704‐GLRX (p < .001). Изученная здесь выборка включала 1089 случаев (средний возраст: 93,1 года, возрастной диапазон 92,2–93,8 года, 29% мужчин и 71% женщин), взятых из подходящих участников датского когортного исследования 1905 года рождения и 736 человека в контрольной группе (средний возраст 50,6, возрастной диапазон 46,0–55,0, распределение по полу 50% мужчин и 50% женщин) из Исследования датских близнецов среднего возраста.",
GSTZ1,rs2111699,intron,Significant,1.4 × 10−3,10.1007/s11357-012-9416-8,both,longevity,"Italian, Calabrian",genomic,,SNP,,,,,,,,554,288,67,,,92,,,candidate genes study,,,
HDAC4,rs10174562,3'UTR,Significant,0.0424,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,T,C,85.2,88.3,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
HIST1H2BD,rs72834698,,Non-significant,0.206,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
HIST1H2BD,rs72834698,,Non-significant,0.003,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
HLA-DQA1,rs34967069,,Non-significant,0.258,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,T,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
HLA-DQA1,rs34967069,,Non-significant,0.243,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,T,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
HLA-DQA1,rs34967069,,Significant,0.0000000043,10.7554/eLife.39856.001,both,increased parental lifespan,European,genomic,,SNP,,,,,T,,,,1012240,,,,71.63,40,117,GWAS,,,
HLA-DQB1 ,rs3830058,intron,Significant,0.00000271,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,G,A,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
HLA-DRA ,rs2239804,intron,Significant,0.00000228,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/G,,,G,A,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
HLA-DRB1,,,Significant,"<0,05",10.1080/03610730600875791,both,longevity,Chinese,genomic,,PCR-RFLP,,,HLA-DR,DR4,,,,81,20,,,,,90,,candidate genes study,,"Аллель HLA-DRB1*04 имеет положительную ассоциацию с долголетием (P <0,05). Размер выборки: долгожители - 20 человек (12 мужчин = 8 женщин) возрасте 90 лет. контрольная группа - 81 здоровых человека (41 мужчина, 40 женщин) Этническая принадлежность: китайцы",
HLA-DRB1,,,Significant,"<0,05",10.1080/03610730600875791,both,longevity,Chinese,genomic,,PCR-RFLP,,,HLA-DR,DR16,,,,81,20,,,,,90,,candidate genes study,,"Аллель HLA-DRB1*16 имеет положительную ассоциацию с долголетием (P <0,05). Размер выборки: долгожители - 20 человек (12 мужчин = 8 женщин) возрасте 90 лет. контрольная группа - 81 здоровых человека (41 мужчина, 40 женщин) Этническая принадлежность: китайцы",
HLA-DRB1,,,Significant,,10.1093/hmg/7.2.187,male,longevity,French,genomic,,PCR-RFLP,,,HLA-DR,DR7,,14,21.2,2950,66,,,,100.9,100,,candidate genes study,,"Размер выборки: 533 долгожителя и 229 братьев и сестер из семей долгожителей. Братьев и сестер из семей долгожителей набирали в соответствии с установленными критериями семейного долголетия: по крайней мере, два долгожителя среди братьев и сестер, то есть> 90 лет для мужчин,> 95 лет для женщин. Контрольная группа: 2950 человек в возрасте от 20 до 60 лет). Возраст: долгожители: > 99 лет на день сбора крови (средний возраст: 100,9 ± 0,35, 101,25 ± 0,21, 101,2 ± 0,18 для мужской, женской и общей групп соответственно). Братья и сестры из семей долгожителей: средний возраст: 93,4 ± 0,78, 95,7 ± 1,05 и 94,7 ± 0,69 для мужской, женской и общей групп соответственно. Пол: 89 мужчин и 444 женщины среди долгожителей. Этническая принадлежность: французы Таким образом, были выделены четыре группы долгожителей: мужчины или женщины долгожители (VIE), братья и сестры из семей долгожителей мужского или женского пола (SIB). 95% доверительные интервалы для частот аллелей составляют, соответственно: DR7, 13,1%, 14,9% в контрольной группе против 16,7%, 26,1% в группе долгожителей мужского пола (VIE + SIB) и 10,95%, 18,65% в группе долгожителей женского пола (VIE + SIB) (OR 1,72 (95% ДИ: 1,19–2,5, P = 0,004) для мужчин долгожителей).",
HLA-DRB1,,,Significant,,10.1093/hmg/7.2.187,both,longevity,French,genomic,,PCR-RFLP,,,HLA-DR,DR13,,12.8,17.4,2950,325,,,,101.25,100,,candidate genes study,,"95% доверительные интервалы для частот аллелей составляют соответственно: DR13, 11,75%, 13,45% в контрольной группе по сравнению с 14,5%, 20,3% у долгожителей (OR 1,46 (95% ДИ: 1,22–1,75, P <0,0001)) Размер выборки: 533 долгожителя и 229 братьев и сестер из семей долгожителей. Братьев и сестер из семей долгожителей набирали в соответствии с установленными критериями семейного долголетия: по крайней мере, два долгожителя среди братьев и сестер, то есть> 90 лет для мужчин,> 95 лет для женщин. Контрольная группа: 2950 человек в возрасте от 20 до 60 лет). Возраст: долгожители: > 99 лет на день сбора крови (средний возраст: 100,9 ± 0,35, 101,25 ± 0,21, 101,2 ± 0,18 для мужской, женской и общей групп соответственно). Братья и сестры из семей долгожителей: средний возраст: 93,4 ± 0,78, 95,7 ± 1,05 и 94,7 ± 0,69 для мужской, женской и общей групп соответственно. Пол: 89 мужчин и 444 женщины среди долгожителей. Этническая принадлежность: французы Таким образом, были выделены четыре группы долгожителей: мужчины или женщины долгожители (VIE), братья и сестры из семей долгожителей мужского или женского пола (SIB).",
HLA-DRB1,,,Significant,0.004,10.1111/j.1399-0039.1997.tb02904.x,both,longevity,"Japanese, Okinawan",genomic,,PCR-RFLP,,,HLA-DR,DRB1*1401,,2.7,11.3,129,120,63.5,20,75,102.3,100,110,candidate genes study,,"Размер выборки: 120 долгожителей и 129 человек в контрольной группе. Этническая принадлежность: японцы Пол: среди долгожителей 25 мужчин и 95 женщин, в контрольной группе 42 мужчины и 87 женщин. Возраст: долгожители 100-110 лет (средний 102,3 года), контрольная 20-75 лет (в среднем 63,5 года). Частота DRB1*1401 (x2 = 12,93, P = 0,0002, Pc = 0,004, RR = 4,146) была увеличена у долгожителей по сравнению с контрольной группой. Положительная ассоциация с DRB1*1401 была статистически значимой даже после теста на скорректированное значение P (Pc = 0,004).",
HLA-DRB1,,,Significant,"<0,001",,both,longevity,,genomic,,PCR-RFLP,,,HLA-DR,DR11,,10,18.3,,102,,,,,90,,candidate genes study,10432438,"Размер выборки: 336 долгожителей (> или = 90 лет) без семейного анамнеза долголетия, и 102 человека из семей долгожителей. Повышенная аллельная частота HLA DR11 наблюдалась у людей из семей долгожителей (18,3%) по сравнению с контрольной группой (10%) (p <0,001) и долгожителями без семейного анамнеза (11,8%).",
HMHA1,"rs1801284, rs2074442, rs36084354, rs142614852, rs150294461, rs139988914, rs61734935, rs139251906",,Significant,"1,54 × 10−03",10.1093/gerona/glab023,both,longevity,German,genomic,,,,,,,,,,6941,1248,,,59,99,94,110,gene-based association approach,,,SKAT-CommonRare function method
HNF4A,rs2071200,intron,Non-significant,0.222,10.1016/j.exger.2009.02.004,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,,364,388,79.5,,,97.7,95,108,candidate genes study,,"Когорта евреев-ашкенази: 388 евреев-ашкенази с высокой продолжительностью жизни [289 женщин и 99 мужчин, средний возраст 97,7 (0,2) года (возрастной диапазон 95–108 лет; 20% старше 100 лет] и контрольные группы евреев-ашкенази [n = 364, средний возраст 79,5 (0,4) года (58% женщины] без семейного анамнеза высокой продолжительности жизни.",
HNF4A,rs2071200,intron,Non-significant,0.764,10.1016/j.exger.2009.02.004,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,"Когорта SOF: n = 9704 женщины европейского происхождения в возрасте 65 лет и старше из США. Когорта наблюдалась более 20 лет с полным последующим наблюдением за смертностью и включала 896 участников SOF, отобранных для включения в исследование продолжительности жизни (293 человек в группе долгожителей ≥ 92 лет, средняя продолжительности жизни = 95,3 ± 2,1 года и 603 человека в контрольной группе, на момент смерти ≤ 79 лет, средняя продолжительности жизни = 75,7 ± 2,6 года).",
HNF4A,rs2071200,intron,Significant,0.0099,10.1016/j.exger.2009.02.004,both,longevity,"Caucasian, African-American",genomic,,SNP,,,,,,,,900,479,,,79,,92,,candidate genes study,,"Когорта CHS: 5888 взрослых мужчин и женщин 65 лет и старше из США. 4925 человек или 95% определили свою этническую принадлежность как белые. В группу долгожителей относили людей, доживших как минимум до 92 лет (n = 479; 61% женщин), а в контрольную группу - людей, умерших в возрасте до 79 лет (n = 900; 46% женщин). ).",
HNF4G,"rs2943549, rs201625743, rs138897994, rs148532560",,Significant,"3,95 × 10−05",10.1093/gerona/glab023,both,longevity,German,genomic,,,,,,,,,,6941,1248,,,59,99,94,110,gene-based association approach,,,SKAT-CommonRare function method
HP,rs12924886,,Non-significant,0.786,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
HP,rs12924886,,Non-significant,0.498,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
HP,rs12924886,,Significant,0.000000014,10.7554/eLife.39856.001,both,increased parental lifespan,European,genomic,,SNP,,,,,,,,,1012240,,,,71.63,40,117,GWAS,,,
HPCAL1,rs1974676,intron,Significant,0.00496,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,35.4,41.6,,1173,,60,75,,85,105,GWAS,,,
HRAS,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,APOE[promoter+promoter+promoter+exon4+exon4]+HRAS[promoter+promoter+promoter+promoter+promoter+promoter+exon1]+LASS1[exon1+exon1],Significant,0.0000288,10.1111/j.1474-9726.2010.00600.x,both,longevity,Caucasian,genomic,,haplotype,,,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,HRAS-CGCGCGT+ApoE-ATTTC+LASS1-CCT,,1,7.3,188,147,40.62,20,59,100.57,98,,candidate genes study,,ε3-содержащий гаполотип ApoE (ATTTC) в комбинации с гаплотипом HRAS (CGCGCGT) и гаплотипами LASS1 (CCT) или (CGT) ассоциирован с высокой продолжительностью жизни. Генетический анализ был проведен на популяциях их Джорджии (N=650) и (N=869) Луизианы.,
HRAS,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,APOE[promoter+promoter+promoter+exon4+exon4]+HRAS[promoter+promoter+promoter+promoter+promoter+promoter+exon1]+LASS1[exon1+exon1],Significant,0.0000466,10.1111/j.1474-9726.2010.00600.x,both,longevity,Caucasian,genomic,,haplotype,,,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,HRAS-CGCGCGT+ApoE-ATTTC+LASS1-CGT,,8.4,19.1,188,147,40.62,20,59,100.57,98,,candidate genes study,,,
HRAS,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,APOE[promoter+promoter+promoter+exon4+exon4]+HRAS[promoter+promoter+promoter+promoter+promoter+promoter+exon1]+LASS1[exon1+exon1],Significant,0.0000568,10.1111/j.1474-9726.2010.00600.x,both,longevity,Caucasian,genomic,,haplotype,,,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,HRAS-CGCGCGT+ApoE-ATTTC+LASS1-CCT,,3.9,10.5,251,204,43.87,20,59,92.8,90,,candidate genes study,,,
HRAS,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,APOE[promoter+promoter+promoter+exon4+exon4]+HRAS[promoter+promoter+promoter+promoter+promoter+promoter+exon1]+LASS1[exon1+exon1],Significant,0.0000005,10.1111/j.1474-9726.2010.00600.x,both,longevity,Caucasian,genomic,,haplotype,,,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,HRAS-CGCGCGT+ApoE-ATTTC+LASS1-CGT,,6.7,17.5,251,204,43.87,20,59,92.8,90,,candidate genes study,,,
HSPA14,rs17268499,,Significant,0.004,10.1007/s11357-011-9373-7,both,longevity,Danish,genomic,,SNP,,,,,,,,736,1089,50.6,46,55,93.2,92.2,93.8,candidate genes study,,,Single-SNP-based test
HSPA14,rs7905174,,Significant,0.005,10.1007/s11357-011-9373-7,both,longevity,Danish,genomic,,SNP,,,,,,,,736,1089,50.6,46,55,93.2,92.2,93.8,candidate genes study,,,Single-SNP-based test
HSPA14,rs9787671,,Significant,0.001,10.1007/s11357-011-9373-7,both,longevity,Danish,genomic,,SNP,,,,,,,,736,1089,50.6,46,55,93.2,92.2,93.8,candidate genes study,,,Single-SNP-based test
HTR3B,rs45597437,intron,Significant,0.0107,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,T,C,96.2,98.2,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
HTT,rs61348208,,Non-significant,0.189,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,T,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
HTT,rs61348208,,Non-significant,0.009,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,T,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
HTT,rs61348208,,Significant,0.0000000058,10.7554/eLife.39856.001,both,increased parental lifespan,European,genomic,,SNP,,,,,T,,,,1012240,,,,71.63,40,117,GWAS,,,
HYKK,rs8042849,,Non-significant,0.403,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
HYKK,rs8042849,,Non-significant,0.577,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,C,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
HYKK,rs8042849,,Significant,0,10.7554/eLife.39856.001,both,increased parental lifespan,European,genomic,,SNP,,,,,T,,,,1012240,,,,71.63,40,117,GWAS,,,
ICAM1,rs5030390,intron,Non-significant,0.809,10.1016/j.exger.2009.02.004,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,"Когорта SOF: n = 9704 женщины европейского происхождения в возрасте 65 лет и старше из США. Когорта наблюдалась более 20 лет с полным последующим наблюдением за смертностью и включала 896 участников SOF, отобранных для включения в исследование продолжительности жизни (293 человек в группе долгожителей ≥ 92 лет, средняя продолжительности жизни = 95,3 ± 2,1 года и 603 человека в контрольной группе, на момент смерти ≤ 79 лет, средняя продолжительности жизни = 75,7 ± 2,6 года).",
ICAM1,rs5030390,intron,Significant,0.0074,10.1016/j.exger.2009.02.004,both,longevity,"Caucasian, African-American",genomic,,SNP,,,,,,,,900,479,,,79,,92,,candidate genes study,,"Когорта CHS: 5888 взрослых мужчин и женщин 65 лет и старше из США. 4925 человек или 95% определили свою этническую принадлежность как белые. В группу долгожителей относили людей, доживших как минимум до 92 лет (n = 479; 61% женщин), а в контрольную группу - людей, умерших в возрасте до 79 лет (n = 900; 46% женщин). ).",
IDE,INSR[rs2252673]+IDE[rs7078413],,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
IGF1,rs6222,,Non-significant,"0,36",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1,rs6219,,Non-significant,"0,26",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1,rs6214,,Non-significant,"0,37",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1,rs978458,,Non-significant,"0,59",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1,rs2162679,,Non-significant,"0,98",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1,rs35765,,Non-significant,"0,5",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs4965425,,Non-significant,"0,51",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs8040132,,Non-significant,"0,73",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs1319868,,Non-significant,"0,88",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs2871865,,Non-significant,"0,42",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs4966008,,Non-significant,"0,74",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs11247361,,Non-significant,"0,61",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs1319869,,Non-significant,"0,71",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs1863276,,Non-significant,"0,78",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs12594040,,Non-significant,"0,44",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs11247367,,Non-significant,"0,84",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs11630479,,Non-significant,"0,32",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs8032477,,Non-significant,"0,67",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs4616271,,Non-significant,"0,42",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs2037448,,Non-significant,"0,97",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs4966035,,Non-significant,"0,69",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs4966036,,Non-significant,"0,67",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs7165875,,Non-significant,"0,98",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R, s45445894,"exon, missense",Non-significant,"0,98",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,V388M,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs2684811,,Non-significant,"0,65",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs45553041,"exon, missense",Non-significant,"0,98",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,R605H,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs3784605,,Non-significant,0.056,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs3784606,,Non-significant,"0,7",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs4966042,,Non-significant,"0,67",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs3743262,,Non-significant,"0,16",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs1546713,,Non-significant,"0,29",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs2229765,,Non-significant,0.099,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs2684796,,Non-significant,"0,8",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs2684794,,Non-significant,"0,73",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs2684792,,Non-significant,"0,78",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs2684790,,Non-significant,"0,67",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs8034284,,Non-significant,"0,13",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs17847203,"exon, missense",Non-significant,"0,26",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,Y1346,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs3833015,,Non-significant,0.079,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs2272037,,Non-significant,0.55,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
IGF1R,,,Significant,0.0006,10.1007/s11357-011-9210-z,both,longevity,Italian,genomic,,haplotype,,,"IGF1R[G/A]+IRS2[Gly/Asp],+UCP2[Ala/Val]",AAV,,,,514,208,49,,85,96,86,104,candidate genes study,,"Комбинация аллелей A-IGF1R/Asp-IRS2/Val-UCP2 связана со сниженным риском смертности от всех причин, более низким HOMA-IR, более высоким респираторным коэффициентом, уровнем метаболизма в состоянии покоя и с повышенным шансом на долголетие (n=722).",
IGF1R,IGF1R[rs12437963]+PTPN1[rs6067484],,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
IGF1R,rs2272037,,Significant,0.0048,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGF1R,rs2272037,,Significant,0.021,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,1400,572,75.9,79,,95,92,,meta-analysis of candidate gene studies,,,
IGF1R,rs2229765,,Significant,,10.1186/1471-2318-9-19,male,longevity,North-eastern Italian,genomic,decreased gene expression,SNP,,,,A,,34.4,43.7,147,89,,70,85,,86,106,candidate genes study,,"У мужчин наблюдалось ассоциированное с возрастом увеличение частоты аллеля A rs2229765 и изменение уровня IGF-1 в плазме, который был значительно ниже у мужчин старше 85 лет (группа 85+). В группе мужчин 85+ носители гомозиготного генотипа A/A имели самый низкий уровень IGF-1 в плазме. Четкой корреляции между генотипом rs2229765 и IGF-1 у женщин не обнаружено (n = 668 человек, возраст 70–106 лет).",
IGF2,,,Significant,0.004,10.1016/j.mad.2004.08.025,female,longevity,Ashkenazi Jewish,genomic,,SNP,A>G,,ApaI,AA,,,,320,74,21.89,13,33,,75,,candidate genes study,,,
IGF2,,,Significant,,10.1016/S0531-5565(01)00146-2,male,longevity,Italian,genomic,,haplotype,,,TH[STR]+IGF2[AvaII],,,,,119,72,,20,70,,100,109,candidate genes study,,"Было показано, что ген тирозингидроксилазы (TH, 11p15.5) связан с долголетием человека. Распределение гаплотипов TH-IGF2 значительно отличалось у мужчин долгожителей (n = 72) по сравнению с мужчинами из контрольной группы (n = 119).",
IGF2R,rs9456497,intron,Non-significant,0.586,10.1016/j.exger.2012.02.010,both,longevity,German,genomic,,SNP,,,,G,A,,,1140,1613,67.2,,,,95,110,candidate genes study,,,
IGF2R,rs111333005,,Non-significant,0.152,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
IGF2R,rs111333005,,Non-significant,0.858,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
IGF2R,rs111333005,,Significant,0.0000000066,10.7554/eLife.39856.001,both,increased parental lifespan,European,genomic,,SNP,,,,G,,,,,1012240,,,,71.63,40,117,iGWAS,,,
IGF2R,rs9456497,intron,Significant,0.005,10.1016/j.exger.2012.02.010,both,longevity,Danish,genomic,,SNP,,,,G,A,,,800,1200,50.5,46,55,93.2,92.2,93.8,candidate genes study,,,
IGFBP1,rs4724445,,Non-significant,"0,77",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP1,rs3763497,,Non-significant,"0,54",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP1,rs1065780,,Non-significant,"0,95",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP1,rs9658194,,Non-significant,"0,84",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP1,rs3793344,,Non-significant,"0,74",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP1,rs2854843,,Non-significant,"0,89",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP1,rs1874479,,Non-significant,"0,47",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP1,rs4619,,Non-significant,"0,29",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP1,rs7454,,Non-significant,"0,47",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP1,rs9658238,,Non-significant,"0,23",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP1,rs1908751,,Non-significant,"0,93",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP2,rs3770473,,Non-significant,"0,92",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP2,rs9341105,,Non-significant,"0,82",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP2,rs2372848,,Non-significant,"0,62",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP2,rs9341130,,Non-significant,"0,75",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP2,rs9341145,,Non-significant,"0,95",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP2,rs9341191,,Non-significant,"0,11",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP2,rs2270360,,Non-significant,"0,88",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP2,rs6413492,,Non-significant,"0,5",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP3,rs6670,,Non-significant,0.63,10.1111/j.1474-9726.2009.00493.x,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,,363,383,79.5,43,94,97.7,95,108,candidate genes study,,,
IGFBP3,rs2453839,,Non-significant,"0,79",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP3,rs2471551,,Non-significant,"0,63",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP3,rs924140,,Non-significant,"0,92",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP3,rs903889,,Non-significant,"0,74",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP3,rs6670,,Non-significant,0.36,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
IGFBP3,rs6670,,Non-significant,0.75,10.1111/j.1474-9726.2009.00493.x,both,longevity,"Caucasian, Ashkenazi Jewish",genomic,,SNP,,,,,,,,1673,955,79.1,43,94,96.5,92,108,meta-analysis of candidate gene studies,,,
IGFBP3,rs6670,,Significant,0.047,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP3,rs11977526,,Significant,0.03,10.18632/aging.100703,both,longevity,Chinese,genomic,,SNP,,,,TT,"TC, CC",59.7,65.2,472,573,51.7,,,94.1,,,candidate genes study,,"Полиморфизм гена IGFBP-3 rs11977526 был связан с долголетием у китайских девяностолетних/долгожителей (p = 0,033 с использованием доминантной модели и p = 0,035 с использованием сверхдоминантной модели). Генотип T/T был более распространен в группе долгожителей (n долгожителей = 573, n контрольной группы = 472).",
IGFBP4,rs1009728,,Non-significant,0.35,10.1111/j.1474-9726.2009.00493.x,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,,363,383,79.5,43,94,97.7,95,108,candidate genes study,,,
IGFBP4,rs7214466,,Non-significant,0.37,10.1111/j.1474-9726.2009.00493.x,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,,363,383,79.5,43,94,97.7,95,108,candidate genes study,,,
IGFBP4,rs525217,,Non-significant,"0,78",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP4,rs584828,,Non-significant,"0,14",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP4,rs4890114,,Non-significant,"0,29",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP4,rs1009728,,Non-significant,"0,43",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP4,rs538399,,Non-significant,"0,57",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP4,rs2245333,,Non-significant,"0,9",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP4,rs1009728,,Non-significant,0.78,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
IGFBP4,rs7214466,,Non-significant,0.68,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
IGFBP4,rs1009728,,Non-significant,0.24,10.1111/j.1474-9726.2009.00493.x,both,longevity,"Caucasian, Ashkenazi Jewish",genomic,,SNP,,,,,,,,1673,955,79.1,43,94,96.5,92,108,meta-analysis of candidate gene studies,,,
IGFBP4,rs7214466,,Non-significant,0.094,10.1111/j.1474-9726.2009.00493.x,both,longevity,"Caucasian, Ashkenazi Jewish",genomic,,SNP,,,,,,,,1673,955,79.1,43,94,96.5,92,108,meta-analysis of candidate gene studies,,,
IGFBP4,rs7214466,,Significant,0.012,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP5,rs4674107,,Non-significant,"0,66",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP5,rs3276,,Non-significant,"0,88",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP5,rs2241199,,Non-significant,"0,76",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP5,rs7565131,,Non-significant,"0,98",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP5,rs7420849,,Non-significant,"0,61",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP5,rs7426116,,Non-significant,"0,77",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP5,rs3755137,,Non-significant,"0,92",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP5,rs2241193,,Non-significant,"0,8",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP5,rs11575134,,Non-significant,"0,71",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP5,rs3770472,,Non-significant,"0,91",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP5,rs1978346,,Non-significant,"0,83",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP5,rs11575134,,Non-significant,0.4,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
IGFBP5,rs3770472,,Non-significant,0.23,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
IGFBP5,rs11575134,,Non-significant,0.36,10.1111/j.1474-9726.2009.00493.x,both,longevity,"Caucasian, Ashkenazi Jewish",genomic,,SNP,,,,,,,,1673,955,79.1,43,94,96.5,92,108,meta-analysis of candidate gene studies,,,
IGFBP5,rs3770472,,Non-significant,0.6,10.1111/j.1474-9726.2009.00493.x,both,longevity,"Caucasian, Ashkenazi Jewish",genomic,,SNP,,,,,,,,1673,955,79.1,43,94,96.5,92,108,meta-analysis of candidate gene studies,,,
IGFBP5,rs11575134,,Significant,0.043,10.1111/j.1474-9726.2009.00493.x,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,,363,383,79.5,43,94,97.7,95,108,candidate genes study,,,
IGFBP5,rs3770472,,Significant,0.042,10.1111/j.1474-9726.2009.00493.x,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,,363,383,79.5,43,94,97.7,95,108,candidate genes study,,,
IGFBP6,rs11170406,,Non-significant,"0,23",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP6,rs12821902,,Non-significant,"0,35",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP6,rs9658605,,Non-significant,"0,16",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IGFBP6,rs822688,,Non-significant,"0,49",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IL12B,rs1368439,,Non-significant,0.9592,10.1093/gerona/glv058,both,longevity,"Italian, Calabrian",genomic,,SNP,,,,major,,80.38,80.94,302,320,75.1,,,96,90,,candidate genes study,,,
IL1B,multiple,,Significant,0.0216,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,,,,,,,,,500,450,73.14,43,93,98.21,95,110,gene-based association approach,,,SKAT analysis
IL1RN,rs315949,3'UTR,Non-significant,0.707,10.1016/j.exger.2009.02.004,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,,364,388,79.5,,,97.7,95,108,candidate genes study,,"Когорта евреев-ашкенази: 388 евреев-ашкенази с высокой продолжительностью жизни [289 женщин и 99 мужчин, средний возраст 97,7 (0,2) года (возрастной диапазон 95–108 лет; 20% старше 100 лет] и контрольные группы евреев-ашкенази [n = 364, средний возраст 79,5 (0,4) года (58% женщины] без семейного анамнеза высокой продолжительности жизни.",
IL1RN,rs315949,3'UTR,Non-significant,0.691,10.1016/j.exger.2009.02.004,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,"Когорта SOF: n = 9704 женщины европейского происхождения в возрасте 65 лет и старше из США. Когорта наблюдалась более 20 лет с полным последующим наблюдением за смертностью и включала 896 участников SOF, отобранных для включения в исследование продолжительности жизни (293 человек в группе долгожителей ≥ 92 лет, средняя продолжительности жизни = 95,3 ± 2,1 года и 603 человека в контрольной группе, на момент смерти ≤ 79 лет, средняя продолжительности жизни = 75,7 ± 2,6 года).",
IL1RN,rs315949,3'UTR,Significant,0.0125,10.1016/j.exger.2009.02.004,both,longevity,"Caucasian, African-American",genomic,,SNP,,,,,,,,900,479,,,79,,92,,candidate genes study,,"Когорта CHS: 5888 взрослых мужчин и женщин 65 лет и старше из США. 4925 человек или 95% определили свою этническую принадлежность как белые. В группу долгожителей относили людей, доживших как минимум до 92 лет (n = 479; 61% женщин), а в контрольную группу - людей, умерших в возрасте до 79 лет (n = 900; 46% женщин). ).",
IL6,rs1800795,,Non-significant,0.71,10.1016/j.arr.2008.09.001,both,longevity,"Danishs, Irish, Italian, Finnish",genomic,,SNP,-174C>G,,,,,,,2032,2273,,18,80,,81,,meta-analysis of candidate gene studies,,"Данные метаанализа подтверждают отрицательную связь между генотипом GG IL-6 -174 SNP и продолжительностью жизни у итальянских долгожителей, при этом у мужчин, несущих этот генотип, в два раза меньше шансов дожить до глубокой старости по сравнению с субъектами, несущими генотипы CC или CG (n долгожителей = 512, n контрольной группы = 441).",
IL6,rs2069837,,Non-significant,0.304,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
IL6,rs2069837,,Non-significant,0.038,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
IL6,rs1800795,,Significant,,10.1016/j.arr.2008.09.001,male,longevity,Italian,genomic,,SNP,-174C>G,,,"CC, CG",GG,,,176,119,,19,80,,81,,meta-analysis of candidate gene studies,,,
IL6,rs2069837,,Significant,"5,2 × 10^−8",10.1038/s41467-019-11558-2,both,longevity,"European, East Asian, African American",genomic,,SNP,,,,A,G,,,27993,13617,,,75,,89,,meta-analysis of GWAS,,,
IL6,rs2069837,,Significant,"1,4 × 10^−8",10.1038/s41467-019-11558-2,both,longevity,"European, East Asian, African American",genomic,,SNP,,,,A,G,,,27993,5662,,,75,,98,,meta-analysis of GWAS,,,
IL6,rs2069837,intron,Significant,0.0000000018,10.1038/srep21243,both,longevity,Chinese,genomic,,SNP,G>A,,,G,A,90.5,94.7,2178,2299,48.4,,,102.7,,,GWAS,,,
IL6R,multiple,,Significant,0.0457,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,,,,,,,,,500,450,73.14,43,93,98.21,95,110,gene-based association approach,,,SKAT analysis
IMPG1,rs6453914,,Non-significant,0.4,10.1001/jamanetworkopen.2018.1670,female,longevity,"Chinese, Han",genomic,,SNP,,,,minor,,19,18,1526,1614,48.2,40,64,103.1,100,,GWAS,,,
IMPG1,rs6453914,,Significant,"4,1 × 10-6",10.1001/jamanetworkopen.2018.1670,male,longevity,"Chinese, Han",genomic,,SNP,,,,minor,,16,23,773,564,48.7,40,64,101.5,100,,GWAS,,,
INS,rs3842755,3'UTR,Non-significant,0.434,10.1016/j.exger.2012.02.010,both,longevity,German,genomic,,SNP,,,,C,A,,,1140,1613,67.2,,,,95,110,candidate genes study,,,
INS,rs3842753,,Non-significant,"0,3",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INS,rs689,,Non-significant,"0,12",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INS,rs3842755,3'UTR,Significant,0.00011,10.1016/j.exger.2012.02.010,both,longevity,Danish,genomic,,SNP,,,,A,C,,,800,1200,50.5,46,55,93.2,92.2,93.8,candidate genes study,,,
INS,,,Significant,,10.1016/S0531-5565(01)00146-2,female,longevity,Italian,genomic,,haplotype,,,TH[STR]+INS[FokI],,,,,137,147,,20,70,,100,109,candidate genes study,,"Было показано, что ген тирозингидроксилазы (TH, 11p15.5) связан с долголетием человека. Распределение гаплотипов TH-INS значительно различалось у женщин-долгожителей (n = 147) по сравнению с женщинами из контрольной группы (n = 137).",
INSR,rs3745544,intron,Non-significant,0.441,10.1016/j.exger.2004.05.007,both,longevity,Japanese,genomic,,SNP,,,,,,,,122,122,33.3,19,63,106.8,105,,candidate genes study,,,Более 80% выборки женского пола.
INSR,rs3745546,intron,Non-significant,0.168,10.1016/j.exger.2004.05.007,both,longevity,Japanese,genomic,,SNP,,,,,,,,122,122,33.3,19,63,106.8,105,,candidate genes study,,,Более 80% выборки женского пола.
INSR,rs3745548,intron,Non-significant,0.057,10.1016/j.exger.2004.05.007,both,longevity,Japanese,genomic,,SNP,,,,,,,,122,122,33.3,19,63,106.8,105,,candidate genes study,,,Более 80% выборки женского пола.
INSR,rs2252673,intron,Non-significant,0.083,10.1016/j.exger.2004.05.007,both,longevity,Japanese,genomic,,SNP,,,,,,,,122,122,33.3,19,63,106.8,105,,candidate genes study,,,Более 80% выборки женского пола.
INSR,rs1799817,"exon, synonymous",Non-significant,0.205,10.1016/j.exger.2004.05.007,both,longevity,Japanese,genomic,,SNP,,,,,,,,122,122,33.3,19,63,106.8,105,,candidate genes study,,,Более 80% выборки женского пола.
INSR,rs2288404,intron,Non-significant,0.277,10.1016/j.exger.2004.05.007,both,longevity,Japanese,genomic,,SNP,,,,,,,,122,122,33.3,19,63,106.8,105,,candidate genes study,,,Более 80% выборки женского пола.
INSR,rs1366600,,Non-significant,0.5886,10.1093/gerona/glv058,both,longevity,"Italian, Calabrian",genomic,,SNP,,,,C,,1.481,1.78,302,320,75.1,,,96,90,,candidate genes study,,,
INSR,rs3745550,,Non-significant,"0,79",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs1051690,,Non-significant,0.086,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs2288404,,Non-significant,"0,27",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs1799817,,Non-significant,"0,33",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs6510950,,Non-significant,"0,65",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs8103483,,Non-significant,"0,83",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs2252673,,Non-significant,"0,67",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs2962,,Non-significant,"0,58",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs2059807,,Non-significant,"0,47",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs2059806,,Non-significant,"0,36",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs9282756,,Non-significant,"0,33",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs7251963,,Non-significant,"0,25",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs11671975,,Non-significant,"0,28",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs8112883,,Non-significant,"0,6",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs10500204,,Non-significant,"0,49",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs891087,,Non-significant,"0,78",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs2860183,,Non-significant,"0,14",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs4804377,,Non-significant,"0,16",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs2115386,,Non-significant,"0,59",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs2042902,,Non-significant,"0,6",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs919275,,Non-significant,"0,3",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs6510975,,Non-significant,"0,42",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs7254487,,Non-significant,"0,55",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs10411676,,Non-significant,"0,48",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs7254921,,Non-significant,"0,39",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs7254060,,Non-significant,"0,51",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs11673642,,Non-significant,"0,39",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs2860184,,Non-significant,"0,76",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs8111710,,Non-significant,"0,94",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs7507911,,Non-significant,"0,65",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs7258126,,Non-significant,"0,65",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,rs8112914,,Non-significant,"0,52",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSR,INSR[rs2252673]+IDE[rs7078413],,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
INSRR,rs4661229,,Non-significant,"0,63",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSRR,rs2644625,,Non-significant,"0,53",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSRR,rs12145540,,Non-significant,"0,56",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
INSRR,rs4661063,,Non-significant,"0,56",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IRS1,rs1801123,"exon, synonymous",Non-significant,0.774,10.1016/j.exger.2004.05.007,both,longevity,Japanese,genomic,,SNP,,,,,,,,122,122,33.3,19,63,106.8,105,,candidate genes study,,,Более 80% выборки женского пола.
IRS1,rs1801278,"exon, missense",Non-significant,0.337,10.1016/j.exger.2004.05.007,both,longevity,Japanese,genomic,,SNP,,R971G,,,,,,122,122,33.3,19,63,106.8,105,,candidate genes study,,,Более 80% выборки женского пола.
IRS1,rs11690232,,Non-significant,"0,86",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IRS1,rs4675094,,Non-significant,"0,6",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IRS1,rs1801278,,Non-significant,"0,8",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IRS1,rs1801276,,Non-significant,"0,13",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IRS1,rs4675096,,Non-significant,"0,8",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IRS1,rs956115,,Non-significant,"0,55",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IRS2,rs1044364,,Non-significant,"0,54",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IRS2,rs2289046,,Non-significant,"0,94",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IRS2,rs1865434,,Non-significant,"0,24",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IRS2,rs913949,,Non-significant,"0,61",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IRS2,rs12584136,,Non-significant,"0,38",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IRS2,rs9559646,,Non-significant,"0,59",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IRS2,rs9515120,,Non-significant,"0,53",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IRS2,rs7323191,,Non-significant,"0,88",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IRS2,rs11841502,,Non-significant,"0,51",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IRS2,rs7997595,,Non-significant,"0,89",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IRS2,rs11618950,,Non-significant,"0,93",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IRS2,rs12853546,,Non-significant,"0,7",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IRS2,rs4773092,,Non-significant,"0,47",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
IRS2,,,Significant,0.0006,10.1007/s11357-011-9210-z,both,longevity,Italian,genomic,,haplotype,,,"IGF1R[G/A]+IRS2[Gly/Asp],+UCP2[Ala/Val]",AAV,,,,514,208,49,,85,96,86,104,candidate genes study,,"Комбинация аллелей A-IGF1R/Asp-IRS2/Val-UCP2 связана со сниженным риском смертности от всех причин, более низким HOMA-IR, более высоким респираторным коэффициентом, уровнем метаболизма в состоянии покоя и с повышенным шансом на долголетие (n=722).",
IRS4,rs1801164,,Non-significant,"0,81",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
JAK2,rs3824432,,Significant,0.03,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,AA,"AG,GG",,,371,433,78.1,72,81,97,95,106,candidate genes study,,,
KALRN,rs3830412,,Significant,"4,3 × 10^−7",10.1038/s41467-019-11558-2,both,longevity,European,genomic,,In/Del,,,,A,AT,,,25483,3484,,,75,,98,,meta-analysis of GWAS,,,suggestive significant
KALRN,rs3830412,,Significant,"8,2 × 10^−7",10.1038/s41467-019-11558-2,both,longevity,"European, East Asian, African American",genomic,,In/Del,,,,A,AT,,,27993,5662,,,75,,98,,meta-analysis of GWAS,,,suggestive significant
KCNA5,rs1157755,,Non-significant,0.38,10.1001/jamanetworkopen.2018.1670,female,longevity,"Chinese, Han",genomic,,SNP,,,,major,,94,94,1526,1614,48.2,40,64,103.1,100,,GWAS,,,
KCNA5,rs1157755,,Significant,"1,9 × 10-6",10.1001/jamanetworkopen.2018.1670,male,longevity,"Chinese, Han",genomic,,SNP,,,,minor,,3,8,773,564,48.7,40,64,101.5,100,,GWAS,,,
KCNK3,rs1275922,,Non-significant,0.089,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
KCNK3,rs1275922,,Non-significant,0.013,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
KCNK3,rs1275922,,Significant,0.000000006,10.7554/eLife.39856.001,both,increased parental lifespan,European,genomic,,SNP,,,,,G,,,,1012240,,,,71.63,40,117,GWAS,,,
KCNT2 ,rs10737670,intron,Significant,0.00000129,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,G,A,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs10754187,intron,Significant,0.00000133,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,G,A,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs10801530,intron,Significant,0.00000131,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,G/T,,,T,T,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs10801531,intron,Significant,0.00000136,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,A,G,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs10801532,intron,Significant,0.000000798,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,G,A,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs10922075,intron,Significant,0.0000014,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,A,G,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs10922083,intron,Significant,0.00000149,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,C/T,,,T,C,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs12069983,intron,Significant,0.00000137,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/C,,,A,C,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs12069990,intron,Significant,0.00000142,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,C/T,,,T,C,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs12729649,intron,Significant,0.0000014,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,G,A,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs1538687,intron,Significant,0.00000116,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,C/T,,,C,T,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs1769996,intron,Significant,0.00000128,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,C/T,,,C,T,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs2027368,intron,Significant,0.00000133,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/C,,,C,A,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs2878557,intron,Significant,0.00000153,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,C/T,,,T,C,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs3855964,intron,Significant,0.000000829,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,G/T,,,T,G,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs3927686,intron,Significant,0.00000122,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,C/T,,,T,C,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs3928857,intron,Significant,0.00000137,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,C/T,,,T,C,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs7531611,intron,Significant,0.000000803,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,C/T,,,T,C,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs7535696,intron,Significant,0.00000137,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,C/T,,,C,T,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs10801537,intron,Significant,0.00000233,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,G,A,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs10922071,intron,Significant,0.00000249,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,A,G,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs10922082,intron,Significant,0.00000277,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,A,G,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs10922084,intron,Significant,0.00000297,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/C,,,C,C,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KCNT2 ,rs11807331,intron,Significant,0.00000233,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,C/T,,,C,T,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
KIF13B,rs62502826,,Significant,"5,6 × 10^−7",10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,G,,,25483,3484,,,75,,98,,meta-analysis of GWAS,,,suggestive significant
KIR3DX1,rs73070152,,Non-significant,0.97,10.1001/jamanetworkopen.2018.1670,male,longevity,"Chinese, Han",genomic,,SNP,,,,minor,,10,10,773,564,48.7,40,64,101.5,100,,GWAS,,,
KIR3DX1,rs73070152,,Significant,"8,0 × 10-6",10.1001/jamanetworkopen.2018.1670,female,longevity,"Chinese, Han",genomic,,SNP,,,,minor,,8,12,1526,1614,48.2,40,64,103.1,100,,GWAS,,,
KL,rs1207362,intron,Non-significant,0.804,10.1016/j.exger.2012.02.010,both,longevity,German,genomic,,SNP,,,,C,A,,,1140,1613,67.2,,,,95,110,candidate genes study,,,
KL,rs1207362,intron,Significant,0.00011,10.1016/j.exger.2012.02.010,both,longevity,Danish,genomic,,SNP,,,,C,A,,,800,1200,50.5,46,55,93.2,92.2,93.8,candidate genes study,,,
KL,rs9536314,"exon, missense",Significant,0.04,10.1016/j.mad.2018.12.003,both,longevity,mixed,genomic,,SNP,1062T>G,Phe352Val,,GG,"TT, TG",,,1831,2714,,0,35,,75,105,meta-analysis of candidate gene studies,,"Полиморфизм rs9536314 (1062T>G, p.Phe352Val, F352V) был ассоциирован с продолжительностью жизни в доминантной модели наследования (FF + FV против VV; P = 0,04), n долгожителей = 2714, n контрольной группы = 1831.",
KL,AOX1[rs2256977]+KL[rs2283368],,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
KL,EXO1[rs1635518]+KL[rs9527026],,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
KLF6,rs61019025,,Non-significant,0.47,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,D,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
KLF6,rs61019025,,Non-significant,0.179,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,D,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
LAMA2,,,Significant,,10.1134/S1022795416100033,female,longevity,Tatars,genomic,,In/Del,,,Alu element insertion/deletion,Alu ins,,39.18,49.59,134,121,,84,91,,92,,candidate genes study,,"Татары Башкортостана, женщины. N = 884. Частота гетерозигот по инсерции/делеции Alu: 46.21% (младше 84 лет), 55.97% (84-91 лет), 62.81% (старше 91 года). Частота гомозигот по делеции Alu: 36.12% (младше 84 лет), 32.84% (84-91 лет), 19.01% (старше 91 года). Частота носителей делеции Alu: 59.23% (младше 84 лет), 60.82% (84-91 лет), 50.41% (старше 91 года).",
LAMA5,rs4925386,,Significant,0.001,10.1016/j.mad.2016.03.003,both,longevity,"Italian, Southern",genomic,,SNP,,,,T,,,,,624,,,,85.83,64,107,candidate genes study,,Аллельный вариант rs4925386-T был ассоциирован с долголетием и более низким ростом. Полиморфизм по гену LAMA5 исследовали среди жителей южной Италии (N=624). ,
LASS1,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,APOE[promoter+promoter+promoter+exon4+exon4]+HRAS[promoter+promoter+promoter+promoter+promoter+promoter+exon1]+LASS1[exon1+exon1],Significant,0.0000288,10.1111/j.1474-9726.2010.00600.x,both,longevity,Caucasian,genomic,,haplotype,,,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,HRAS-CGCGCGT+ApoE-ATTTC+LASS1-CCT,,1,7.3,188,147,40.62,20,59,100.57,98,,candidate genes study,,ε3-содержащий гаполотип ApoE (ATTTC) в комбинации с гаплотипом HRAS (CGCGCGT) и гаплотипами LASS1 (CCT) или (CGT) ассоциирован с высокой продолжительностью жизни. Генетический анализ был проведен на популяциях их Джорджии (N=650) и (N=869) Луизианы.,
LASS1,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,APOE[promoter+promoter+promoter+exon4+exon4]+HRAS[promoter+promoter+promoter+promoter+promoter+promoter+exon1]+LASS1[exon1+exon1],Significant,0.0000466,10.1111/j.1474-9726.2010.00600.x,both,longevity,Caucasian,genomic,,haplotype,,,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,HRAS-CGCGCGT+ApoE-ATTTC+LASS1-CGT,,8.4,19.1,188,147,40.62,20,59,100.57,98,,candidate genes study,,,
LASS1,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,APOE[promoter+promoter+promoter+exon4+exon4]+HRAS[promoter+promoter+promoter+promoter+promoter+promoter+exon1]+LASS1[exon1+exon1],Significant,0.0000568,10.1111/j.1474-9726.2010.00600.x,both,longevity,Caucasian,genomic,,haplotype,,,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,HRAS-CGCGCGT+ApoE-ATTTC+LASS1-CCT,,3.9,10.5,251,204,43.87,20,59,92.8,90,,candidate genes study,,,
LASS1,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,APOE[promoter+promoter+promoter+exon4+exon4]+HRAS[promoter+promoter+promoter+promoter+promoter+promoter+exon1]+LASS1[exon1+exon1],Significant,0.0000005,10.1111/j.1474-9726.2010.00600.x,both,longevity,Caucasian,genomic,,haplotype,,,APOE[rs449647+rs769446+rs405509+rs429358+rs7412]+HRAS[rs8176330+rs8176331+rs8176332+rs8176333+rs8176334+rs8176335+rs12628]+LASS1[rs60774903+rs3746263+Exon1-234,HRAS-CGCGCGT+ApoE-ATTTC+LASS1-CGT,,6.7,17.5,251,204,43.87,20,59,92.8,90,,candidate genes study,,,
LDLR,rs142158911,,Non-significant,0.011,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
LDLR,rs142158911,,Non-significant,0.02,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
LDLR,rs142158911,,Significant,0.0000000081,10.7554/eLife.39856.001,both,increased parental lifespan,European,genomic,,SNP,,,,,A,,,,1012240,,,,71.63,40,117,GWAS,,,
LEP,rs11761556,,Non-significant,0.06353,10.1093/gerona/glv058,both,longevity,"Italian, Calabrian",genomic,,SNP,,,,major,,54.32,60.34,302,320,75.1,,,96,90,,candidate genes study,,,
LIMCH1,rs10007810,,Non-significant,0.521,10.1093/gerona/glu166,both,increased lifespan,Caucasian,genomic,,SNP,,,,,,,,,4567,,,,,25,110,"meta-analysis of GWAS, replication",,,
LIMCH1,rs10007810,,Non-significant,0.841,10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,914,801,73,54,90,104,95,119,"meta-analysis of GWAS, replication",,,
LIMCH1,rs10007810,intron,Non-significant,0.979,10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,16121,5409,,,65,,90,,"meta-analysis of GWAS, replication",,,
LIMCH1,rs10007810,intron,Significant,"8,80 × 10^−6",10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,3757,6036,,55,80,,90,,meta-analysis of GWAS,,,suggestive significant
LMNA,rs915179+rs2485662+rs4641+rs1468772,,Significant,0.037,10.1111/j.1474-9726.2012.00808.x,both,longevity,"American, Caucasians; Italian, Southern; French; Ashkenazi Jewish",genomic,,haplotype,,,,G+T+C+T,,,,1980,2779,,18,92,,90,113,meta-analysis of candidate gene studies,,,
LNPK,rs4972778,,Non-significant,0.7,10.1001/jamanetworkopen.2018.1670,male,longevity,"Chinese, Han",genomic,,SNP,,,,minor,,75,76,773,564,48.7,40,64,101.5,100,,GWAS,,,
LNPK,rs4972778,,Significant,"5,4 × 10-6",10.1001/jamanetworkopen.2018.1670,female,longevity,"Chinese, Han",genomic,,SNP,,,,major,,74,80,1526,1614,48.2,40,64,103.1,100,,GWAS,,,
LOC105369165,rs116362179,,Significant,"4,9 × 10^−7",10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,T,C,,,25483,11262,,,75,,89,,meta-analysis of GWAS,,,suggestive significant
LOC105377989,rs7754015,,Significant,"6,8 × 10^−7",10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,T,G,,,25483,11262,,,75,,89,,meta-analysis of GWAS,,,suggestive significant
LOC105377992,rs1262476,,Significant,"9,8 × 10^−7",10.1038/s41467-019-11558-2,both,longevity,"European, East Asian, African American",genomic,,SNP,,,,A,G,,,27993,13617,,,75,,89,,meta-analysis of GWAS,,,suggestive significant
LOC107985852,rs2008465,intron,Significant,"3,48 × 10−07",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,A,G,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,suggestive significant
LONP1,ATM[rs170548]+LONP1[rs2436514],,Significant,0.002,10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,ATM[A]+LONP1[AG],,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
LPA,rs55730499,,Non-significant,0.009,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
LPA,rs10455872,,Non-significant,0.007,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
LPA,rs55730499,,Non-significant,0.009,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,C,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
LPA,rs10455872,,Non-significant,0.007,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
LPA,rs55730499,,Non-significant,0.024,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
LPA,rs10455872,,Non-significant,0.022,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
LPA,rs55730499,,Non-significant,0.024,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,C,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
LPA,rs10455872,,Non-significant,0.022,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
LPA,rs55730499,,Significant,0,10.18632/aging.101334,both,increased parental lifespan,European,genomic,,,,,,,C,,,,389166,,,,56.66,40,73,GWAS,,,
LPA,rs10455872,,Significant,0,10.7554/eLife.39856.001,both,increased parental lifespan,European,genomic,,SNP,,,,,A,,,,1012240,,,,71.63,40,117,GWAS,,,
LPA,rs10455872,,Significant,0.000000016,10.1038/ncomms15842,both,increased parents' age at death,European,genomic,,,,,,,,,,,276796,,,,,40,,iGWAS,,,
LPA ,rs10455872,intron,Significant,0.00000272,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,A,G,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
LPL,rs1581675,,Non-significant,0.000000211,10.1038/ncomms15842,both,increased parents' age at death,European,genomic,,,,,,,,,,,276796,,,,,40,,iGWAS,,,
LPL,rs1581675,,Non-significant,0.199,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
LPL,rs1581675,,Non-significant,0.965,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
LRRFIP1,rs6740706,,Non-significant,0.39,10.1001/jamanetworkopen.2018.1670,female,longevity,"Chinese, Han",genomic,,SNP,,,,major,,75,77,1526,1614,48.2,40,64,103.1,100,,GWAS,,,
LRRFIP1,rs6740706,,Significant,"2,3 × 10-7",10.1001/jamanetworkopen.2018.1670,male,longevity,"Chinese, Han",genomic,,SNP,,,,major,,80,71,773,564,48.7,40,64,101.5,100,,GWAS,,,
LY6G5C ,rs2280800,intron,Significant,0.00000044,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/C,,,A,C,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
LY6G6F ,rs2242653,"exon, missense",Significant,0.00000162,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/G,,,A,G,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
MAGI3,rs1230666,,Non-significant,0.186,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
MAGI3,rs1230666,,Non-significant,0.361,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
MAGI3,rs1230666,,Significant,0.0000000064,10.7554/eLife.39856.001,both,increased parental lifespan,European,genomic,,SNP,,,,,G,,,,1012240,,,,71.63,40,117,GWAS,,,
MAP3K5,rs2076260,,Significant,0.0043,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,,,,,344,393,78.1,72,81,97,95,106,candidate genes study,,,
MAP3K5,rs6904753,,Significant,0.0318,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,,,,,344,393,78.1,72,81,97,95,106,candidate genes study,,,
MAP3K5,rs2076260,,Significant,0.0000025,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,"CT,TT",CC,,,344,393,78.1,72,81,97,95,106,candidate genes study,,,
MAP3K7,rs282070,intron,Significant,1.1 × 10−3,10.1007/s11357-012-9416-8,both,longevity,"Italian, Calabrian",genomic,,SNP,,,,,,,,554,288,67,,,92,,,candidate genes study,,,
MAP3K9,rs7713083,,Significant,0.014,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,"TG,GG",TT,,,374,440,78.1,72,81,97,95,106,candidate genes study,,,
MAPK4,multiple,,Significant,0.0334,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,,,,,,,,,500,450,73.14,43,93,98.21,95,110,gene-based association approach,,,SKAT analysis
MAPK9,rs7713083,,Significant,0.0135,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,,,,,374,440,78.1,72,81,97,95,106,candidate genes study,,,
MAPK9,rs1363513,intergenic,Significant,0.05,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,G,T,98.2,99.2,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
MAPK9,multiple,,Significant,0.0391,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,,,,,,,,,500,450,73.14,43,93,98.21,95,110,gene-based association approach,,,SKAT analysis
MBOAT1,rs11753077,,Non-significant,0.633,10.1093/gerona/glu166,both,increased lifespan,Caucasian,genomic,,SNP,,,,,,,,,4567,,,,,25,110,"meta-analysis of GWAS, replication",,,
MBOAT1,rs7763815,,Non-significant,0.572,10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,914,801,73,54,90,104,95,119,"meta-analysis of GWAS, replication",,,
MBOAT1,rs11753077,−76,Non-significant,0.095,10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,16121,5409,,,65,,90,,"meta-analysis of GWAS, replication",,,
MBOAT1,rs11753077,−76,Significant,"7,51 × 10^−6",10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,3757,6036,,55,80,,90,,meta-analysis of GWAS,,,suggestive significant
MC2R,rs28926173,,Non-significant,0.339,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
MC2R,rs28926173,,Non-significant,0.873,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
MC2R,rs28926173,,Significant,0.000000023,10.18632/aging.101334,both,increased parental lifespan top 10%,European,genomic,,,,,,,G,,,79767,7182,,,,,87,,GWAS,,,
MIR3156-3,rs145672791,"downstream, –28000",Significant,0.0000000895,10.1038/srep21243,both,longevity,Chinese,genomic,,SNP,A>G,,,A,G,98.2,99.6,2178,2299,48.4,,,102.7,,,GWAS,,,
MLH1,1172T/A,,Significant,0.0443,10.1007/s00439-006-0148-7,both,longevity,Korean,genomic,,SNP,1172T>A,,,A,,,,106,85,56.2,,,102.33,,,candidate genes study,,"P = 0,0443, скорректированное отношение шансов (AOR) = 0,199, 95% доверительный интервал (CI): 0,041–0,96). Долгожители: средний возраст 102 года. , 14 мужчин, 71 женщина Контрольная группа: средний возраст 56 лет, мужчин 49, женщин 57. Этническая принадлежность: корейцы",
MRE11A,rs512150+rs592068,,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
MRE11A,rs10831227+rs604845,,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
MRE11A,GHSR[rs572169]+MRE11A[rs533984],,Significant,0.001,10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,GHSR[GG]+MRE11A[G],,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
MRE11A,GHSR[rs572169]+MRE11A[rs533984]+PARK7[rs225119],,Significant,0.001,10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,GHSR[GG]+MRE11A[G]+PARK7[G],,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
MSANTD1,rs362296,,Non-significant,0.0000038,10.1038/ncomms15842,both,increased parents' age at death,European,genomic,,,,,,,,,,,276796,,,,,40,,iGWAS,,,
MSANTD1,rs362296,,Non-significant,0.251,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
MSANTD1,rs362296,,Non-significant,0.24,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
MSH5 ,rs3115672,"exon, synonymous",Significant,0.00000149,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,C/T,,,C,T,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
MSTN,,,Significant,0.001,10.1007/s11357-013-9513-3,both,longevity,Spanish,genomic,,SNP,,K153R,,R,K,2.7,7.1,384,156,,,49,,100,111,candidate genes study,,,
MSTN,,,Significant,0.004,10.1007/s11357-013-9513-3,both,longevity,Italian,genomic,,SNP,,K153R,,R,K,3,7.6,316,79,,,49,,100,104,candidate genes study,,,
MT-146,,,Significant,"<0,005",10.1007/s11033-012-1784-8,both,longevity,"Chinese, Bama Yao, Guangxi Province",genomic,,SNP,,,,C,"T, A",13,29.2,200,113,,10,89,,90,110,candidate genes study,,,"В когорте 90–110 лет уровни триглицеридов были намного выше у лиц с mt146C, чем у лиц с mt146T (P < 0,01)."
MT-ATP6,,"exon, missense",Significant,,10.1007/s11033-012-1784-8,both,longevity,"Chinese, Bama Yao, Guangxi Province",genomic,,SNP,8860A>G,Thr/Ala,,G,A,,,200,113,,10,89,,90,110,candidate genes study,,Эти замены были впервые обнаружены у 10 долгожителей Bama ,Эти замены были впервые обнаружены у 10 долгожителей Bama 
MT-CYB,,"exon, missense",Significant,,10.1007/s11033-012-1784-8,both,longevity,"Chinese, Bama Yao, Guangxi Province",genomic,,SNP,14766C>T,Thr/Ile,,T,C,,,200,113,,10,89,,90,110,candidate genes study,,Эти замены были впервые обнаружены у 10 долгожителей Bama ,Эти замены были впервые обнаружены у 10 долгожителей Bama 
MT-CYB,,"exon, missense",Significant,,10.1007/s11033-012-1784-8,both,longevity,"Chinese, Bama Yao, Guangxi Province",genomic,,SNP,15326A>G,Thr/Ala,,G,A,,,200,113,,10,89,,90,110,candidate genes study,,Эти замены были впервые обнаружены у 10 долгожителей Bama ,Эти замены были впервые обнаружены у 10 долгожителей Bama 
MT-DLOOP,,non-coding,Significant,,10.1007/s11033-012-1784-8,both,longevity,"Chinese, Bama Yao, Guangxi Province",genomic,,SNP,73A>G,,,G,A,,,200,113,,10,89,,90,110,candidate genes study,,Эти замены были впервые обнаружены у 10 долгожителей Bama ,Эти замены были впервые обнаружены у 10 долгожителей Bama 
MT-DLOOP,,non-coding,Significant,,10.1007/s11033-012-1784-8,both,longevity,"Chinese, Bama Yao, Guangxi Province",genomic,,SNP,263A>G,,,G,A,,,200,113,,10,89,,90,110,candidate genes study,,Эти замены были впервые обнаружены у 10 долгожителей Bama ,Эти замены были впервые обнаружены у 10 долгожителей Bama 
MT-ND4,,"exon, synonymous",Significant,,10.1007/s11033-012-1784-8,both,longevity,"Chinese, Bama Yao, Guangxi Province",genomic,,SNP,11719G>A,Gly/Gly,,A,G,,,200,113,,10,89,,90,110,candidate genes study,,Эти замены были впервые обнаружены у 10 долгожителей Bama ,Эти замены были впервые обнаружены у 10 долгожителей Bama 
MT-RNR2,,non-coding,Significant,,10.1007/s11033-012-1784-8,both,longevity,"Chinese, Bama Yao, Guangxi Province",genomic,,SNP,2076A>G,,,G,A,,,200,113,,10,89,,90,110,candidate genes study,,Эти замены были впервые обнаружены у 10 долгожителей Bama ,Эти замены были впервые обнаружены у 10 долгожителей Bama 
MTHFD1,rs1950902,,Non-significant,0.95,10.1001/jamanetworkopen.2018.1670,female,longevity,"Chinese, Han",genomic,,SNP,,,,minor,,31,32,1526,1614,48.2,40,64,103.1,100,,GWAS,,,
MTHFD1,rs1950902,,Significant,"1,1 × 10-7",10.1001/jamanetworkopen.2018.1670,male,longevity,"Chinese, Han",genomic,,SNP,,,,minor,,26,37,773,564,48.7,40,64,101.5,100,,GWAS,30294719,564 мужчин старше 100 лет были сопоставлены с 773 мужчинами в возрасте 40-64 лет.,
MTHFR,rs1801133,,Significant,0.029,10.1016/j.mad.2004.08.025,female,longevity,Ashkenazi Jewish,genomic,increased protein activity,SNP,677C>T,,,C,,,,320,74,21.89,13,33,,75,,candidate genes study,15621215,"Евреи Ашкенази участвовали в исследовании, в частности, полиморфизм C677T как фактор выживаемости до 75 лет. Частота аллеля С была выше у пожилых женщин. Аллель T был связан с высоким уровнем гомоцистеина в сыворотке крови. (возрастная группа: 224 участника в возрасте 75 лет на момент взятия образцов, молодая группа: 13-33 года, 441 участник)",
MTHFR,rs1801133,,Significant,,10.1046/j.1365-2362.1999.00578.x,both,longevity,Swiss,genomic,increased protein activity,SNP,677C>T,,,C,,61.5,72.7,118,106,,,65,,66,,candidate genes study,,"Это исследование не показывает связи между мутацией и возникновением сосудистых заболеваний, но обнаружена корреляция между мутацией и продолжительностью жизни в популяции Швейцарии. (в исследовании участвовал 361 человек, среди которых без заболевания 118 молодых и 106 пожилых) ",
MTTP,rs2866164,,Significant,,10.1093/gerona/gls103,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,CC,,21,30,288,205,74,,,97,,,candidate genes study,,"Генотип СС чаще встречался в группе долгожителей, но снижал выживаемость в контроле и потомстве долгожителей.","The CC genotype was more common in the group of centenarians, but reduced survival in the controls and offspring of centenarians."
MTTP,rs2866164,,Significant,,10.1093/gerona/gls103,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,CC,,,,,433,,,,,68,75,candidate genes study,,"Генотип СС чаще встречался в группе долгожителей, но снижал выживаемость в контроле и потомстве долгожителей.","The CC genotype was more common in the group of centenarians, but reduced survival in the controls and offspring of centenarians."
MYOF,rs1927465,,Non-significant,0.412,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
MYOF,rs1927465,,Non-significant,0.176,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
NBN,rs12680687+rs2735385,,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
NBS1,rs14448,,Non-significant,0.9155,10.1093/gerona/glv058,both,longevity,"Italian, Calabrian",genomic,,SNP,,,,C,,4.494,4.902,302,320,75.1,,,96,90,,candidate genes study,,,
NCAM2,rs2826891,intron,Significant,0.00402,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,36.5,43.1,,1173,,60,75,,85,105,GWAS,,,
NECTIN2,rs6857,3'UTR,Significant,"1,68 × 10−27",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,C,T,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
NECTIN2,rs34342646,,Significant,"1,64 × 10−21",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,G,A,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
NECTIN2,rs12972970,,Significant,"3,02 × 10−21",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,G,A,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
NECTIN2,rs12972156,,Significant,"4,13 × 10−21",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,C,G,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
NECTIN2,rs283815,,Significant,"4,20 × 10−15",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,A,G,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
NECTIN2,rs283811,,Significant,"9,68 × 10−14",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,A,G,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
NECTIN2,rs283812,,Significant,"3,60 × 10−13",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,T,C,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
NFATC2,multiple,,Significant,0.0293,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,,,,,,,,,500,450,73.14,43,93,98.21,95,110,gene-based association approach,,,SKAT analysis
NFATC3,multiple,,Significant,0.0294,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,,,,,,,,,500,450,73.14,43,93,98.21,95,110,gene-based association approach,,,SKAT analysis
NFKB1,multiple,,Significant,0.0287,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,,,,,,,,,500,450,73.14,43,93,98.21,95,110,gene-based association approach,,,SKAT analysis
NFKB1,rs4648110,,Significant,,,both,longevity,,genomic,,SNP,,,,*А/*А,2592+58T>A,,,,1620,,,,,21,109,candidate genes study,22184967,"Статья на на русском. В данном исследовании охарактеризовано распределение частот генотипов и аллелей по полиморфному локусу 2592+58T>A (rs4648110) гена NFΚB1 в выборке мужчин и женщин 21-109 лет. Исследования масштабное: были вовлечены 1 620 индивидов (715 мужчин и 905 женщин) 21–109 лет. Возрастные группы: 1 )зрелый возраст (22-35 для мужчин, n=130; 21-35 для женщин, n=18); 2) зрелый возраст (36–60 для мужчин, n=206; 36–55 для женщин, n=66); 3) пожилой (61–74 года для мужчин, n=103; 56–74 года для женщин, n=245); 4) старческий возраст (75–89 лет для мужчин, n=243, и женщин, n=397); 5) долгожители (90 лет и старше для мужчин, n= 33, и женщин, n=179). Не выявлено статистически значимых различий по частотам генотипов и аллелей между долгожителями, стариками и другими возрастными группами. На основании результатов логистического регрессионного анализа представляется возможным сделать заключение о том, что полиморфизм 2592+58T>A гена NFΚB1 ассоциированы с возрастом, главным образом, на протяжении пожилых и старческих диапазонов лет, и относительные шансы достижения 80-90-летнего возраста выше у носителей генотипа NFΚB1*А/*А. ",
NFKBIA,,upstream,Non-significant,0.0847,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,increased gene expression,,,,,minor,,0.5,1.3,500,450,73.14,43,93,98.21,95,110,candidate genes study,,,
NFKBIA,,upstream,Significant,0.0022,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,In/Del,,,,T,TAGAG,0.1,1.2,500,450,73.14,43,93,98.21,95,110,candidate genes study,,,
NFKBIA,rs2233407,upstream,Significant,0.0018,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,increased gene expression,SNP,,,,A,T,2.3,5,500,450,73.14,43,93,98.21,95,110,candidate genes study,,,
NFKBIA,multiple,,Significant,0.0053,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,,,,,,,,,500,450,73.14,43,93,98.21,95,110,gene-based association approach,,,SKAT analysis
NLRC5,rs41383,intron,Significant,0.00455,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,25,31,,1173,,60,75,,85,105,GWAS,,,
NOS1,rs1879417,promoter,Significant,0.018,10.1007/s10522-013-9421-z,both,longevity,"Italian, Southern",genomic,,SNP,T/C,,,T,C,,,442,321,64.9,19,91,96.2,89,107,candidate genes study,,,
NOS1AP,rs347278,intron,Significant,0.0114,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,T,C,95.9,97.9,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
NOTCH3,rs55882518,,Significant,"1,07 × 10−05",10.1093/gerona/glab023,both,longevity,German,genomic,,SNP,,,,T,,,,6941,1248,,,59,99,94,110,single-variant association approach,,,
NOTCH4,rs416352,,Non-significant,0.93,10.1001/jamanetworkopen.2018.1670,male,longevity,"Chinese, Han",genomic,,SNP,,,,minor,,51,48,773,564,48.7,40,64,101.5,100,,GWAS,,,
NOTCH4,rs416352,,Significant,"7,8 × 10-6",10.1001/jamanetworkopen.2018.1670,female,longevity,"Chinese, Han",genomic,,SNP,,,,minor,,47,51,1526,1614,48.2,40,64,103.1,100,,GWAS,,,
NPIPB8,rs2008514,,Non-significant,0.000000822,10.1038/ncomms15842,both,increased parents' age at death,European,genomic,,,,,,,,,,,276796,,,,,40,,iGWAS,,,
NPIPB8,rs2008514,,Non-significant,0.692,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
NPIPB8,rs2008514,,Non-significant,0.026,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
NR3C1,rs2963155,,Significant,0.0228,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,,,,,374,440,78.1,72,81,97,95,106,candidate genes study,,"р = 0,0228. В исследовании приняли участие 3741 мужчина в возрасте от 71 до 93 лет. “Случаи” (фенотип долголетия) определялись как лица, дожившие по меньшей мере до 95 лет. Контрольной группой были 374 мужчины средней продолжительности жизни, случайно отобранные из когорты как лица, умершие в возрасте до 81 года. Настоящее исследование случай-контроль"" было проведено в рамках Гавайского исследования продолжительности жизни (японская когорта).""",
NR3C1,rs9324921,,Significant,0.0056,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,"CC,CA",AA,,,374,440,78.1,72,81,97,95,106,candidate genes study,,"В исследовании приняли участие 3741 мужчина в возрасте от 71 до 93 лет. “Случаи” (фенотип долголетия) определялись как лица, дожившие по меньшей мере до 95 лет. Контрольной группой были 374 мужчины средней продолжительности жизни, случайно отобранные из когорты как лица, умершие в возрасте до 81 года. Настоящее исследование случай-контроль"" было проведено в рамках Гавайского исследования продолжительности жизни (японская когорта).""",
NRF1,rs13241028,,Non-significant,0.3039,10.1093/gerona/glv058,both,longevity,"Italian, Calabrian",genomic,,SNP,,,,C,,11.72,13.93,302,320,75.1,,,96,90,,candidate genes study,,,
NTHL1,rs3211994,3',Non-significant,0.627,10.1016/j.exger.2012.02.010,male,longevity,German,genomic,,SNP,,,,G,A,,,1140,1613,67.2,,,,95,110,candidate genes study,,,
NTLH1,rs3211994,3',Significant,0.0056,10.1016/j.exger.2012.02.010,male,longevity,Danish,genomic,,SNP,,,,A,G,,,800,1200,50.5,46,55,93.2,92.2,93.8,candidate genes study,,,
NUDT12,rs79072042,,Non-significant,0.6,10.1001/jamanetworkopen.2018.1670,female,longevity,"Chinese, Han",genomic,,SNP,,,,major,,87,87,1526,1614,48.2,40,64,103.1,100,,GWAS,,,
NUDT12,rs79072042,,Significant,"7,2 × 10-6",10.1001/jamanetworkopen.2018.1670,male,longevity,"Chinese, Han",genomic,,SNP,,,,major,,85,91,773,564,48.7,40,64,101.5,100,,GWAS,,,
OLFM4,rs9568833,"downstream, –200000",Significant,0.0000177,10.1038/srep21243,both,longevity,Chinese,genomic,,SNP,T>C,,,T,C,82.3,86,2178,2299,48.4,,,102.7,,,GWAS,,,
OTOL1,"rs199791179, rs149127996, rs199985412, rs3921595, rs202021352",,Significant,"2,56 × 10−04",10.1093/gerona/glab023,both,longevity,German,genomic,,,,,,,,,,6941,1248,,,59,99,94,110,gene-based association approach,,,SKAT-CommonRare function method
PAPPA,PRDX3 [rs1553850]+PAPPA[rs449807],,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
PAPPA,GHSR[rs572169]+GHSR[rs512692]+PAPPA[rs4837525],,Significant,0.001,10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,GHSR[GG]+GHSR[TT]+PAPPA[AG],,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
PARK7,GHSR[rs572169]+MRE11A[rs533984]+PARK7[rs225119],,Significant,0.001,10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,GHSR[GG]+MRE11A[G]+PARK7[G],,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
PARP1,rs1805415,"exon, missense",Non-significant,0.07,10.1016/j.exger.2009.02.004,both,longevity,"Caucasian, African-American, Ashkenazi Jewish",genomic,,SNP,"T>A,C,G",,,T,,,,1867,1160,,,,,92,,candidate genes study,,"Когорта CHS: 5888 взрослых мужчин и женщин 65 лет и старше из США. 4925 человек или 95% определили свою этническую принадлежность как белые. В группу долгожителей относили людей, доживших как минимум до 92 лет (n = 479; 61% женщин), а в контрольную группу - людей, умерших в возрасте до 79 лет (n = 900; 46% женщин). ). Когорта евреев-ашкенази: 388 евреев-ашкенази с высокой продолжительностью жизни [289 женщин и 99 мужчин, средний возраст 97,7 (0,2) года (возрастной диапазон 95–108 лет; 20% старше 100 лет] и контрольные группы евреев-ашкенази [n = 364, средний возраст 79,5 (0,4) года (58% женщины] без семейного анамнеза высокой продолжительности жизни. Когорта SOF: n = 9704 женщины европейского происхождения в возрасте 65 лет и старше из США. Когорта наблюдалась более 20 лет с полным последующим наблюдением за смертностью и включала 896 участников SOF, отобранных для включения в исследование продолжительности жизни (293 человек в группе долгожителей ≥ 92 лет, средняя продолжительности жизни = 95,3 ± 2,1 года и 603 человека в контрольной группе, на момент смерти ≤ 79 лет, средняя продолжительности жизни = 75,7 ± 2,6 года). Исследование CHS: Отношение шансов в исследовании ассоциации с долголетием для каждой дополнительной копии минорного аллеля rs1805415 составляло 0,66 (95% CI 0,55–0,81; p = 0,001). При анализе модели времени-до-события для лиц европейского происхождения из этой когорты каждая дополнительная копия минорного аллеля PARP1 rs1805415 была связана с 1,11-кратным повышением риска общей смертности (95% доверительный интервал 1,02 - 1,18; p = 0,01) . Исследование когорты евреев-ашкенази: Аллель PARP1 rs1805415 был ассоциирован со сниженным риском долголетия (отношение шансов = 0,75; 95% CI 0,56–0,99; p = 0,04). В исследовании когорты SOF не было показано ассоциации аллеля PARP1 rs1805415 с продолжительностью жизни (отношение шансов = 1,02; 95% CI 0,77–1,36; p = 0,88). В объединенном анализе всех 3 выборок «риск» долголетия, связанный с минорным аллелем PARP1 rs1805415, составил 0,79 (95% CI 0,62–1,02; p = 0,07).",
PARP1,rs1805415,"exon, missense",Non-significant,0.886,10.1016/j.exger.2009.02.004,female,longevity,Caucasian,genomic,,SNP,"T>A,C,G",,,T,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,"Когорта SOF: n = 9704 женщины европейского происхождения в возрасте 65 лет и старше из США. Когорта наблюдалась более 20 лет с полным последующим наблюдением за смертностью и включала 896 участников SOF, отобранных для включения в исследование продолжительности жизни (293 человек в группе долгожителей ≥ 92 лет, средняя продолжительности жизни = 95,3 ± 2,1 года и 603 человека в контрольной группе, на момент смерти ≤ 79 лет, средняя продолжительности жизни = 75,7 ± 2,6 года).",
PARP1,rs1805415,"exon, missense",Significant,0.04,10.1016/j.exger.2009.02.004,both,longevity,Ashkenazi Jewish,genomic,,SNP,"T>A,C,G",,,T,,,,364,388,79.5,,,97.7,95,108,candidate genes study,,"Когорта евреев-ашкенази: 388 евреев-ашкенази с высокой продолжительностью жизни [289 женщин и 99 мужчин, средний возраст 97,7 (0,2) года (возрастной диапазон 95–108 лет; 20% старше 100 лет] и контрольные группы евреев-ашкенази [n = 364, средний возраст 79,5 (0,4) года (58% женщины] без семейного анамнеза высокой продолжительности жизни.",
PARP1,rs1805415,"exon, missense",Significant,0.0014,10.1016/j.exger.2009.02.004,both,longevity,"Caucasian, African-American",genomic,,SNP,"T>A,C,G",,,T,,,,900,479,,,79,,92,,candidate genes study,,"Когорта CHS: 5888 взрослых мужчин и женщин 65 лет и старше из США. 4925 человек или 95% определили свою этническую принадлежность как белые. В группу долгожителей относили людей, доживших как минимум до 92 лет (n = 479; 61% женщин), а в контрольную группу - людей, умерших в возрасте до 79 лет (n = 900; 46% женщин). ).",
PARP1,PARP1[rs1136410]+FOXO3A[rs479744],,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
PARVG,rs139170,intron,Significant,0.00332,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,34.7,41.4,,1173,,60,75,,85,105,GWAS,,,
PDE4B,multiple,,Significant,0.0324,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,,,,,,,,,500,450,73.14,43,93,98.21,95,110,gene-based association approach,,,SKAT analysis
PDK1,rs1530865,,Non-significant,0.9918,10.1093/gerona/glv058,both,longevity,"Italian, Calabrian",genomic,,SNP,,,,C,,3.86,4.085,302,320,75.1,,,96,90,,candidate genes study,,,
PDK1,rs11904366,,Non-significant,0.6516,10.1093/gerona/glv058,both,longevity,"Italian, Calabrian",genomic,,SNP,,,,T,,14.07,14.38,302,320,75.1,,,96,90,,candidate genes study,,,
PDPK1,rs758319,,Non-significant,0.088,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PDPK1,rs7201584,,Non-significant,"0,85",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PDPK1,rs1005273,,Non-significant,"0,19",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PFKM,rs2228500,,Non-significant,0.349,10.1093/gerona/glu166,both,increased lifespan,Caucasian,genomic,,SNP,,,,,,,,,4567,,,,,25,110,"meta-analysis of GWAS, replication",,,
PFKM,rs2228500,,Non-significant,0.796,10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,914,801,73,54,90,104,95,119,"meta-analysis of GWAS, replication",,,
PFKM,rs10875746,intron,Non-significant,0.24,10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,16121,5409,,,65,,90,,"meta-analysis of GWAS, replication",,,
PFKM,rs10875746,intron,Significant,"7,83 × 10^−6",10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,3757,6036,,55,80,,90,,meta-analysis of GWAS,,,suggestive significant
PGGT1B,rs3805586,,Non-significant,0.13,10.1001/jamanetworkopen.2018.1670,male,longevity,"Chinese, Han",genomic,,SNP,,,,major,,77,79,773,564,48.7,40,64,101.5,100,,GWAS,,,
PGGT1B,rs3805586,,Significant,"8,9 × 10-6",10.1001/jamanetworkopen.2018.1670,female,longevity,"Chinese, Han",genomic,,SNP,,,,minor,,30,35,1526,1614,48.2,40,64,103.1,100,,GWAS,,,
PGP,"rs200526199, rs116977380, rs200615324",,Significant,"2,50 × 10−06",10.1093/gerona/glab023,both,longevity,German,genomic,,,,,,,,,,6941,1248,,,59,99,94,110,gene-based association approach,,,SKAT-CommonRare function method
PIK3CA,rs6443624,,Non-significant,"0,53",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3CA,rs7640662,,Non-significant,"0,83",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3CA,rs2677764,,Non-significant,"0,8",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3CA,rs13320527,,Non-significant,"0,54",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3CA,rs3729692,,Non-significant,"0,69",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3CB,rs361072,promoter,Non-significant,0.829,10.1016/j.exger.2004.05.007,both,longevity,Japanese,genomic,,SNP,,,,,,,,122,122,33.3,19,63,106.8,105,,candidate genes study,,,Более 80% выборки женского пола.
PIK3CB,rs497900,,Non-significant,0.089,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3CB,rs10513055,,Non-significant,"0,62",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3CB,rs361072,,Non-significant,"0,18",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3CG,rs3779501,intron,Non-significant,0.139,10.1016/j.exger.2004.05.007,both,longevity,Japanese,genomic,,SNP,,,,,,,,122,122,33.3,19,63,106.8,105,,candidate genes study,,,Более 80% выборки женского пола.
PIK3R1,rs6449959,,Non-significant,"0,79",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs706711,,Non-significant,"0,6",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs706713,,Non-significant,"0,37",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs7713645,,Non-significant,"0,95",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs17317833,,Non-significant,"0,58",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs12652661,,Non-significant,"0,67",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs251406,,Non-significant,"0,25",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs173704,,Non-significant,"0,98",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs173702,,Non-significant,"0,9",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs251401,,Non-significant,"0,4",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs4122269,,Non-significant,"0,46",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs1823023,,Non-significant,"0,43",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs34303,,Non-significant,"0,22",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs16897561,,Non-significant,"0,83",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs10515074,,Non-significant,"0,4",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs831123,,Non-significant,"0,9",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs171649,,Non-significant,"0,27",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs6876003,,Non-significant,"0,6",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs251409,,Non-significant,"0,95",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs17318918,,Non-significant,"0,24",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs34306,,Non-significant,"0,48",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs1550805,,Non-significant,"0,39",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs1862162,,Non-significant,"0,98",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs831125,,Non-significant,"0,56",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs3730089,,Non-significant,"0,36",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs12659907,,Non-significant,"0,34",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs1043526,,Non-significant,"0,58",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs3756668,,Non-significant,"0,7",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R1,rs7709243,,Significant,0.00083,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,TT,"TC, CC",,,366,421,78.1,72,81,97,95,106,candidate genes study,,"р = 0,0008 Исследовали генотип ТТ по отношению к ТС, СС OR = 1,63 (95% CI = 1,22–2,18) Количество людей в группе долгожителей и группе контролей было 421и 366, соответственно. Испытуемые были американскими мужчинами японского происхождения.",
PIK3R1,rs7709243,,Significant,0.0008,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,,,,,366,421,78.1,72,81,97,95,106,candidate genes study,,,
PIK3R1,rs7713645,,Significant,0.0041,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,,,,,366,421,78.1,72,81,97,95,106,candidate genes study,,,
PIK3R1,rs6881033,,Significant,0.0057,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,,,,,366,421,78.1,72,81,97,95,106,candidate genes study,,,
PIK3R2,rs273269,,Non-significant,"0,35",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PIK3R2,rs273266,,Non-significant,"0,31",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PKHD1,rs12199884,,Non-significant,0.94,10.1001/jamanetworkopen.2018.1670,female,longevity,"Chinese, Han",genomic,,SNP,,,,major,,94,94,1526,1614,48.2,40,64,103.1,100,,GWAS,,,
PKHD1,rs12199884,,Significant,"4,1 × 10-6",10.1001/jamanetworkopen.2018.1670,male,longevity,"Chinese, Han",genomic,,SNP,,,,major,,92,96,773,564,48.7,40,64,101.5,100,,GWAS,,,
PKN2,multiple,,Significant,0.0274,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,,,,,,,,,500,450,73.14,43,93,98.21,95,110,gene-based association approach,,,SKAT analysis
PLCB1,rs117816042,intron,Significant,0.0216,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,A,C,0.6,1.8,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
PLCB1,multiple,,Significant,0.0319,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,,,,,,,,,500,450,73.14,43,93,98.21,95,110,gene-based association approach,,,SKAT analysis
PLCB4,rs11360322,intron,Significant,0.0217,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,In/Del,,,,TA,T,0.5,1.6,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
PLCG2,rs72824905,,Significant,"6,3 × 10^−3",10.1007/s00401-019-02026-8,both,longevity,Caucasian,genomic,,SNP,,,,G,,,,9677,3516,,,89,,90,,meta-analysis of candidate gene studies,,"Вариант rs72824905-G ассоциирован с повышением вероятности достижения возраста 90 лет (OR = 1,49; 95% CI 1,12–1,98) . Когорта: 3 516 долгожителей (> 90 лет) и 9677 человек в контрольной группе (умерших в возрасте до 90 лет или прошедших последнее обследование до 90 лет). Национальность: европейцы Выборка состоит из 5 когорт: AgeCoDe: лица европейского происхождения, 861 человек в контрольной группе: 496 женщин (57,6%), средний возраст 83,3 (± 3,58); 462 долгожителей: 324 женщины (70,1%), средний возраст 92,21 (± 2,16) Amsterdam: лица европейского происхождения (голландцы), 880 человек в контрольной группе: 343 женщины (39%), средний возраст 60,2 (± 8,9); Danish studies: лица европейского происхождения, 2793 человека в контрольной группе: 2005 женщины (71,8%), средний возраст 26,5 (± 5,5); 853 долгожителей: 646 женщин (75,5%), средний возраст 99,9 (± 3,5) Leiden Longevity Study: лица европейского происхождения, 743 человека в контрольной группе: 428 женщин (57,6%), средний возраст 58,7 (± 7,5); 942 долгожителей: 591 женщина (62,7%), средний возраст 93,4 (± 2,7) Исследования GBS: лица европейского происхождения (большинство шведов), 2709 человек в контрольной группе: 1690 женщин (62%), средний возраст 77,9 (± 7,2); 770 долгожителей: 612 женщин (78,5%), средний возраст 96 лет (± 4,5)",
PLCG2,rs72824905,"exon, non-synonymous",Significant,0.0094,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,G,C,98.7,99.8,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
PLCG2,rs140070662,intron,Significant,0.0148,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,A,C,0.1,0.9,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
PLCG2,multiple,,Significant,0.0496,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,,,,,,,,,500,450,73.14,43,93,98.21,95,110,gene-based association approach,,,SKAT analysis
PLCH1,,intron,Significant,0.0336,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,G,A,99.4,100,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
PMF1,rs2758603,,Significant,"9,8 × 10^−7",10.1038/s41467-019-11558-2,both,longevity,"European, East Asian, African American",genomic,,SNP,,,,C,T,,,27993,5662,,,75,,98,,meta-analysis of GWAS,,,suggestive significant
POLB,rs2953983,intron,Non-significant,0.683,10.1016/j.exger.2012.02.010,both,longevity,German,genomic,,SNP,,,,G,A,,,1140,1613,67.2,,,,95,110,candidate genes study,,,
POLB,rs2953983,intron,Significant,0.0225,10.1016/j.exger.2012.02.010,both,longevity,Danish,genomic,,SNP,,,,G,A,,,800,1200,50.5,46,55,93.2,92.2,93.8,candidate genes study,,,
POM121C,rs113160991,,Non-significant,0.563,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
POM121C,rs113160991,,Non-significant,0.927,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
POM121C,rs113160991,,Significant,0.0000000075,10.7554/eLife.39856.001,both,increased parental lifespan,European,genomic,,SNP,,,,G,,,,,1012240,,,,71.63,40,117,iGWAS,,,
PON1,rs662,"exon, missense",Non-significant,0.088,10.1007/s00391-015-0892-1,both,longevity,"American, Dutch, Italian, Tatars, German, Danish, French",genomic,,SNP,A>G,Q192R,,G,,,,4320,5061,,0,66.8,,80,104,meta-analysis of candidate gene studies,,"Метаанализ был основан на 9 исследованиях PON1 Q192R, которые охватили в общей сложности 5061 долгожителей и 4320 людей в контрольной группе. В целом, значительного увеличения рисков для Q192R не наблюдалось. Результаты статистических расчетов для Q192R были следующими: R против Q (аддитивная модель): OR = 1,080, 95% CI = 0,989-1,179, p = 0,088 и RR + RQ против QQ (доминирующая модель): OR = 1,099, 95% ДИ = 0,975–1,240, p = 0,124.",
PON1,rs662,"exon, missense",Non-significant,0.09,10.1016/j.exger.2003.11.019,both,longevity,Northern Irish,genomic,,SNP,A>G,Q192R,,G (R),,,,296,296,13,,,,80,,candidate genes study,,,
PON1,rs662,"exon, missense",Significant,0.02,10.1016/j.exger.2003.11.019,both,longevity,Italian,genomic,,SNP,A>G,Q192R,,G (R),,26.4,31.7,579,308,40.7,20,65,100.8,100,,candidate genes study,,"PON1 Q192R (rs662 A> G) представляет собой полиморфизм, который приводит к замене аминокислоты в кодоне 192: глутамин (Q) заменяется на аргинин (R). Характеристика выборок: 1. Италия. Выборка из 579 итальянских неродственных молодых людей (347 мужчин и 232 женщины, средний возраст 40,7 года, SD 12,7 лет, возрастной диапазон от 20 до 65 лет) и выборка из 308 неродственных долгожителей старше 100 лет (241 женщина и 67 мужчин). 2. Северная Ирландия. Восьмидесятилетние и девяностолетние участники — 296 пожилых людей (92 мужчины и 204 женщины, средний возраст 89,8 SD 5,7 лет). Молодые участники — 296 человек (92 мужчины, 204 женщины, возраст 13,0 SD 1,4 года). Наблюдалась достоверная разница между генотипами PON1 192 (rs662) в Италии между пожилыми и молодыми людьми с большей долей QR-гетерозигот (AG) среди пожилых людей. Сравнивая аллели Q и R PON1 192, выявили значимые различия между возрастными группами долгожителей и молодых из Италии с аналогичными, но не достоверными изменениями в когорте Северной Ирландии. В соответствии с анализом на основе генотипа частота аллеля R (G) увеличивалась примерно на 4–5% у пожилых людей по сравнению с молодыми людьми. Логистическая регрессия использовалась для сравнения генотипов PON1 192 с поправкой на влияние страны или пола. Результаты показывают значительное ступенчатое увеличение отношения шансов, связанное с генотипом QR 1,29 (CI, 1,01–1,65; p = 0:04) и генотипом RR 1,68 (CI, 1,08–2,62; p = 0:02). ) относительно генотипа QQ. Аллель R PON1 192 показал повышенное отношение шансов по сравнению с аллелем Q (1,26, CI 1,07–1,5; p = 0: 007).",
PON1,rs662,"exon, missense",Significant,0.004,10.12659/msm.898231,both,longevity,Chinese,genomic,,SNP,A>G,Q192R,,A,G,20.5,37.7,110,110,49.1,28,82,95.5,90,110,candidate genes study,,"Частота минорного аллеля (A) rs662 в PON1 был значительно выше в группе долголетия, чем в двух контрольных группах (χ2 = 16,348, p = 0,000). Характеристики выборки Группа долгожителей: 110 долгожителей (возраст 90-110 лет, в среднем 95,47 ± 5,10), 27 мужчин и 83 женщины. Контрольная группа 1: 110 здоровых жителей округа Бама (возраст 43-82 года, средний 72,68 ± 9,38), 40 мужчин и 70 женщин, без семейного анамнеза долголетия. Контрольная группа 2: 110 здоровых жителей округа Нандан (в возрасте 28-82 года, в среднем 49,13 ± 14,19), 40 мужчин и 70 женщин, без семейного анамнеза долголетия. Этническая принадлежность: китайцы",
PON1,rs662,"exon, missense",Significant,0.005,,both,longevity,Tatars,genomic,,SNP,A>G,Q192R,,G (R),,,,253,105,,75,89,93.4,90,109,candidate genes study,17936978,"PON1 Q192R (rs662 A> G) представляет собой полиморфизм, который приводит к замене аминокислоты в кодоне 192: глутамин (Q) заменяется на аргинин (R). Характеристика выборки Младшая n=163 возраст 1-20 средний возраст 15.0 ± 3.5 Средняя n=239 возраст 21-55 средний возраст 36.3 ± 10.3 Пожилая n=356 возраст 56-74 средний возраст 66.8 ± 5.3 Старческая n=253 возраст 75-89 средний возраст 79.8 ± 3.6 Долгожители n=105 возраст 90-109 средний возраст 93.4 ± 3.3 Всего 1116 человек Этническая принадлежность: татары В группе долгожителей частоты аллеля PON1*R (P = 0.005) и генотипа PON1*R/*R (P = 0.01) существенно выше, чем у стариков.",
PPAP2B,rs17114036,,Non-significant,0.0000018,10.1038/ncomms15842,both,increased parents' age at death,European,genomic,,,,,,G,,,,,276796,,,,,40,,iGWAS,,,
PPAP2B,rs17114036,,Non-significant,0.712,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
PPAP2B,rs17114036,,Non-significant,0.137,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
PPARA,rs11704979,,Non-significant,0.1272,10.1093/gerona/glv058,both,longevity,"Italian, Calabrian",genomic,,SNP,,,,A,,8.118,11.27,302,320,75.1,,,96,90,,candidate genes study,,,
PPARA,rs41388244,,Non-significant,0.7981,10.1093/gerona/glv058,both,longevity,"Italian, Calabrian",genomic,,SNP,,,,major,,98.134,98.371,302,320,75.1,,,96,90,,candidate genes study,,,
PPARG,rs1175542,intron,Non-significant,0.565,10.1016/j.exger.2009.02.004,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,,364,388,79.5,,,97.7,95,108,candidate genes study,,"Когорта евреев-ашкенази: 388 евреев-ашкенази с высокой продолжительностью жизни [289 женщин и 99 мужчин, средний возраст 97,7 (0,2) года (возрастной диапазон 95–108 лет; 20% старше 100 лет] и контрольные группы евреев-ашкенази [n = 364, средний возраст 79,5 (0,4) года (58% женщины] без семейного анамнеза высокой продолжительности жизни.",
PPARG,rs1175542,intron,Non-significant,0.415,10.1016/j.exger.2009.02.004,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,"Когорта SOF: n = 9704 женщины европейского происхождения в возрасте 65 лет и старше из США. Когорта наблюдалась более 20 лет с полным последующим наблюдением за смертностью и включала 896 участников SOF, отобранных для включения в исследование продолжительности жизни (293 человек в группе долгожителей ≥ 92 лет, средняя продолжительности жизни = 95,3 ± 2,1 года и 603 человека в контрольной группе, на момент смерти ≤ 79 лет, средняя продолжительности жизни = 75,7 ± 2,6 года).",
PPARG,rs1801282,"exon, missense",Significant,,10.1016/j.exger.2004.03.034,male,longevity,European,genomic,,SNP,G>C,Pro12Ala,,Pro/Ala,,8.5,20,345,134,,,84,,86,109,candidate genes study,,"Характеристики выборки 222 участика-долгожителя >85 лет (диапазон 86-109 лет, средний возраст 97 SD 4, 94 мужчины) и 250 участников <85 лет (средний возраст 55 SD 21, 71 мужчина). Этническая принадлежность: европейского происхождения Исследователи обнаружили различное распределение частот генотипа Pro/Ala (AG) между долгожителями и пожилыми мужчинами, причем долгожители-мужчины имели повышенную частоту генотипа Pro/Ala (20 против 8,5%); не было обнаружено различий при анализе распределения аллелей и генотипов полиморфизма гена Pro/Ala в двух возрастных группах женщин.",
PPARG,rs1175542,intron,Significant,0.0081,10.1016/j.exger.2009.02.004,both,longevity,"Caucasian, African-American",genomic,,SNP,,,,,,,,900,479,,,79,,92,,candidate genes study,,"Когорта CHS: 5888 взрослых мужчин и женщин 65 лет и старше из США. 4925 человек или 95% определили свою этническую принадлежность как белые. В группу долгожителей относили людей, доживших как минимум до 92 лет (n = 479; 61% женщин), а в контрольную группу - людей, умерших в возрасте до 79 лет (n = 900; 46% женщин). ).",
PPARG,,"exon, missense",Significant,0.03,10.1089/rej.2012.1365,male,longevity,"Italian, Southern",genomic,,SNP,,Pro12Ala,,Pro/Pro,Pro/Ala,79,92,52,48,,,,,90,,candidate genes study,,,
PPARGC1A,rs8192678,"exon, missense",Non-significant,0.469,10.1016/j.exger.2004.05.007,both,longevity,Japanese,genomic,,SNP,,S482G,,,,,,122,122,33.3,19,63,106.8,105,,candidate genes study,,,Более 80% выборки женского пола.
PPARGC1A,rs3736265,"exon, missense",Non-significant,0.509,10.1016/j.exger.2004.05.007,both,longevity,Japanese,genomic,,SNP,,M612T,,,,,,122,122,33.3,19,63,106.8,105,,candidate genes study,,,Более 80% выборки женского пола.
PPP1R26,rs2590504,"downstream, −6153",Significant,0.00854,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,37.3,43.2,,1173,,60,75,,85,105,GWAS,,,
PPP2R1A,multiple,,Significant,0.0327,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,,,,,,,,,500,450,73.14,43,93,98.21,95,110,gene-based association approach,,,SKAT analysis
PPP2R2C,rs10937739,intron,Significant,0.00404,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,41.9,48.4,,1173,,60,75,,85,105,GWAS,,,
PRDX3,PRDX3 [rs1553850]+PAPPA[rs449807],,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
PRKAR2A,multiple,,Significant,0.0297,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,,,,,,,,,500,450,73.14,43,93,98.21,95,110,gene-based association approach,,,SKAT analysis
PRKCB,rs78946887,3'UTR,Significant,0.0211,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,G,A,0,0.5,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
PRKCD,multiple,,Significant,0.0079,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,,,,,,,,,500,450,73.14,43,93,98.21,95,110,gene-based association approach,,,SKAT analysis
PRKCH,rs2463117,intron,Significant,0.0496,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,decreased gene expression,SNP,,,,T,C,7.6,10.4,500,450,73.14,43,93,98.21,95,110,candidate genes study,,,
PRKCH,rs17098729,intron,Significant,0.0015,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,decreased gene expression,SNP,,,,G,C,5.5,9.7,500,450,73.14,43,93,98.21,95,110,candidate genes study,,,
PRKCH,rs1088680,"exon, synonymous",Significant,0.0033,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,T,C,7.8,12.2,500,450,73.14,43,93,98.21,95,110,candidate genes study,,,
PRKCH,rs1088679,intron,Significant,0.0013,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,C,T,6.5,10.9,500,450,73.14,43,93,98.21,95,110,candidate genes study,,,
PRKCH,rs1092331,intron,Significant,0.0004,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,G,A,6.3,11.2,500,450,73.14,43,93,98.21,95,110,candidate genes study,,,
PRKCH,rs1088680,"exon, synonymous",Significant,0.0011,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,T,C,7.6,11.9,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
PRKCH,rs12878845,upstream,Significant,0.0022,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,C,T,65,71.4,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
PRKCH,multiple,,Significant,0.0495,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,,,,,,,,,500,450,73.14,43,93,98.21,95,110,gene-based association approach,,,SKAT analysis
PRKCI,,intron,Significant,0.0141,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,In/Del,,,,AT,A,1.2,2.8,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
PRKCQ,rs73619607,"ncRNA, exon",Significant,0.0463,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,G,A,99,99.8,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
PRKD3,multiple,,Significant,0.0137,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,,,,,,,,,500,450,73.14,43,93,98.21,95,110,gene-based association approach,,,SKAT analysis
PROX2,rs61978928,,Non-significant,0.73,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,T,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
PROX2,rs61978928,,Non-significant,0.624,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
PROX2,rs61978928,,Significant,0.00000002,10.18632/aging.101334,both,increased parental lifespan,European,genomic,,,,,,T,,,,,389166,,,,56.66,40,73,GWAS,,,
PSG7,"rs199532805, rs112354282",,Significant,"2,64 × 10−05",10.1093/gerona/glab023,both,longevity,German,genomic,,,,,,,,,,6941,1248,,,59,99,94,110,gene-based association approach,,,SKAT-CommonRare function method
PSORS1C3,rs3130507,,Non-significant,0.841,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
PSORS1C3,rs3130507,,Non-significant,0.273,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
PSORS1C3,rs3130507,,Significant,0.00000000021,10.18632/aging.101334,female,increased mothers' lifespan,European,genomic,,,,,,,G,,,,212672,,,,54.65,,,GWAS,,,
PSRC1,rs4970836,,Non-significant,0.196,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
PSRC1,rs4970836,,Non-significant,0.306,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
PSRC1,rs4970836,,Significant,0.0000000016,10.7554/eLife.39856.001,both,increased parental lifespan,European,genomic,,SNP,,,,G,,,,,1012240,,,,71.63,40,117,iGWAS,,,
PTEN,rs1234221,,Non-significant,"0,9",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PTEN,rs1234220,,Non-significant,"0,14",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PTEN,rs2299939,,Non-significant,"0,59",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PTEN,rs10490920,,Non-significant,"0,87",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PTEN,rs12357281,,Non-significant,"0,21",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PTEN,rs2673832,,Non-significant,"0,42",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PTEN,rs532678,,Non-significant,"0,98",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PTEN,rs478839,,Non-significant,"0,4",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PTEN,rs1022427,,Non-significant,0.99,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,797,279,76.1,,79,94.5,92,,candidate genes study,,,
PTEN,rs1022427,,Non-significant,0.13,10.1111/j.1474-9726.2009.00493.x,both,longevity,Caucasian,genomic,,SNP,,,,,,,,1400,572,75.9,79,,95,92,,meta-analysis of candidate gene studies,,,
PTEN,rs1022427,,Significant,0.033,10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
PTK2,rs7460,,Non-significant,0.78,10.1089/rej.2014.1570,both,longevity,Italian,genomic,decreased gene expression,SNP,,,,T,A,46,46,316,79,,29,50,,100,104,candidate genes study,,,
PTK2,rs7843014,,Non-significant,0.42,10.1089/rej.2014.1570,both,longevity,Italian,genomic,decreased gene expression,SNP,,,,C,A,67,50,316,79,,29,50,,100,104,candidate genes study,,,
PTK2,rs7460,,Non-significant,0.37,10.1089/rej.2014.1570,both,longevity,Japanese,genomic,decreased gene expression,SNP,,,,T,A,37,36,499,742,,23,59,,100,116,candidate genes study,,,
PTK2,rs7843014,,Non-significant,0.21,10.1089/rej.2014.1570,both,longevity,Japanese,genomic,decreased gene expression,SNP,,,,C,A,76,73,499,742,,23,59,,100,116,candidate genes study,,,
PTK2,rs7460,,Significant,"<0,01",10.1089/rej.2014.1570,both,longevity,Spanish,genomic,decreased gene expression,SNP,,,,T,A,56,74,344,175,,20,50,,110,111,candidate genes study,24930376,"У аллеля А наблюдалась негативная ассоциация с долгожительством: OR=0.40 (95%CI: 0.3, 0.6, P<0.01); генотип TT имел положительную ассоциацию с долгожительством: OR=6.68 (95%CI: 4.1, 10.8, P<0.01). Объем выборки: 175 долгожителей (100-111 лет, 144 женщин, 31 мужчин), 344 контролей (20-50 лет, 284 женщины, 214 мужчин). Все испанские участники имели испанское происхождение ≥3 поколений. Результаты не были воспроизведены на итальянской и японской выборках.",
PTK2,rs7843014,,Significant,"<0,01",10.1089/rej.2014.1570,both,longevity,Spanish,genomic,decreased gene expression,SNP,,,,C,A,47,69,344,175,,20,50,,110,111,candidate genes study,24930376,"У аллеля А наблюдалась негативная ассоциация с долгожительством: OR=0.37 (95%CI: 0.3, 0.5), P<0.01. Генотип СС имел положительную ассоциацию с долгожительством: OR=7.58 (95%CI: 4.6, 12.3), P<0.01. Объем выборки: 175 долгожителей (100-111 лет, 144 женщин, 31 мужчин), 344 контролей (20-50 лет, 284 женщины, 214 мужчин). Все испанские участники имели испанское происхождение ≥3 поколений. Результаты не были воспроизведены на итальянской и японской выборках.",
PTPN1,rs2038526+rs6067484,,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
PTPN1,rs2426164+rs6067484,,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
PTPN1,rs6063534+rs6067484,,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
PTPN1,IGF1R[rs12437963]+PTPN1[rs6067484],,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
PTPN1,GHSR[rs572169]/PTPN1[rs6067484],,Significant,0.001,10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,GHSR[GG]+PTPN1[AG],,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
PVRL2 ,rs6857,3'UTR,Significant,0,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,C/T,,,C,C,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
PVRL2 ,rs6859,3'UTR,Significant,0.000000246,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,G,A,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
PVRL2 ,rs3852861,intron,Significant,0.00000249,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,G/T,,,T,G,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
RAC2,rs13053175,"upstream, −7992",Significant,0.00697,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,28,33.6,,1173,,60,75,,85,105,GWAS,,,
RAD23B,rs1805329,"exon, missense",Non-significant,0.507,10.1016/j.exger.2012.02.010,both,longevity,German,genomic,,SNP,,,,G,A,,,1140,1613,67.2,,,,95,110,candidate genes study,,,
RAD23B,rs1805329,"exon, missense",Significant,0.0309,10.1016/j.exger.2012.02.010,both,longevity,Danish,genomic,,SNP,,,,G,A,,,800,1200,50.5,46,55,93.2,92.2,93.8,candidate genes study,,,
RAD23B,AOX1[rs2465661]+RAD23B[rs11573709,,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
RAD50,rs2706372,,Non-significant,"3,11 × 10−4",0.1111/acel.12471,both,longevity,German,genomic,,SNP,,,,T,C,25.65,22.41,6368,1458,57.2,,,99,,,immunochip,,,
RAD50,rs2706372,,Non-significant,"4,95 × 10−4",0.1111/acel.12471,both,longevity,"Danes, French",genomic,,SNP,,,,T,C,,,2551,1750,56.1,,,99.3,,,"immunochip, replication",,,
RAD50,rs2706372,,Non-significant,0.503,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,T,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
RAD50,rs2706372,,Non-significant,0.043,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,T,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
RAD50,rs2706372,,Significant,"5,42 × 10−7",0.1111/acel.12471,both,longevity,"German, Danes, French",genomic,,SNP,,,,T,C,,,8919,3208,56.5,,,99.2,,,"immunochip, discovery + replication",,,
RAD52,rs11571461,intron,Non-significant,0.191,10.1016/j.exger.2012.02.010,both,longevity,German,genomic,,SNP,,,,A,G,,,1140,1613,67.2,,,,95,110,candidate genes study,,,
RAD52,rs11571461,intron,Significant,0.00011,10.1016/j.exger.2012.02.010,both,longevity,Danish,genomic,,SNP,,,,A,G,,,800,1200,50.5,46,55,93.2,92.2,93.8,candidate genes study,,,
RDH5,rs3138136,,Significant,"5,4 × 10^−7",10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,C,T,,,25483,11262,,,75,,89,,meta-analysis of GWAS,,,suggestive significant
RELA,multiple,,Significant,0.0279,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,,,,,,,,,500,450,73.14,43,93,98.21,95,110,gene-based association approach,,,SKAT analysis
RELN,rs115734214,exon,Significant,0.0464,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,T,G,1,2.1,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
RGS7,rs75361849,,Non-significant,0.728,10.1093/gerona/glu166,both,increased lifespan,Caucasian,genomic,,SNP,,,,,,,,,4567,,,,,25,110,"meta-analysis of GWAS, replication",,,
RGS7,rs4611001,−28,Non-significant,0.207,10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,16121,5409,,,65,,90,,"meta-analysis of GWAS, replication",,,
RGS7,rs4611001,−28,Significant,"1,84 × 10^−6",10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,3757,6036,,55,80,,90,,meta-analysis of GWAS,,,suggestive significant
RGS7,rs7536260,,Significant,0.013,10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,914,801,73,54,90,104,95,119,"meta-analysis of GWAS, replication",,,
RP1,rs35262860,,Significant,"3,9 × 10^−7",10.1038/s41467-019-11558-2,both,longevity,European,genomic,,In/Del,,,,GCT,G,,,25483,11262,,,75,,89,,meta-analysis of GWAS,,,suggestive significant
RP1,rs35262860,,Significant,"5,6 × 10^−7",10.1038/s41467-019-11558-2,both,longevity,"European, East Asian, African American",genomic,,In/Del,,,,GCT,G,,,27993,13617,,,75,,89,,meta-analysis of GWAS,,,suggestive significant
RP1-223B1.1,rs1205035,"intergenic, −109050        ",Significant,0.00983,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,36.2,42,,1173,,60,75,,85,105,GWAS,,,
RP11-149P14.1,rs3120819,"intergenic, −84906",Significant,0.00806,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,42.1,48.4,,1173,,60,75,,85,105,GWAS,,,
RP11-24C3.2,rs9876781,non-coding,Significant,0.000868,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,34.9,42.4,,1173,,60,75,,85,105,GWAS,,,
RP11-65J3.3,rs10819510,"intergenic, −37267",Significant,0.00774,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,26.5,32,,1173,,60,75,,85,105,GWAS,,,
RPA1,rs11656253+rs17292175,,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
RPS6KB1,"rs201316437, rs1051424",,Significant,"1,56 × 10−05",10.1093/gerona/glab023,both,longevity,German,genomic,,,,,,,,,,6941,1248,,,59,99,94,110,gene-based association approach,,,SKAT-CommonRare function method
RPTOR,rs9908495,,Significant,0.0114,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,,,,,346,419,78.1,72,81,97,95,106,candidate genes study,,,
RPTOR,rs9908495,,Significant,0.011,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,TT,"TC,CC",,,346,419,78.1,72,81,97,95,106,candidate genes study,,,
RUNX3,rs4648884,intron,Significant,0.00992,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,27.7,33,,1173,,60,75,,85,105,GWAS,,,
SDC4,rs2228384,,Non-significant,0.14,10.1016/j.mad.2015.08.003,both,longevity,"Italian, Southern",genomic,,SNP,,,,,,,,,624,,,,,64,107,candidate genes study,,,
SDC4,rs2072785,,Non-significant,0.124,10.1016/j.mad.2015.08.003,both,longevity,"Italian, Southern",genomic,,SNP,,,,,,,,,624,,,,,64,107,candidate genes study,,,
SDC4,rs2267871,,Non-significant,0.082,10.1016/j.mad.2015.08.003,both,longevity,"Italian, Southern",genomic,,SNP,,,,,,,,,624,,,,,64,107,candidate genes study,,,
SDC4,rs2284277,,Non-significant,0.836,10.1016/j.mad.2015.08.003,both,longevity,"Italian, Southern",genomic,,SNP,,,,,,,,,624,,,,,64,107,candidate genes study,,,
SDC4,rs2070639,,Non-significant,0.203,10.1016/j.mad.2015.08.003,both,longevity,"Italian, Southern",genomic,,SNP,,,,,,,,,624,,,,,64,107,candidate genes study,,,
SDC4,rs4599,,Non-significant,0.545,10.1016/j.mad.2015.08.003,both,longevity,"Italian, Southern",genomic,,SNP,,,,,,,,,624,,,,,64,107,candidate genes study,,,
SDC4,rs749111,,Non-significant,0.63,10.1016/j.mad.2015.08.003,both,longevity,"Italian, Southern",genomic,,SNP,,,,,,,,,624,,,,,64,107,candidate genes study,,,
SDC4,rs11697824,,Non-significant,0.769,10.1016/j.mad.2015.08.003,both,longevity,"Italian, Southern",genomic,,SNP,,,,,,,,,624,,,,,64,107,candidate genes study,,,
SDC4,rs1981429,,Significant,0.028,10.1016/j.mad.2015.08.003,both,longevity,"Italian, Southern",genomic,,SNP,,,,,G,,,,624,,,,,64,107,candidate genes study,,,
SDC4,rs2251252,,Significant,0.018,10.1016/j.mad.2015.08.003,both,longevity,"Italian, Southern",genomic,,SNP,,,,A,,,,,624,,,,,64,107,candidate genes study,,,
SDC4,rs6130811,,Significant,0.02,10.1016/j.mad.2015.08.003,both,longevity,"Italian, Southern",genomic,,SNP,,,,G,,,,,624,,,,,64,107,candidate genes study,,,
SEMA6D,rs74011415,,Non-significant,0.164,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
SEMA6D,rs74011415,,Non-significant,0.678,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
SEMA6D,rs74011415,,Significant,0.000000014,10.18632/aging.101334,male,increased fathers' lifespan,European,genomic,,,,,,,G,,,,176494,,,,45.35,,,GWAS,,,
SERPINE1,rs1194865614,,Significant,,10.1126/sciadv.aao1617,both,increased lifespan,Amish,genomic,decreased gene expression,In/Del,,,,TATA/TATATA,,,,,177,,,,,,,candidate genes study,,"Испытуемыми были 177 представителей общины амишей в Берне (штат Индиана). 43 из них были носителями дупликации c.699_700dupTA в гене SERPINE1. Средняя продолжительность жизни гетерозиготных носителей дупликации была равна 82 годам, а продолжительность жизни гомозигот по нормальному аллелю — 75. ",
SETD9,"rs2257505, rs149334074, rs40497, rs141692637, rs150526244, rs146260337",,Significant,"1,19 × 10−05",10.1093/gerona/glab023,both,longevity,German,genomic,,,,,,,,,,6941,1248,,,59,99,94,110,gene-based association approach,,,SKAT-CommonRare function method
SH2B3,rs3184504,,Non-significant,0.022,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
SH2B3,rs3184504,,Non-significant,0.015,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,G,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
SH2B3 ,rs3184504,"exon, missense",Significant,0.000000788,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/G,,,G,A,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
SHC1,rs8191979,,Non-significant,0.192,10.1016/j.exger.2003.10.001,both,longevity,Dutch,genomic,,SNP,,,,C,,2.8,4.6,,977,,85,90,,95,,candidate genes study,,"Испытуемые были жителями Нидерландов (n=977, смешанная выборка). Частота аллеля C была 2.8%, 3.6% и 4.6% среди испытуемых в возрасте 85–90, 90–95 и 95 лет, соответственно. Тем не менее, эти различия не достигли порога значимости (p=0.192). ",
SHC1,rs4845401,,Non-significant,"0,61",10.1111/j.1474-9726.2009.00493.x,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,,
SIAH1,rs7185374,,Non-significant,0.1,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
SIAH1,rs7185374,,Non-significant,0.08,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
SIAH1,rs7185374,,Significant,"1,69 × 10−07",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,A,C,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,suggestive significant
SIAH1,rs113311037,,Significant,"2,30 × 10−07",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,T,C,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,suggestive significant
SIRT1,rs7069102,,Non-significant,0.84,10.1073/pnas.0801030105,male,longevity,Japanese,genomic,,SNP,,,,minor,,18.1,18.5,402,213,,,81,,95,,candidate genes study,,,
SIRT1,rs12778366,,Significant,,10.1371/journal.pone.0058636,both,increased lifespan,Dutch,genomic,,SNP,,,,TC+CC,TT,,,,1357,,,,,36,79,candidate genes study,,,
SIRT1,rs7896005,,Significant,5.6 × 10−3,10.1007/s10522-011-9360-5,both,longevity,"American, Caucasian",genomic,,SNP,,,,A,G,30,39.1,293,224,,21,59,,90,103,candidate genes study,,,
SIRT1,rs4746720,,Significant,0.0263,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,,,,,356,408,78.1,72,81,97,95,106,candidate genes study,,,
SIRT1,rs4746720,,Significant,0.026,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,TT,"TC,CC",,,356,408,78.1,72,81,97,95,106,candidate genes study,,,
SIRT2,rs10823112,,Non-significant,0.44,10.1073/pnas.0801030105,male,longevity,Japanese,genomic,,SNP,,,,major,,64,66.3,402,213,,,81,,95,,candidate genes study,,,
SIRT2,rs45592833,,Significant,"1,090 × 10-6",10.1093/gerona/glv058,both,longevity,"Italian, Calabrian",genomic,,SNP,,,,G,T,86.6,96.3,302,320,75.1,,,96,90,,candidate genes study,,"Носители аллеля rs45592833-T имели более низкую вероятность достичь долголетия в лог-аддитивной модели. Носитель одной копии рецессивного аллеля Т имеет шансы стать долгожителем в 3,7 раза меньшие, а носитель двух копий — в 13 раз меньшие по сравнению с гомозиготным носителем аллели G [ОШ = 0,2701, 95% ДИ = 0,1596-0,4572, р = 1,090*10^-6].",
SIRT2,rs10405150,,Significant,0.033,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,CC,"CT,TT",,,364,409,78.1,72,81,97,95,106,candidate genes study,,,
SIRT3,rs4980329,,Non-significant,0.96,10.1007/s11357-013-9559-2,male,increased lifespan,Italian,genomic,,SNP,,,,,,,,,311,,,,,70,105.5,candidate genes study,,,
SIRT3,rs11555236,,Non-significant,0.52,10.1007/s11357-013-9559-2,male,increased lifespan,Italian,genomic,increased gene expression,SNP,,,,,,,,,311,,,,,70,105.5,candidate genes study,,,
SIRT3,rs1885472,,Non-significant,0.71,10.1073/pnas.0801030105,male,longevity,Japanese,genomic,,SNP,,,,minor,,17.9,18.8,402,213,,,81,,95,,candidate genes study,,,
SIRT3,rs11555236,,Significant,0.03,10.1007/s11357-013-9559-2,female,increased lifespan,Italian,genomic,increased gene expression,SNP,,,,TT,,,,,357,,,,,70,105.5,candidate genes study,,"Повышенный уровень SIRT3 был обнаружен у субъектов, гомозиготных по аллелю (T). Значительный эффект минорных аллелей rs4980329 и rs11555236 был обнаружен только для женщин (скорректированные значения p и HR: значение p, 0,02; HR, 0,54 и значение p, 0,03; HR, 0,27, соответственно), в то время как ассоциация отсутствовала у мужчин (скорректированные значения p, 0,96 и 0,52 соответственно). Сообщаемое значение p скорректировано с учетом возможных мешающих факторов, влияющих на продолжительность жизни (возраст, пол, ученость, уровень холестерина, сердечно-сосудистые заболевания, сосудистые церебропатии, диабет и рак). Ассоциация была значимой только после корректировки нескольких других переменных, влияющих на продолжительность жизни, в то время как нескорректированное взаимодействие (пол × полиморфизм) не было значимым.",
SIRT3,rs511744,,Significant,0.046,10.1371/journal.pone.0115616,both,increased lifespan,"Caucasian, American",genomic,,SNP,,,,TT,,,,,1192,,,,,72,107,candidate genes study,,"Гомозиготные генотипы минорного аллеля в rs511744 (SIRT3) были связаны с увеличенной продолжительностью жизни. Члены когорты с генотипом rs511744 (SIRT3) TT имели увеличенную продолжительность жизни по сравнению с таковыми с генотипом CT или CC (0,5 и 1,3 года соответственно). ",
SIRT3,rs4758633,,Significant,,10.1371/journal.pone.0115616,female,increased lifespan,"Caucasian, American",genomic,,SNP,,,,AA,,,,,,,,,,72,107,candidate genes study,,"Наблюдался значительный эффект взаимодействия пол × rs4758633 (p = 0,08), но не rs511744 (p = 0,49). Женщины с генотипом rs4758633 AA имели увеличенную продолжительность жизни по сравнению с женщинами с генотипом GA (0,7 года) или GG (1,8 года).",
SIRT3,rs4980329,,Significant,0.02,10.1007/s11357-013-9559-2,female,longevity,Italian,genomic,,SNP,,,,AA,,,,,357,,,,,70,105.5,candidate genes study,,"Значительный эффект минорных аллелей rs4980329 и rs11555236 был обнаружен только для женщин (скорректированные значения p и HR: значение p, 0,02; HR, 0,54 и значение p, 0,03; HR, 0,27, соответственно), в то время как ассоциация отсутствовала у мужчин (скорректированные значения p, 0,96 и 0,52 соответственно). Сообщаемое значение p скорректировано с учетом возможных мешающих факторов, влияющих на продолжительность жизни (возраст, пол, ученость, уровень холестерина, сердечно-сосудистые заболевания, сосудистые церебропатии, диабет и рак). Ассоциация была значимой только после корректировки нескольких других переменных, влияющих на продолжительность жизни, в то время как нескорректированное взаимодействие (пол × полиморфизм) не было значимым.",
SIRT3,rs11246009,,Significant,0.019,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,"AA,TT",AT,,,362,415,78.1,72,81,97,95,106,candidate genes study,,,
SIRT4,rs2522134,,Significant,0.0038,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,"GG,AA ",GG,,,366,424,78.1,72,81,97,95,106,candidate genes study,,,
SIRT5,rs2841505,,Significant,0.043,10.1371/journal.pone.0115616,both,increased lifespan,"Caucasian, American",genomic,,SNP,,,,TT,,,,,1192,,,,,72,107,candidate genes study,,,
SIRT5,rs2253217,,Significant,0.000041,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,TT,"TC,CC",,,367,428,78.1,72,81,97,95,106,candidate genes study,,"Объектами исследования были американские мужчины японского происхождения, 440 из них прожившие ≥95 лет и 374 со средней продолжительностью жизни. После поправки на множественную проверку гипотез, полиморфизм SIRT5 остался значимым (р=0,0007). Генотип TT ассоциирован с долголетием (рецессивная модель, ОШ=2.30 (1.54–3.42), p=0.000041). Частота минорного аллеля = 0.0529. Отношение случай:контроль было 428:367.",
SIRT5,rs2253217,,Significant,0.0001,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,,,,,367,428,78.1,72,81,97,95,106,candidate genes study,,,
SIRT6,rs350846,,Non-significant,0.8372,10.1093/gerona/glv058,both,longevity,"Italian, Calabrian",genomic,,SNP,,,,major,,91.273,91.639,302,320,75.1,,,96,90,,candidate genes study,,,
SIRT6,rs107251,,Significant,0.012,10.1371/journal.pone.0115616,both,increased lifespan,"Caucasian, American",genomic,,SNP,,,,CT,,,,,1192,,,,,72,107,candidate genes study,,,
SIRT6,rs107251,,Significant,0.001,10.1007/s11357-011-9373-7,both,longevity,Danish,genomic,,SNP,,,,,,,,736,1089,50.6,46,55,93.2,92.2,93.8,candidate genes study,,,Single-SNP-based test
SIRT7,rs34829162,,Significant,0.0031,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,,,,,352,371,78.1,72,81,97,95,106,candidate genes study,,,
SIRT7,rs34829162,,Significant,0.0000025,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,"GG,TT",GT,,,352,371,78.1,72,81,97,95,106,candidate genes study,,,
SKIV2L ,rs438999,"exon, missense",Significant,0.00000505,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/G,,,G,A,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
SKIV2L ,rs429608,intron,Significant,0.00000875,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/G,,,A,G,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
SKOR1,rs200956599,,Significant,"5,24 × 10−05",10.1093/gerona/glab023,both,longevity,German,genomic,,SNP,,,,T,,,,6941,1248,,,59,99,94,110,single-variant association approach,,,
SKOR1,"rs200956599, rs143419968",,Significant,"3,38 × 10−05",10.1093/gerona/glab023,both,longevity,German,genomic,,,,,,,,,,6941,1248,,,59,99,94,110,gene-based association approach,,,SKAT-CommonRare function method
SLC39A11,rs9894443,,Non-significant,0.41,10.1001/jamanetworkopen.2018.1670,female,longevity,"Chinese, Han",genomic,,SNP,,,,major,,63,65,1526,1614,48.2,40,64,103.1,100,,GWAS,,,
SLC39A11,rs9894443,,Significant,"8,2 × 10-6",10.1001/jamanetworkopen.2018.1670,male,longevity,"Chinese, Han",genomic,,SNP,,,,minor,,34,42,773,564,48.7,40,64,101.5,100,,GWAS,,,
SLC41A1,rs56052552,intron,Significant,0.0221,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,A,C,2,3.7,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
SLC6A3,rs1042098,,Non-significant,0.1313,10.1093/gerona/glv058,both,longevity,"Italian, Calabrian",genomic,,SNP,,,,major,,60.67,65.05,302,320,75.1,,,96,90,,candidate genes study,,,
SMAD7,rs35715456,,Non-significant,0.519,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
SMAD7,rs35715456,,Non-significant,0.296,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
SNX29,rs729583,,Non-significant,0.00000515,10.1038/ncomms15842,both,increased parents' age at death,European,genomic,,,,,,,,,,,276796,,,,,40,,iGWAS,,,
SNX29,rs729583,,Non-significant,0.188,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
SNX29,rs729583,,Non-significant,0.39,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
SOD2,,"exon, missense",Significant,0.009,10.1016/j.mad.2004.08.025,male,longevity,Ashkenazi Jewish,genomic,,SNP,9C>T,Ala/Val,,T,C,,,121,150,21.89,13,33,,75,,candidate genes study,,,
SOD2,rs4880,,Significant,0.002,10.1016/j.mad.2009.01.005,both,longevity,Danish,genomic,,SNP,,,,"CC,CT",,,,,1650,,,,,92,93,candidate genes study,,"Были изучены 1650 человек из датской когорты 1905 года (время наблюдения: 1998-2008 годы, возраст на момент поступления: 92-93 года, количество смертей: 1589 (96,3%)). Была исследована связь со старением и долголетие. Было обнаружено снижение смертности лиц, имеющих аллели GPX1 rs1050450 T HR (GPX1 (TT/TC)) = 0,93, p = 0,008). Наблюдались умеренные положительные ассоциации с хорошей самооценкой здоровья, снижением инвалидности и повышением когнитивных способностей.",
SOD3,rs2855262,,Non-significant,0.05971,10.1093/gerona/glv058,both,longevity,"Italian, Calabrian",genomic,,SNP,,,,T,,33.8,39.74,302,320,75.1,,,96,90,,candidate genes study,,,
SOD3,rs2536512,,Significant,0.048,10.1371/journal.pone.0115616,both,increased lifespan,"Caucasian, American",genomic,,SNP,,,,GG,,,,,1192,,,,,72,107,candidate genes study,,,
SOD3,rs4946935,,Significant,0.042,10.1371/journal.pone.0115616,both,increased lifespan,"Caucasian, American",genomic,,SNP,,,,AA,,,,,1192,,,,,72,107,candidate genes study,,,
SOX6,rs11023744,,Non-significant,0.397,10.1093/gerona/glu166,both,increased lifespan,Caucasian,genomic,,SNP,,,,,,,,,4567,,,,,25,110,"meta-analysis of GWAS, replication",,,
SOX6,rs2196961,,Non-significant,0.668,10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,914,801,73,54,90,104,95,119,"meta-analysis of GWAS, replication",,,
SOX6,rs11023737,−28,Non-significant,0.684,10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,16121,5409,,,65,,90,,"meta-analysis of GWAS, replication",,,
SOX6,rs11023737,−28,Significant,"3,64 × 10^−6",10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,3757,6036,,55,80,,90,,meta-analysis of GWAS,,,suggestive significant
SPZ1,rs184214819,,Significant,"4,72 × 10−05",10.1093/gerona/glab023,both,longevity,German,genomic,,SNP,,,,A,,,,6941,1248,,,59,99,94,110,single-variant association approach,,,
SPZ1,"rs1862136, rs139471643, rs184214819, rs200249535, rs35337118",,Significant,"8,09 × 10−05",10.1093/gerona/glab023,both,longevity,German,genomic,,,,,,,,,,6941,1248,,,59,99,94,110,gene-based association approach,,,SKAT-CommonRare function method
STAT3,rs4796791,,Significant,0.015,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,"CC,CT",TT,,,374,440,78.1,72,81,97,95,106,candidate genes study,,,
STAT5A,rs9889323,,Significant,0.0001,10.1134/S1022795419050077,female,longevity,Tatars,genomic,,SNP,1985T>C,,,TC,"TT, CC",,,,924,46,,,,,82,candidate genes study,,"Авторы применили метод логистической регрессии и обнаружили, что частота встречаемости генотипа T/C повышается в возрастном диапазоне от 46 до 82 лет (р < 0.0001, рFDR < 0.001, OR = 1.044, CI: 1.021–1.068).",
STK10,rs73329622,,Non-significant,0.88,10.1001/jamanetworkopen.2018.1670,female,longevity,"Chinese, Han",genomic,,SNP,,,,major,,88,88,1526,1614,48.2,40,64,103.1,100,,GWAS,,,
STK10,rs73329622,,Significant,"9,2 × 10-6",10.1001/jamanetworkopen.2018.1670,male,longevity,"Chinese, Han",genomic,,SNP,,,,major,,82,73,773,564,48.7,40,64,101.5,100,,GWAS,,,
STK24,rs9517320,intron,Significant,0.00204,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,30.8,37.7,,1173,,60,75,,85,105,GWAS,,,
SULT1A2,rs710410,,Non-significant,0.03922,10.1093/gerona/glv058,both,longevity,"Italian, Calabrian",genomic,,SNP,,,,C,,19.7,25.88,302,320,75.1,,,96,90,,candidate genes study,,,
SVEP1,rs1327533,intron,Significant,0.000356,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,25.3,33.7,,1173,,60,75,,85,105,GWAS,,,
SYDE2,rs200536623,,Non-significant,0.54,10.1001/jamanetworkopen.2018.1670,female,longevity,"Chinese, Han",genomic,,SNP,,,,minor,,2,2,1526,1614,48.2,40,64,103.1,100,,GWAS,,,
SYDE2,rs200536623,,Significant,"8,8 × 10-6",10.1001/jamanetworkopen.2018.1670,male,longevity,"Chinese, Han",genomic,,SNP,,,,minor,,1,4,773,564,48.7,40,64,101.5,100,,GWAS,,,
TAS2R16,rs978739,upstream,Significant,0.001,10.1371/journal.pone.0045232,both,longevity,"Italian, Southern",genomic,,SNP,,,,AA,,35,55,593,348,59.17,20,84,93.82,85,106,candidate genes study,,,
TBX3,rs2161877,,Non-significant,0.72,10.1001/jamanetworkopen.2018.1670,male,longevity,"Chinese, Han",genomic,,SNP,,,,major,,58,59,773,564,48.7,40,64,101.5,100,,GWAS,,,
TBX3,rs2161877,,Significant,"2,7 × 10-6",10.1001/jamanetworkopen.2018.1670,female,longevity,"Chinese, Han",genomic,,SNP,,,,major,,54,61,1526,1614,48.2,40,64,103.1,100,,GWAS,,,
TCF3,rs2074888,,Significant,0.03687,10.1016/j.redox.2020.101448,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,С,T,93.5,95.6,147,197,71,43,92,,95,,candidate genes study,,"Частота аллеля T в контроле 0,06538, частота у долгожителей — 0,04427 (р=0,03687). Была изучена столетняя когорта ашкенази (AJ). Возраст 197 долгожителей мужского пола с исключительным долголетием составлял 95 лет или выше. Потомство долгожителей состояло из 223 человек (49,3% мужчин и 50,7% женщин) со средним возрастом 68,4 года (диапазон от 49 до 88 лет). Контрольная группа, используемая для сравнения с группой потомства, состояла из 147 человек (64% мужчин и 36% женщин) , набранных из двух разных источников: (i) супруги потомства (n = 65) и (ii) группа независимо набранных AJ из исследования старения Эйнштейна (n = 82). В контрольной группе лица были исключены, если родители дожили до возраста >85 лет. Средний возраст контрольной группы составил 71 год (диапазон от 43 до 92 лет).",
TCF3,rs2240590,,Significant,0.049,10.1016/j.redox.2020.101448,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,T,,7.6,10.1,147,197,71,43,92,,95,,candidate genes study,,"Частота аллеля T в контроле 0,07596, частота у долгожителей 0,1006 (p=0,04989). Была изучена столетняя когорта ашкенази (AJ). Возраст 197 долгожителей мужского пола с исключительным долголетием составлял 95 лет или выше. Потомство долгожителей состояло из 223 человек (49,3% мужчин и 50,7% женщин) со средним возрастом 68,4 года (диапазон от 49 до 88 лет). Контрольная группа, используемая для сравнения с группой потомства, состояла из 147 человек (64% мужчин и 36% женщин) , набранных из двух разных источников: (i) супруги потомства (n = 65) и (ii) группа независимо набранных AJ из исследования старения Эйнштейна (n = 82). В контрольной группе лица были исключены, если родители дожили до возраста >85 лет. Средний возраст контрольной группы составил 71 год (диапазон от 43 до 92 лет).",
TCF3,rs145777664,intron,Significant,0.04629,10.1016/j.redox.2020.101448,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,0.324,147,197,71,43,92,,95,,candidate genes study,,"Полиморфизм был обнаружен в интроне. Частота в контроле 0, частота у долгожителей 0,00324 (p=0,04629). Была изучена столетняя когорта ашкенази (AJ). Возраст 197 долгожителей мужского пола с исключительным долголетием составлял 95 лет или выше. Потомство долгожителей состояло из 223 человек (49,3% мужчин и 50,7% женщин) со средним возрастом 68,4 года (диапазон от 49 до 88 лет). Контрольная группа, используемая для сравнения с группой потомства, состояла из 147 человек (64% мужчин и 36% женщин) , набранных из двух разных источников: (i) супруги потомства (n = 65) и (ii) группа независимо набранных AJ из исследования старения Эйнштейна (n = 82). В контрольной группе лица были исключены, если родители дожили до возраста >85 лет. Средний возраст контрольной группы составил 71 год (диапазон от 43 до 92 лет).",
TEP1,rs938886,,Non-significant,0.2424,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,C>G,,,C,G,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TEP1,rs1760904,,Non-significant,0.9697,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,T>C,,,,,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TEP1,rs1760897,,Non-significant,0.7029,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,T>C,,,C,T,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TEP1,rs1760890,,Non-significant,0.295,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,T>G,,,T,G,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TEP1,rs4246977,,Non-significant,0.5271,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,A>G,,,A,G,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERC,rs3772190,,Significant,0.006,10.1111/j.1474-9726.2011.00775.x,both,increased lifespan,Danish,genomic,,SNP,,,,GG,"AA, AG",,,,720,,,,,58,100,candidate genes study,,"Аллель A rs3772190 (TERC) отрицательно связан с долголетием [уровень риска (AG + AA) = 1,31, P = 0,006]. По сравнению с группой rs3772190 GG гетерозиготы AG показали пониженную выживаемость (HR = 1,31, p = 0,009), тогда как гомозиготы AA показали ту же, но незначительную тенденцию (HR = 1,32, p = 0,112). Объединение групп AG и AA усилило результат (HR = 1,31 p = 0,006).",
TERC,rs3772190,,Significant,0.006,,both,increased lifespan,,genomic,,SNP,,,,GG,AG,,,,864,,,,,,,candidate genes study,22549493,"Редкий вариант rs3772190 (A) связан как с уменьшением выживаемости в пожилом возрасте, так и с более короткой длиной теломер лейкоцитов.",
TERC,rs12696304,,Significant,0.0437,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,C>G,,,C,G,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERF1,rs2929586,,Non-significant,0.3804,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,A>G,,,G,A,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERF1,rs2975842,,Non-significant,0.9492,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,C>T,,,T,C,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERF1,rs12334686,,Non-significant,0.2292,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,G>A,,,G,A,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERF1,rs6982126,,Non-significant,0.7211,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,C>T,,,T,C,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERF1,rs10107605,,Non-significant,0.21,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,A>C,,,A,C,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERF1,rs12335203,,Non-significant,0.12,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,T>C,,,C,T,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERF1,rs7845139,,Non-significant,0.6047,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,G>A,,,A,G,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERF1,rs12335203,,Significant,0.0006,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,T>C,,,С,T,,,324,387,47,44,49,78,77,80,candidate genes study,,"Популяция, проанализированная в настоящем исследовании, включала 985 человек (509 женщин и 476 мужчин) в возрасте от 20 до 106 лет. Репликационная выборка включала 788 субъектов (376 женщин и 412 мужчин) из Северной Италии в возрасте от 33 до 111 лет. rs1233520 полиморфизм, вариант С TERF1 гена, был связан с долголетием после поправки на множественные сравнения (поправка Бонферрони). Аллель C rs12335203 гена TERF1 положительно повлиял на вероятность быть частью старшей группы (OR = 1,50, p = 6,17 9 10-4).",
TERF2,rs3785074,,Non-significant,0.0734,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,T>C,,,C,T,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERF2_IP,rs3784929,,Non-significant,0.4651,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,A>G,,,G,A,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERF2_IP,rs2233807,,Non-significant,0.3891,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,C>T,,,T,C,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERF2_IP,rs11639771,,Non-significant,0.719,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,C>T,,,T,C,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERT,rs10078761,,Non-significant,0.8436,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,T>A,,,T,A,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERT,rs2853691,,Non-significant,0.5778,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,T>C,,,C,C,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERT,rs2736122,,Non-significant,0.2549,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,G>A,,,G,A,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERT,rs2075786,,Non-significant,0.9391,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,G>A,,,A,A,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERT,rs4246742,,Non-significant,0.4822,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,T>A,,,T,A,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERT,rs2242652,,Non-significant,0.1247,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,G>A,,,G,A,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERT,rs2853676,,Non-significant,0.2955,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,C>T,,,C,T,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERT,rs2736098,,Non-significant,0.114,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,C>T,,,C,T,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERT,rs2853669,,Non-significant,0.2442,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,T>C,,,T,C,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERT,rs2853690,3'UTR,Non-significant,0.566,10.1016/j.exger.2009.02.004,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,,,,,364,388,79.5,,,97.7,95,108,candidate genes study,,"Когорта евреев-ашкенази: 388 евреев-ашкенази с высокой продолжительностью жизни [289 женщин и 99 мужчин, средний возраст 97,7 (0,2) года (возрастной диапазон 95–108 лет; 20% старше 100 лет] и контрольные группы евреев-ашкенази [n = 364, средний возраст 79,5 (0,4) года (58% женщины] без семейного анамнеза высокой продолжительности жизни.",
TERT,rs2853690,3'UTR,Non-significant,0.836,10.1016/j.exger.2009.02.004,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,"Когорта SOF: n = 9704 женщины европейского происхождения в возрасте 65 лет и старше из США. Когорта наблюдалась более 20 лет с полным последующим наблюдением за смертностью и включала 896 участников SOF, отобранных для включения в исследование продолжительности жизни (293 человек в группе долгожителей ≥ 92 лет, средняя продолжительности жизни = 95,3 ± 2,1 года и 603 человека в контрольной группе, на момент смерти ≤ 79 лет, средняя продолжительности жизни = 75,7 ± 2,6 года).",
TERT,rs4975605,,Significant,0.0129,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,C>A,,,A,A,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERT,rs2736100,,Significant,0.0111,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,C>A,,,A,A,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TERT,rs2853690,3'UTR,Significant,0.0183,10.1016/j.exger.2009.02.004,both,longevity,"Caucasian, African-American",genomic,,SNP,,,,,,,,900,479,,,79,,92,,candidate genes study,,"Когорта CHS: 5888 взрослых мужчин и женщин 65 лет и старше из США. 4925 человек или 95% определили свою этническую принадлежность как белые. В группу долгожителей относили людей, доживших как минимум до 92 лет (n = 479; 61% женщин), а в контрольную группу - людей, умерших в возрасте до 79 лет (n = 900; 46% женщин). ).",
TERT,MNS16A,,Significant,0.02,10.1016/j.exger.2013.03.009,both,longevity,"Italian, Central",genomic,,VNTR,,,MNS16A,short,long,,,539,200,,66,91,,88,,candidate genes study,,,
TERT,rs2853676,,Significant,0.0159,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,,,,,350,379,78.1,72,81,97,95,106,candidate genes study,,,
TERT,rs2853677,,Significant,0.0011,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,"AA,GG",AG,,,350,379,78.1,72,81,97,95,106,candidate genes study,,,
TFDP1,rs11839469,,Significant,0.0364,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,,,,,374,440,78.1,72,81,97,95,106,candidate genes study,,,
TFDP1,rs11839469,,Significant,0.036,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,"GC,CC",GG,,,374,440,78.1,72,81,97,95,106,candidate genes study,,,
TGFA,rs432203,intron,Significant,0.00779,10.1089/rej.2011.1257,both,longevity,"Caucasian, American",genomic,,SNP,,,,minor,,38,44.3,,1173,,60,75,,85,105,GWAS,,,
TH,,,Significant,,10.1016/S0531-5565(01)00146-2,male,longevity,Italian,genomic,,haplotype,,,TH[STR]+IGF2[AvaII],,,,,119,72,,20,70,,100,109,candidate genes study,,"Было показано, что ген тирозингидроксилазы (TH, 11p15.5) связан с долголетием человека. Распределение гаплотипов TH-IGF2 значительно отличалось у мужчин долгожителей (n = 72) по сравнению с мужчинами из контрольной группы (n = 119).",
TH,,,Significant,,10.1016/S0531-5565(01)00146-2,female,longevity,Italian,genomic,,haplotype,,,TH[STR]+INS[FokI],,,,,137,147,,20,70,,100,109,candidate genes study,,"Было показано, что ген тирозингидроксилазы (TH, 11p15.5) связан с долголетием человека. Распределение гаплотипов TH-INS значительно различалось у женщин-долгожителей (n = 147) по сравнению с женщинами из контрольной группы (n = 137).",
TIRAP,rs8177352,intron,Non-significant,0.765,10.1016/j.exger.2009.02.004,female,longevity,Caucasian,genomic,,SNP,,,,,,,,603,293,75.7,,79,95.3,92,,candidate genes study,,"Когорта SOF: n = 9704 женщины европейского происхождения в возрасте 65 лет и старше из США. Когорта наблюдалась более 20 лет с полным последующим наблюдением за смертностью и включала 896 участников SOF, отобранных для включения в исследование продолжительности жизни (293 человек в группе долгожителей ≥ 92 лет, средняя продолжительности жизни = 95,3 ± 2,1 года и 603 человека в контрольной группе, на момент смерти ≤ 79 лет, средняя продолжительности жизни = 75,7 ± 2,6 года).",
TIRAP,rs8177352,intron,Significant,0.0089,10.1016/j.exger.2009.02.004,both,longevity,"Caucasian, African-American",genomic,,SNP,,,,,,,,900,479,,,79,,92,,candidate genes study,,"Когорта CHS: 5888 взрослых мужчин и женщин 65 лет и старше из США. 4925 человек или 95% определили свою этническую принадлежность как белые. В группу долгожителей относили людей, доживших как минимум до 92 лет (n = 479; 61% женщин), а в контрольную группу - людей, умерших в возрасте до 79 лет (n = 900; 46% женщин). ).",
TMEM131L,rs13119846,,Non-significant,"6,92 × 10−01",10.1093/gerona/glab023,both,longevity,French,genomic,,SNP,,,,C,,,,1824,1270,,,61,102.4,91,115,"single-variant association approach, replication",,,
TMEM131L,rs13119846,,Non-significant,"9,15 × 10−01",10.1093/gerona/glab023,both,longevity,Danish,genomic,,SNP,,,,C,,,,1002,738,66.3,,,97.4,90,102.5,"single-variant association approach, replication",,,
TMEM131L,rs13119846,,Significant,"1,73 × 10−05",10.1093/gerona/glab023,both,longevity,German,genomic,,SNP,,,,C,,,,6941,1248,,,59,99,94,110,single-variant association approach,,,
TMEM18,rs6744653,,Non-significant,0.212,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
TMEM18,rs6744653,,Non-significant,0.061,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
TMEM18,rs6744653,,Significant,0.0000000007,10.7554/eLife.39856.001,both,increased parental lifespan,European,genomic,,SNP,,,,A,,,,,1012240,,,,71.63,40,117,iGWAS,,,
TMTC2,rs7976168,,Non-significant,0.168,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
TMTC2,rs7976168,,Non-significant,0.796,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
TMTC2,rs7976168,,Significant,"3,82 × 10−09",10.1093/gerona/glx027,both,longevity,European,genomic,decreased gene expression,SNP,,,,A,G,64,69,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TMTC2,rs1036345,,Significant,"8,71 × 10−09",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,A,G,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TMTC2,rs7309892,,Significant,"1,36 × 10−08",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,C,T,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TMTC2,rs10862576,,Significant,"1,43 × 10−08",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,C,T,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TMTC2,rs11115558,,Significant,"1,57 × 10−08",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,T,C,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TMTC2,rs10778938,,Significant,"1,98 × 10−08",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,T,C,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TMTC2,rs11115563,,Significant,"1,98 × 10−08",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,C,T,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TMTC2,rs10778939,,Significant,"2,26 × 10−08",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,A,G,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TMTC2,rs11531136,,Significant,"2,39 × 10−08",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,C,T,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TMTC2,rs10778936,,Significant,"2,49 × 10−08",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,C,T,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TMTC2,rs453843,,Significant,"2,71 × 10−08",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,C,T,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TMTC2,rs2020085,,Significant,"2,73 × 10−08",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,T,C,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TMTC2,rs7308896,,Significant,"3,03 × 10−08",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,G,A,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TMTC2,rs7961389,,Significant,"3,14 × 10−08",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,C,G,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TMTC2,rs11115564,,Significant,"3,78 × 10−08",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,C,G,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TMTC2,rs10778937,,Significant,"4,24 × 10−08",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,T,C,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TMTC2,rs7975671,,Significant,"4,37 × 10−08",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,A,G,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TMTC2,rs7314554,,Significant,"4,85 × 10−08",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,A,G,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TMTC2,rs11115556,,Significant,"6,57 × 10−08",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,A,G,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,suggestive significant
TMTC2,rs6539700,,Significant,"7,07 × 10−08",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,G,A,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,suggestive significant
TMTC2,rs8181713,,Significant,"1,20 × 10−07",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,A,G,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,suggestive significant
TMTC2,rs10862575,,Significant,"1,34 × 10−07",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,A,T,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,suggestive significant
TMTC2,rs7304484,,Significant,"4,73 × 10−07",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,C,A,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,suggestive significant
TNF,rs1800629,,Significant,0.019,10.1136/jmg.40.4.296,male,longevity,Italian,genomic,increased gene expression,SNP,-308G>A,,,GG,"AG, AA",28,46,76,115,,22,60,,90,,candidate genes study,,,
TNKS,rs6990097,,Non-significant,0.1073,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,T>C,,,T,C,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TNKS2,rs2066276,,Significant,0.006,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,T>C,,,T,C,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TNKS2,rs10509637,,Significant,0.0102,10.1007/s10522-015-9551-6,both,longevity,"Italian, Calabrian",genomic,,SNP,A>G,,,G,A,,,324,274,47,44,49,96,95,97,candidate genes study,,,
TNNI3K,rs146254978,,Significant,0.000000046,10.18632/aging.101334,both,increased parents' age at death,European,genomic,,,,,,,T,,,,208118,,,,75.41,51,105,GWAS,,,
TOMM40,rs2075650,intron,Significant,"7,01 × 10−9",0.1111/acel.12471,both,longevity,German,genomic,,SNP,,,,A,G,89.2,85.12,6368,1458,57.2,,,99,,,immunochip,,,
TOMM40,rs2075650,,Significant,"3,51 × 10−07",10.1093/gerona/glab023,both,longevity,German,genomic,,SNP,,,,,G,,,6941,1248,,,59,99,94,110,single-variant association approach,,,
TOMM40,"rs157580, rs2075650, rs142412517",,Significant,"1,35 × 10−06",10.1093/gerona/glab023,both,longevity,German,genomic,,,,,,,,,,6941,1248,,,59,99,94,110,gene-based association approach,,,SKAT-CommonRare function method
TOMM40,rs2075650,intron,Significant,"4,8 × 10^−4",10.1093/gerona/glu166,both,longevity,Caucasian,genomic,,SNP,,,,,,,,3757,6036,,55,80,,90,,"meta-analysis of GWAS, replication of previous findings",,,
TOMM40,rs34404554,intron,Significant,"1,42 × 10−24",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,C,G,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TOMM40,rs71352238,"upstream, 2000",Significant,"3,58 × 10−24",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,T,C,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TOMM40,rs11556505,exon,Significant,"4,12 × 10−24",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,C,T,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TOMM40,rs2075650,intron,Significant,"4,30 × 10−24",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,A,G,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TOMM40,rs34095326,intron,Significant,"9,78 × 10−19",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,G,A,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TOMM40,rs157582,intron,Significant,"2,86 × 10−16",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,C,T,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TOMM40,rs157581,exon,Significant,"1,41 × 10−15",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,T,C,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TOMM40,rs184017,intron,Significant,"2,67 × 10−15",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,T,G,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TOMM40,rs59007384,intron,Significant,"4,80 × 10−15",10.1093/gerona/glx027,both,longevity,European,genomic,,SNP,,,,G,T,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
TOMM40,rs2075650,"intron, boundary",Significant,0.000000000236,10.1371/journal.pone.0029848,both,longevity,"Caucasian, American",genomic,,SNP,,,,A,G,85.5737705,92.4657534,913,801,,0,90,104,95,119,GWAS,,,
TOMM40 ,rs2075650,intron,Significant,0,10.1371/journal.pgen.1005728,both,longevity,Caucasian,genomic,,SNP,A/G,,,A,G,,,914,801,,0,75,104,95,119,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
TOMM40 ,rs2075650,intron,Significant,0,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,A,G,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
TOMM40 ,rs157582,intron,Significant,0,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,C/T,,,C,C,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
TOMM40 ,rs10119,3'UTR,Significant,0.000000000828,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,G,G,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
TOMM40 ,rs157580,intron,Significant,0.0000000877,10.1371/journal.pgen.1005728,both,longevity,European,genomic,,SNP,A/G,,,G,A,,,16121,7330,,,65,,90,,iGWAS,,,One of 98 SNPs representing 8 unique genetic loci are significant in a longevity GWAS weighted by disease
TORC,rs10038,,Non-significant,0.9741,10.1093/gerona/glv058,both,longevity,"Italian, Calabrian",genomic,,SNP,,,,A,,23.61,23.65,302,320,75.1,,,96,90,,candidate genes study,,,
TOX,rs13262617,,Non-significant,0.255,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
TOX,rs13262617,,Non-significant,0.182,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
TOX,rs13262617,,Significant,0.000000031,10.18632/aging.101334,male,increased fathers' lifespan,European,genomic,,,,,,A,,,,,176494,,,,45.35,,,GWAS,,,
TP53,rs1042522,"exon, missense",Non-significant,,10.1093/gerona/gls223,male,longevity,Italian,genomic,,SNP,C>G,Arg72Pro,,G (Arg72),,74.3,76.5,259,100,,66,88,,89,,candidate genes study,,,
TP53,rs1042522,"exon, missense",Significant,,10.4161/cc.7.2.5249,both,increased lifespan,Danish,genomic,increased protein activity,SNP,C>G,Arg72Pro,,CC (Pro72Pro),,,,,9219,,,,,20,95,candidate genes study,,Полиморфизм C/G (P72R). Исследование проведено среди населения Дании (n=9219),"In the Danish general population (n = 9219) homozygotes for the minor allele versus homozygotes for the major allele had an increase in median survival of 3 years. This is partly explained by increased survival after development of cancer or other diseases, in accordance with the observation that this Arg72Pro substitution in the p53 protein has important influence on cell death via increased apoptosis. This gain-of-function p53 SNP of importance for cell repair mechanisms has a profound influence on longevity."
TP53,rs1042522,"exon, missense",Significant,0.008,10.1093/gerona/gls223,female,longevity,Italian,genomic,,SNP,C>G,Arg72Pro,,G (Arg72),,73,82.5,280,100,,73,91,,92,,candidate genes study,,Полиморфизм C/G (P72R). Исследование проведено среди населения центральной Италии (n=1072),
TP53,TP53[rs2078486]+ERCC2[rs50871],,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
TP53,TXNRD1rs17202060]+TP53[rs2078486],,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
TP53,ERCC2[rs50871]+TP53[rs2078486],,Significant,0.001,10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,ERCC2[C]+TP53[G],,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
TRAIP,rs2352974,,Non-significant,0.00000253,10.1038/ncomms15842,both,increased parents' age at death,European,genomic,,,,,,,,,,,276796,,,,,40,,iGWAS,,,
TRAIP,rs2352974,,Non-significant,0.383,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
TRAIP,rs2352974,,Non-significant,0.046,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
TTR,rs28933981,exon,Significant,0.04,10.1161/ATVBAHA.113.301273,both,increased lifespan,Danish,genomic,,SNP,C/T,T119M,,CT,CC,,,,68602,,,,,20,80,candidate genes study,,,
TXN,rs3808888,,Significant,0.0051,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,,,,,374,437,78.1,72,81,97,95,106,candidate genes study,,,
TXN,rs3808888,,Significant,0.0051,10.1093/gerona/glx247,male,longevity,Japanese,genomic,,SNP,,,,"GA,AA",GG,,,374,437,78.1,72,81,97,95,106,candidate genes study,,,
TXNRD1,TXNRD1rs17202060]+TP53[rs2078486],,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
UCP1,,promoter,Significant,,10.1016/j.exger.2011.07.011,both,longevity,Italian,genomic,increased gene expression,haplotype,-3826A>G+-3740C>A,,rs1800592+C-3740A,A+C,,,,,910,,40,,,,99,candidate genes study,,"Два полиморфизма, A-3826G (rs1800592) и C-3740A, попадающие в вышестоящую промоторную область UCP1, были проанализированы в выборке из 910 человек из южной Италии (475 женщин и 435 мужчин; возрастной диапазон 40-109 лет). Гаплотип AC способствует выживанию в пожилом возрасте. Хотя гаплотипы A-C и G-A положительно влияют на транскрипционную активность UCP1 по сравнению с гаплотипом G-C, они оказывают противоположное влияние на долголетие. Этот явно контрастирующий результат можно объяснить с учетом специфического для гаплотипа эффекта после гормональной стимуляции. Фактически, прогестерон активирует, тогда как эстрадиол подавляет транскрипционную активность A-C гаплотипа, при этом ни один из них не изменяет транскрипционную активность G-A гаплотипа.",
UCP2,rs659366,,Non-significant,0.555,10.1371/journal.pone.0029650,both,longevity,Italian,genomic,,SNP,,,,,,,,375,223,77.42,64,89,95.09,90,,candidate genes study,,,
UCP2,,,Significant,0.0006,10.1007/s11357-011-9210-z,both,longevity,Italian,genomic,,haplotype,,,"IGF1R[G/A]+IRS2[Gly/Asp],+UCP2[Ala/Val]",AAV,,,,514,208,49,,85,96,86,104,candidate genes study,,"Комбинация аллелей A-IGF1R/Asp-IRS2/Val-UCP2 связана со сниженным риском смертности от всех причин, более низким HOMA-IR, более высоким респираторным коэффициентом, уровнем метаболизма в состоянии покоя и с повышенным шансом на долголетие (n=722).",
UCP2,rs660339,,Significant,0.003,10.1371/journal.pone.0029650,,longevity,Italian,genomic,,SNP,,,,T,,,,375,223,77.42,64,89,95.09,90,,candidate genes study,,,
UCP2,UCP2[rs660339]+UCP2[rs659366]+UCP3[rs15763],,Significant,0.046,10.1371/journal.pone.0029650,both,longevity,Italian,genomic,,haplotype,,,,UCP2[T]+UCP2[G]+UCP3[T],,,,375,223,77.42,64,89,95.09,90,,candidate genes study,,"Гаплотип САС, состоящий из минорного аллеля для rs660339 (UCP2), основной аллель для rs659366 (UCP2) и минорный аллель rs15763 (UCP3) был связан с пониженной вероятностью достижения долголетия (P = 0,003), в то время как гаплотип TGT (противоположная комбинация аллелей) действовали в обратном направлении, увеличивая эту вероятность (p = 0,046). Всего 598 человек (293 мужчины и 305 женщин, возрастной диапазон 64–105 лет; средний возраст 82,74 (+-11,66) и 85,23 (+-10,84) года,соответственно) участвовали в этом исследовании. Все испытуемые их предки до поколения бабушек и дедушек родились в Калабрии (южная Италия). Два «порога долголетия», использовалось для определения этих возрастных категорий — 88 лет для мужчин и 91 год для женщин.",
UCP3,rs3781907,,Significant,,10.1016/j.mad.2012.06.004,,increased lifespan,Danish,genomic,,SNP,,,,G,,,,,908,,,,93,,,candidate genes study,,"Значительное влияние на шансы на выживание наблюдалось для rs3781907 (p = 0,050). Носители аллеля А (менее частый аллель для этого SNP) показали пониженный шанс выживания (коэффициент = -0,080). Несмотря на пограничную связь с характеристиками захвата руки (p = 0,062), этот аллель значительно повлиял на выживаемость в этой когорте. Была проанализирована выборка, включающая 908 субъектов в возрасте 93 лет (265 мужчин и 643 женщины), взятых из датской когорты 1905 года, общенационального опроса всех датчан, родившихся в Дании в 1905 году.",
UCP3,rs11235972,,Significant,,10.1016/j.mad.2012.06.004,both,increased lifespan,Danish,genomic,,SNP,,,,G,,,,,908,,,,93,,,candidate genes study,,"Значительное влияние на шансы на выживание в старшей возрастной группе наблюдалось для rs11235972 (p = 0,029). Носители аллеля A локуса rs11235972 (который является менее частым аллелем для этого SNP) показали пониженный шанс выживания (коэффициент = -0,090). Интересно, что вариация rs11235972-A также была связана со снижением эффективности захвата руки в предыдущем анализе в этой когорте. Была проанализирована выборка, включающая 908 субъектов в возрасте 93 лет (265 мужчин и 643 женщины), взятых из датской когорты 1905 года, общенационального опроса всех датчан, родившихся в Дании в 1905 году.",
UCP3,rs1800849,"upstream, –2000",Significant,0.003,10.1371/journal.pone.0029650,both,longevity,Italian,genomic,,SNP,,,,,,,,375,223,77.42,64,89,95.09,90,,candidate genes study,,"Доминантный аллель для rs1800849 (UCP3) оказался в значительной степени связан с фенотипом долголетия. (p = 0,001). Всего 598 человек (293 мужчины и 305 женщин, возрастной диапазон 64–105 лет; средний возраст 82,74 (+-11,66) и 85,23 (+-10,84) года,соответственно) участвовали в этом исследовании. Все испытуемые и их предки поколения бабушек и дедушек родились в Калабрии (южная Италия). Два «порога долголетия», использовалось для определения этих возрастных категорий — 88 лет для мужчин и 91 год для женщин.",
UCP3,rs15763,,Significant,0.029,10.1371/journal.pone.0029650,both,longevity,Italian,genomic,,SNP,,,,,,,,375,223,77.42,64,89,95.09,90,,candidate genes study,,"Рецессивный аллель для rs15763 (UCP3) оказался в значительной степени связан с фенотипом долголетия (p<0.05). Всего 598 человек (293 мужчины и 305 женщин, возрастной диапазон 64–105 лет; средний возраст 82,74 (+-11,66) и 85,23 (+-10,84) года,соответственно) участвовали в этом исследовании. Все испытуемые и их предки поколения бабушек и дедушек родились в Калабрии (южная Италия). Два «порога долголетия», использовалось для определения этих возрастных категорий — 88 лет для мужчин и 91 год для женщин.",
UCP3,UCP2[rs660339]+UCP2[rs659366]+UCP3[rs15763],,Significant,0.046,10.1371/journal.pone.0029650,both,longevity,Italian,genomic,,haplotype,,,,UCP2[T]+UCP2[G]+UCP3[T],,,,375,223,77.42,64,89,95.09,90,,candidate genes study,,"Гаплотип САС, состоящий из минорного аллеля для rs660339 (UCP2), основной аллель для rs659366 (UCP2) и минорный аллель rs15763 (UCP3) был связан с пониженной вероятностью достижения долголетия (P = 0,003), в то время как гаплотип TGT (противоположная комбинация аллелей) действовали в обратном направлении, увеличивая эту вероятность (p = 0,046). Всего 598 человек (293 мужчины и 305 женщин, возрастной диапазон 64–105 лет; средний возраст 82,74 (+-11,66) и 85,23 (+-10,84) года,соответственно) участвовали в этом исследовании. Все испытуемые их предки до поколения бабушек и дедушек родились в Калабрии (южная Италия). Два «порога долголетия», использовалось для определения этих возрастных категорий — 88 лет для мужчин и 91 год для женщин.",
UCP4,rs10498769,,Non-significant,0.761,10.1371/journal.pone.0029650,both,longevity,Italian,genomic,,SNP,,,,,,,,375,223,77.42,64,89,95.09,90,,candidate genes study,,,
UCP4,rs9472817,,Significant,0.001,10.1371/journal.pone.0029650,both,longevity,Italian,genomic,,SNP,,,,,,,,375,223,77.42,64,89,95.09,90,,candidate genes study,,,
UCP5,rs2235800,,Non-significant,0.058,10.1371/journal.pone.0029650,both,longevity,Italian,genomic,,SNP,,,,,,,,375,223,77.42,64,89,95.09,90,,candidate genes study,,,
UCP5,rs5975178,,Non-significant,0.959,10.1371/journal.pone.0029650,both,longevity,Italian,genomic,,SNP,,,,,,,,375,223,77.42,64,89,95.09,90,,candidate genes study,,,
USP2-AS1,rs139137459,,Significant,0.000000027,10.18632/aging.101334,both,increased parental lifespan top 10%,European,genomic,,,,,,,G,,,79767,7182,,,,,87,,GWAS,,,
USP42,rs3764814,,Non-significant,0.166,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,C,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
USP42,rs3764814,,Non-significant,0.031,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,C,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
USP42,rs3764814,,Significant,"5,49 × 10−15",10.1093/gerona/glx027,both,longevity,European,genomic,increased gene expression,SNP,,,,C,T,,,6259,2070,,0,95,,96,119,meta-analysis of GWAS,,,
VEGFA,rs1570360,promoter,Non-significant,0.93,10.1016/j.neurobiolaging.2007.05.003,both,longevity,Italian,genomic,,SNP,1154G>A,,,A,G,34.9,35.5,166,166,,25,65,,85,99,candidate genes study,,,
VEGFA,rs2010963,promoter,Non-significant,0.22,10.1016/j.neurobiolaging.2007.05.003,both,longevity,Italian,genomic,,SNP,-634G>C,,,G,C,61.7,66.6,166,166,,25,65,,85,99,candidate genes study,,,
VEGFA,rs699947+rs13207351+rs1570360+rs2010963,promoter,Significant,0.03,10.1016/j.neurobiolaging.2007.05.003,both,longevity,Italian,genomic,,haplotype,-2578C>A+-1190G>A+-1154G>A+-634G>C,,,A+A+G+G,,10.4,14.9,324,166,,25,84,,85,99,candidate genes study,,"Были проанализированы четыре полиморфизма в промоторной области гена VEGF у 490 неродственных здоровых итальянских субъектов: -2578C/A (rs699947), -1190G/A (rs13207351), -1154G/A (rs1570360) и -634G/C(rs2010963) . Значимые отличия в распределении генотипов наблюдались между молодыми/пожилыми (25-84 года) и долгоживущими (85-99 лет) субъектами (-2578/AA против -2578/CC: OR = 2,08, p = 0,007; -1190/AA против -1190/GG: OR = 2,01, p = 0,011). Гаплотип AAGG встречался чаще у долгоживущих субъектов по сравнению с молодым людьми (14,9% по сравнению с 10,4%, p = 0,03). Эти результаты предполагают, что вариабельность гена VEGF может быть включена в число генетических факторов, влияющих на продолжительность жизни.",
VEGFA,rs699947,promoter,Significant,0.007,10.1016/j.neurobiolaging.2007.05.003,both,longevity,Italian,genomic,,SNP,-2578C>A,,,AA,CC,28.9,17,324,166,,25,84,,85,99,candidate genes study,,"Были проанализированы четыре полиморфизмав промоторной области гена VEGF у 490 неродственных здоровых итальянских субъектов: -2578C/A (rs699947), -1190G/A (rs13207351), -1154G/A (rs1570360) и -634G/C(rs2010963) . Значимые отличия в распределении генотипов наблюдались между молодыми/пожилыми (25-84 года) и долгоживущими (85-99 лет) субъектами (-2578/AA против -2578/CC: OR = 2,08, p = 0,007; -1190/AA против -1190/GG: OR = 2,01, p = 0,011). Гаплотип AAGG встречался чаще у долгоживущих субъектов по сравнению с молодым людьми (14,9% по сравнению с 10,4%, p = 0,03). Эти результаты предполагают, что вариабельность гена VEGF может быть включена в число генетических факторов, влияющих на продолжительность жизни.",
VEGFA,rs13207351,promoter,Significant,0.011,10.1016/j.neurobiolaging.2007.05.003,both,longevity,Italian,genomic,,SNP,-1190G>A,,,AA,GG,28.9,17,324,166,,25,84,,85,99,candidate genes study,,"Были проанализированы четыре полиморфизма в промоторной области гена VEGF у 490 неродственных здоровых итальянских субъектов: -2578C/A (rs699947), -1190G/A (rs13207351), -1154G/A (rs1570360) и -634G/C(rs2010963) . Значимые отличия в распределении генотипов наблюдались между молодыми/пожилыми (25-84 года) и долгоживущими (85-99 лет) субъектами (-2578/AA против -2578/CC: OR = 2,08, p = 0,007; -1190/AA против -1190/GG: OR = 2,01, p = 0,011). Гаплотип AAGG встречался чаще у долгоживущих субъектов по сравнению с молодым людьми (14,9% по сравнению с 10,4%, p = 0,03). Эти результаты предполагают, что вариабельность гена VEGF может быть включена в число генетических факторов, влияющих на продолжительность жизни.",
VEGFA,rs699947,promoter,Significant,0.02,10.1016/j.neurobiolaging.2007.05.003,both,longevity,Italian,genomic,,SNP,-2578C>A,,,A,C,42.5,51.2,166,166,,25,65,,85,99,candidate genes study,,,
VEGFA,rs13207351,promoter,Significant,0.03,10.1016/j.neurobiolaging.2007.05.003,both,longevity,Italian,genomic,,SNP,-1190G>A,,,A,G,43.1,51.5,166,166,,25,65,,85,99,candidate genes study,,,
WRN,rs13251813,intron,Non-significant,0.998,10.1016/j.exger.2012.02.010,both,longevity,German,genomic,,SNP,,,,G,A,,,1140,1613,67.2,,,,95,110,candidate genes study,,,
WRN,rs1801195,"exon, missense",Significant,,10.1002/1096-8628(20001211)95:4<374::AID-AJMG14>3.0.CO;2-4,both,longevity,Finnish,genomic,increased gene expression,SNP,,Leu1074Phe,,G,,57.4,64.5,183,176,0,0,0,100.8,100,106,candidate genes study,,"Анализ продолжительности жизни, ишемической болезни сердца и ишемических инсультах неизменно указывают на то, что аллель T(1074Phe) является факторами риска. При этом аллель G(Leu1074) — защитный аллель I. В этом исследовании используются образцы новорожденных из Финляндии (Турку, Финляндия) (n = 183), долгожителей из Финляндии (n = 176) и новорожденных из Мексики (Гвадалахара, Мексика) (n = 183).",
WRN,rs13251813,intron,Significant,0.00021,10.1016/j.exger.2012.02.010,both,longevity,Danish,genomic,,SNP,,,,A,G,,,800,1200,50.5,46,55,93.2,92.2,93.8,candidate genes study,,,
WRN,WRN[rs11574218]+ERCC1[rs3212961],,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
XRCC1,rs1799782+rs3213403,,Significant,"<0,0001",10.1111/acel.12755,both,longevity,Danish,genomic,,haplotype,,,,,,,,736,1089,50.6,46,55,93.1,92.2,93.8,candidate genes study,,,
YWHAZ,,upstream,Significant,0.0335,10.1111/acel.13362,both,longevity,Ashkenazi Jewish,genomic,,SNP,,,,G,A,97.8,99,551,474,74.44,39,94,98.33,95,110,candidate genes study,,,
ZC3HC1,rs56179563,,Non-significant,0.001,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
ZC3HC1,rs56179563,,Non-significant,0.026,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
ZC3HC1,rs56179563,,Significant,0.0000000056,10.7554/eLife.39856.001,both,increased parental lifespan,European,genomic,,SNP,,,,A,,,,,1012240,,,,71.63,40,117,iGWAS,,,
ZFP69B,rs12568089,,Non-significant,0.81,10.1001/jamanetworkopen.2018.1670,male,longevity,"Chinese, Han",genomic,,SNP,,,,minor,,20,22,773,564,48.7,40,64,101.5,100,,GWAS,,,
ZFP69B,rs12568089,,Significant,"2,7 × 10-6",10.1001/jamanetworkopen.2018.1670,female,longevity,"Chinese, Han",genomic,,SNP,,,,minor,,17,23,1526,1614,48.2,40,64,103.1,100,,GWAS,,,
ZFYVE28,rs57681851,intron,Significant,0.00000183,10.1038/srep21243,both,longevity,Chinese,genomic,,SNP,G>T,,,T,G,13.1,17,2178,2299,48.4,,,102.7,,,GWAS,,,
ZW10,rs61905747,,Non-significant,0.011,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,11262,,,75,,89,,"meta-analysis of GWAS, replication of previous findings",,,
ZW10,rs61905747,,Non-significant,0.097,10.1038/s41467-019-11558-2,both,longevity,European,genomic,,SNP,,,,A,,,,25483,3484,,,75,,98,,"meta-analysis of GWAS, replication of previous findings",,,
ZW10,rs61905747,,Significant,0.0000000055,10.18632/aging.101334,male,increased fathers' lifespan,European,genomic,,,,,,,A,,,,176494,,,,45.35,,,GWAS,,,
